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Critical Developmental Periods
Abstract
Obesity is a costly and growing health concern for the modern world and puts individuals at increased risk
for chronic illnesses. Although obesity is associated with many detrimental peripheral effects, food over
consumption is centrally mediated. The hypothalamus and brainstem regions control homeostatic food
intake, while hedonic food intake is mainly controlled by the central reward system. Palatable foods are
rewarding and over ride the homeostatic system and cause over consumption. Foods high in sugar and
fat acutely activate dopamine neurons in the classical reward pathway consisting of the ventral tegmental
area projecting to the nucleus accumbens and prefrontal cortex. Chronic intake of palatable foods is
associated with neuroadaptations that can lead to behavioral changes and further over consumption.
This dissertation characterizes the behavioral, transcriptional, and circuitry changes in the central
dopamine system after chronic high fat diet and high fat withdrawal in male and female mice. Four
models of diet-induced obesity were examined. Chapters 2 and 3 examined diet induced obesity models
and standard chow intervention in different age groups in order to reveal a developmental period sensitive
to programming effects. We discovered that both age and sex were critical factors in the development
and the reversal of neuroadaptations seen in obesity. Early life nutrition is particularly important to the
developing brain and overnutrition during this time period leads to epigenetic changes that may
contribute to the neuroadaptations that persist after intervention. In chapter 4, we examined exercise as
an intervention to prevent the neuroadaptations and neuroinflammation associated with high fat diet
intake. We discovered that although exercise had a beneficial effect of weight gain, it was not able to
reverse reward dysfunction or neuroinflammation in all cases of high fat intake. It is possible that the
neuroadaptations that occur after high fat consumption contribute to the difficulty individuals have with
weight loss. Understanding how age and sex impact brain and behavior in the high fat withdrawal stage
will have implication for obesity management and interventions. We know now that the brain of an
individual is markedly different than the brain of a lean individual and these differences can predispose
one to overconsumption during dietary intervention. Since both pharmacological and behavioral therapies
are often combined with diet replacement, understanding the brain during this switch and factors that can
raise adherence rates will help the success of therapies in the future.
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ABSTRACT	
  
HIGH FAT DIET AFFECTS THE DOPAMINE REWARD SYSTEM: IMPORTANCE OF
SEX AND CRITICAL DEVELOPMENTAL PERIODS
Jesse Lea Carlin
Teresa M Reyes, Ph.D.

Obesity is a costly and growing health concern for the modern world and puts
individuals at increased risk for chronic illnesses. Although obesity is associated with
many detrimental peripheral effects, food over consumption is centrally mediated. The
hypothalamus and brainstem regions control homeostatic food intake, while hedonic
food intake is mainly controlled by the central reward system. Palatable foods are
rewarding and over ride the homeostatic system and cause over consumption. Foods
high in sugar and fat acutely activate dopamine neurons in the classical reward pathway
consisting of the ventral tegmental area projecting to the nucleus accumbens and
prefrontal cortex. Chronic intake of palatable foods is associated with neuroadaptations
that can lead to behavioral changes and further over consumption. This dissertation
characterizes the behavioral, transcriptional, and circuitry changes in the central
dopamine system after chronic high fat diet and high fat withdrawal in male and female
mice. Four models of diet-induced obesity were examined. Chapters 2 and 3 examined
diet induced obesity models and standard chow intervention in different age groups in
order to reveal a developmental period sensitive to programming effects. We discovered
that both age and sex were critical factors in the development and the reversal of
neuroadaptations seen in obesity. Early life nutrition is particularly important to the
developing brain and overnutrition during this time period leads to epigenetic changes
that may contribute to the neuroadaptations that persist after intervention. In chapter 4,
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we examined exercise as an intervention to prevent the neuroadaptations and
neuroinflammation associated with high fat diet intake. We discovered that although
exercise had a beneficial effect of weight gain, it was not able to reverse reward
dysfunction or neuroinflammation in all cases of high fat intake. It is possible that the
neuroadaptations that occur after high fat consumption contribute to the difficulty
individuals have with weight loss. Understanding how age and sex impact brain and
behavior in the high fat withdrawal stage will have implication for obesity management
and interventions. We know now that the brain of an individual is markedly different than
the brain of a lean individual and these differences can predispose one to
overconsumption during dietary intervention. Since both pharmacological and behavioral
therapies are often combined with diet replacement, understanding the brain during this
switch and factors that can raise adherence rates will help the success of therapies in
the future.	
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CHAPTER	
  1:	
  General	
  Introduction	
  
	
  
The current statistics on obesity in the U.S are staggering with 34.4% of adult
males and 36.1% of adult females considered obese in 2010 (Ogen et al., 2012). The
obesity trend in adolescents is just as dire; 23.9 million children ages 5-19 are
overweight or obese and the epidemic continues to grow (Go et al., 2013). Both genetic
and environmental factors contribute to the development of obesity. Population studies
have revealed specific gene mutations to cause monogenic forms of human obesity
(Farooqi et al., 2005), and monozygotic twin studies reveal adiposity levels to be strongly
heritable (Stunkard et al., 1986; Maes et al., 1997). However, those single gene
mutations are very rare and human genetics are very stable. Therefore, it is unlikely that
the current obesity epidemic is explained by mutations or gene x environment
interactions alone. The most drastic change for humans has occurred in the
environment. The broad availability of energy dense foods and the decrease in daily
activity has most Americans living in an environment that drives obesity and makes
weight loss extremely difficult. The obesogenic environment affects the individual as
early as the fetal stage. Over nutrition or poor nutrition during early life development can
put one on a trajectory toward obesity in adulthood. Body weight and eating patterns
early in life are extremely important in setting the risk for development of obesity and the
ability to lose weight. In fact, it has recently been shown that establishment of obesity at
age 5 predicts obesity at age 18 (Cunningham et al., 2014). Sex is another factor that
plays a role in an individual’s obesity risk. Women tend to have higher rates of obesity
compared to males (Go et al., 2013). Women have higher overall body fat content as
well as additional distribution to the breast, buttocks, and lower body (Martin et al.,
2013). Not only do women have a different physical presentation of obesity, women also
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have different behaviors toward palatable foods that could put them at increased risk for
overconsumption. Women rate food images as more pleasant, they have more negative
feelings in the hunger state, and have a higher fMRI response to food cues compared to
males (Geliebter et al., 2013). In an effort to better treat and/or prevent obesity, an
understanding of how sex and early life experiences interact to affect obesity risk is
required.
Central	
  Acting	
  Interventions	
  for	
  Obesity	
  
	
  
Approaches to the treatment of obesity include dietary intervention, exercising,
pharmacological treatments, and gastric bypass surgery. Success rates at weight loss
vary enormously between individuals and, in most cases, lost weight is gained back.
Although obesity is associated with peripheral effects, such as increased adiposity, high
blood pressure, and inflammation, food consumption is controlled centrally. In fact, many
of the single gene mutations known to cause obesity do so by failing to produce satiety.
The most studied Mendelian inherited obesity genes (leptin, leptin receptor, proopiomelanocortin, melanocortin 3 receptor, melanocortin 4 receptor) lie within the central
leptin-melanocortin signaling pathway of the hypothalamus and result in human obesity
when loss of function occurs from mutation (Montague et al., 1997; Clement et al., 1998;
Farooqi et al., 2007; Krude et al., 1998; Yeo et al., 1998). Looking at obesity as a
central food intake issue is an important direction for the field and has led to the
development of centrally acting drugs to combat adiposity. Clinical drug trials for weight
loss have targeted the brain in order to attempt to decrease food intake. Most
medications prescribed for obesity regulate satiety through an effect on serotonergic,
noradrenergic or dopaminergic receptor systems (Bray et al., 2000, Clapham et al.,
2001). Action on these neurotransmitter systems has led to reduced appetite or hunger
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and, thus decreased food-seeking behavior. Four centrally acting noradrenergic agents
(phentermine, diethylpropion, phendimetrazine, benzphetamine) are currently FDAapproved for management of obesity (Yanovski et al., 2014). These agents reduce
appetite by activation of adrenergic and dopaminergic receptors. However, even in the
most successful trials, high rates of drop out and weight gain occur at follow-up time
points (Ioannides-Demos et al., 2012). There are still many obstacles, including nonCNS effects that make it so difficult to lose weight and need to be overcome during
obesity intervention. Age of onset of obesity is one factor not taken into consideration
when analyzing clinical weight loss trial data. It is true that weight loss becomes more
challenging as one ages, and adults who were obese as children find it even more
difficult to lose weight (Cockrell & Skinner, 2008). Identifying the factors that make
childhood obesity more resistant to weight loss may lead to changes in
pharmacotherapy for this population in the future.
The	
  Obese	
  Brain	
  	
  
	
  
Obesity is associated with excessive overeating and preference for palatable, high-fat
foods even when body energy stores are high (Sclafani, 2001; Gaillard et al.,
2008). There seems to be a mismatch between the caloric needs of the body and what
the brain tells the body to consume. Since the brain controls food intake, much research
has been done to see how the obese brain has changed in comparison to its lean
counterpart. Imaging studies in obese patients have given us insight into the regions
possibly involved in the loss of homeostatic food consumption. Combined evidence
points to regions involved mainly in reward processing, taste, and attention that are
altered in obese patients. Imaging studies in obese patients have detected increased
blood flow to the striatum, the orbitalfrontal cortex, and the insula when viewing pictures
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of highly palatable foods (Rothemond et al., 2007; Scheinle et al., 2009, Sharmueller et
al., 2012). Imaging studies have also revealed diminished functional connectivity
between these regions important for reward evaluation (Stoeckel et al., 2009; Kulleman
et al., 2011). These changes are thought to lead to deficiencies in evaluating food
reward value and contribute to the drive to overeat. In fact, behavioral studies have
shown obese individuals to direct their attention to food related stimuli more so than lean
individuals (Nijs et al., 2010). This shift in attention and preference may also increase the
vulnerability to further over consume food. The shift in attention toward a learned reward
is not specific to obesity in general, but has also been seen to occur in addicted
individuals and drug cues. Obese patients seem to have an increased central response
to food cues, but how does the brain react during actual food consumption?
Interestingly, studies have revealed a decrease in the hedonic response to food intake.
Over weight individuals have reduced activation of the striatum in response to ingesting
a palatable solution (Stice et al., 2010). Although obese individuals seem to react
strongly to food cues, the hedonic response to intake is diminished. Hedonic drive is
mediated by the dopamine reward system and is acutely activated by rewards like
palatable foods, sex, and drugs of abuse. A decrease in dopamine receptors have been
reported in the striatum of obese patients and this has implications for appetite control as
well as other reward behaviors (Wang et al., 2001, Steele et al., 2010). Some, but not
all, differences in the obese brain reverse after individuals lose weight. Imaging studies
have also looked at the post-obese population and have shown insula activation remains
elevated after weight loss (DelParigi et al., 2004). On the other hand, experiments have
also shown normalization of dopamine receptors after bariatric surgery (Steele et al.,
2010). The neurobiological changes that persist after intervention may contribute to the
high failure rates and relapse to unhealthy eating habits. It is important to understand if
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some kinds obesity interventions can reverse or prevent the brain changes seen in
obesity better than other types on intervention.
The previous studies support the theory of reward dysfunction in obesity. Obese
individuals seem to be more sensitive to food cues; however, reward activation is
diminished during food intake. This would suggest that there is an increased drive to
obtain food. However, because patients are less sensitive to the rewarding effects of
food, they would therefore consume more in an effort to obtain sufficient reward levels.
This has been demonstrated in progressive ratio studies where obese individuals give a
higher reinforcing value to food (Epstein et al., 2007; Temple et al., 2008). Future studies
are warranted to see if a higher reinforcing value plus diminished reward activation are
behind the overconsumption of palatable foods in obese individuals and if there are sub
populations of obese patients that may benefit from targeting overconsumption
behaviors.
Obesity	
  Interventions	
  
	
  
Successful weight loss is extremely difficult for the obese population and is
influenced by many factors, such as age of onset and sex. Caloric restriction or “dieting”
is very effective for weight loss, but has proven to be very difficult to adhere to in the
general population. One reason is caloric restriction induces biological changes that
make adherence difficult. The over abundance of highly rewarding, highly palatable
foods makes relapse even easier. Dieting produces changes in appetite, notably an
increase in hunger (Pasman et al., 1997) and persistent thoughts about eating (Green et
al., 2005). Other approaches to the treatment of obesity include, exercise,
pharmacological treatments, and gastric bypass surgery. Pharmacological interventions
cause a moderate loss in body weight and have many negative side effects.
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Pharmaceutical trials focus exclusively on reduction of body mass and normalization of
markers of obesity and do not usually assess the state of mind or drive to eat. Gastric
bypass surgery is a last line of defense treatment for extreme obesity and is very
successful in long-term body weight reduction. Adaptive responses that increase
appetite after weight loss do not seem to occur after weight loss induced by bariatric
surgeries as they do with typical dieting interventions (Berthoud et al., 2012). Bariatric
surgery patients have a diminished desire to eat (Shultes et al., 2010) and exhibit
normalization of dopamine receptor D2 (DR2) levels after surgery (Steele et al., 2010;
Dunn et al., 2010). However, dieting is still the most common way to attempt weight loss
in the obese population. How the dopamine reward system changes after high fat
replacement needs to be studied in order to better understand the behavioral changes
that either promote or hinder adherence to a diet. Characterizing how dopamine circuitry
changes when high fat diet is switched to a low fat diet may help us discover why dieting
is so difficult for obese individuals. Additionally, characterizing important factors, such as
age and sex that impact the response to high fat withdrawal will be important for
analyzing clinical weight loss trial results in the future.
Many factors, such as stress, can make caloric restriction difficult and cause
return to high fat food consumption. High-fat diet removal elicits palatable food cravings
and exposure to foods cues and/or stressful experiences can cause relapse (Nair et al.,
2009). Many kinds of stress, such as physical, psychosocial, and pharmacological
stressors can stimulate palatable food seeking and return to unhealthy eating habits
(Grilo et al., 1989; Ghitza et al., 2006; Nair et al., 2011). This is comparable to what is
seen in drug addiction. After extinction of the drug reward, different types of stressors
can reinstate drug seeking (Hyman et al., 2006). Many researchers have noted
similarities between drug withdrawal and palatable food removal. It has even been
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documented that removal of a high fat/high sugar diet causes withdrawal symptoms
similar to opiate withdrawal (Avena et al., 2008a). The mechanisms behind stressinduced reinstatement of palatable food seeking are still being examined. Nair et al.,
(2011) have discovered that blocking dopamine receptors in the prefrontal cortex can
inhibit stress-induced reinstatement of food seeking. Ghitza et al. (2006) discovered a
similar role for CFR1 receptors in the amygdala. By blocking activation of CRF1, food
seeking is not reinstated by a pharmacological stressor. Food cues also have the ability,
like stress, to trigger relapse to palatable food seeking. The reinstatement by food cues
is likely to be mediated by additional mechanisms and brain regions than reinstatement
by stressors. Priming with drugs that increase dopamine, such as cocaine or
amphetamine works to reinstate palatable food seeking as well as priming with food or a
cue that predicts palatable food (Ghitza et al., 2007; Keiflin et al., 2008; Odum &
Shahan, 2004). One factor to consider when interpreting these results is many of these
studies were performed in lean rodent models. There are many neurobiological changes
that occur after diet induced obesity and research on palatable food reinstatement after
acute high fat withdrawal or long term high fat withdrawal need to be examined.
We have seen that stressors can be a trigger to cause increased intake of
palatable foods. However, can removal of the palatable food be a stressor in itself?
Little is known about the consumption of palatable foods following withdrawal from
chronic HFD and the reward-relevant neurobehavioral changes that may occur. We
know that food restriction in lean animals causes stress and increases administration of
drugs of abuse like cocaine and amphetamine (Carroll and Meisch, 1980; Stuber et al.,
2002). Other studies have confirmed a strong relationship with food restriction and the
increase in the rewarding properties of drugs such as amphetamine (Takahashi et al.,
1978), heroin (Oei et al., 1980) and cocaine (Carroll et al., 1981). It is unlikely however,
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that food restriction in lean animals is similar to withdrawal of a high fat diet in obese
animals, given what is known about the differences in reward relevant circuitry in the
brains of lean and obese animals. High fat diet withdrawal has also been shown to
increase responding for sucrose in obesity prone rats (Pickering et al., 2009). This
suggests that the propensity to relapse may be stronger in some individuals than others.
Further, we know from Zorilla lab and colleagues (Cottone et al., 2008a; 2008b; 2009)
that intermittent access to a high fat diet causes anxiety behavior and increases
responding to palatable food reward in rodents. Others have found that an acute
withdrawal (only 24 hours) causes anxiety behavior in an open field test (Teegarden et
al., 2007). Withdrawal from a high fat diet can increase basal corticosterone levels
(Sharma et al., 2013) but has no effect on stress induced cort levels (Pickering et al.,
2009) and changes in CRF levels in the amygdala (Teegarden et al., 2007). Removal of
other rewarding substances, such as sucrose, can also be a stressor and cause an
increase in anxiety-like behaviors (Avena et al., 2008b). Body weight loss goes hand in
hand with high fat diet removal. It is possible that body weight loss can cause an
activation of the body’s stress system as well (Bailey et al., 2004). Looking at a time
point where high adiposity is still present but the diet has been withdrawn can be a
helpful way to control for the stress of high body weight loss. Although changes in CRF1
levels were not seen in the amygdala after high fat withdrawal in a diet induced obese
model (Sharma et al., 2013), it is still possible that activation of stress circuitry after high
fat diet removal can contribute to reward behavior observed after high fat diet removal.

Homeostatic	
  Regulation	
  of	
  Food	
  Intake	
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The hypothalamic and mesolimbic dopamine systems participate in the
integration and control of food intake. Dopamine acting in the hypothalamus is important
for basal food intake and influences feeding frequency and volume (Meguid, et al.,
2000). For example, dopamine is released in the lateral hypothalamic area in response
to feeding and normalizes after meal termination (Yang et al., 1996). Dopamine release
in the hypothalamus leads to activation of neuropeptides involved in both food intake
stimulation (e.g. melanin concentrating hormone (MCH), neuropeptide Y (NPY), Agouti
related peptide (AgRP), galanin, and orexin) and food intake inhibition (e.g., amelanocyte-stimulating hormone (MSH), cocaine and amphetamine-regulated transcript
(CART), and corticotrophin-releasing factor (CRF)) depending on the complex metabolic
conditions occurring in the body. The basic circuitry of the hypothalamus and brain stem
is under multiple points of regulation and has the ability to sense macronutrients,
hormones, gut signals, and energy stores to control energy metabolism and food intake
behavior in order to maintain homeostasis. There are two main sources of circulating
nutrients: food intake, and production of glucose and lipids by the liver. Increased
availability of macronutrients such as glucose and lipids activates sensing pathways in
the brain, either directly through metabolic signals (e.g., fatty acids), or indirectly,
through stimulation of insulin and leptin biosynthesis and secretion. Leptin is
synthesized by white adipose tissue, and its level increases in proportion to fat mass.
Among its many actions, high levels of leptin potently suppress food intake and stimulate
metabolic processes to dissipate excessive energy stores. The activation of brain
efferent pathways in turn suppresses food intake and hepatic output of glucose and
lipids. (Schwartz et al., 1996; Obici et al., 2002; Loftus et al. 2000; and reviewed in Lam
et al., 2005). In obesity, however, this feeding circuit is altered and palatable foods are
consumed after energy requirements are met. It has been confirmed that
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overconsumption of palatable foods and obesity can eliminate the ability of
intracerebroventricular (icv) administration of insulin to reduce food intake (Posey et al.,
2009). The hypothalamus also becomes insensitive to leptin signals and there is a
decrease in AGRP signaling to the mesolimbic pathway (Varela & Horvath, 2012). How
the high fat diet impairs the negative feedback system is unclear. One hypothesis is that
high fat diet causes neuroinflammation in the hypothalamus that impairs insulin
sensitivity and the signal to stop eating (DeSouza et al., 2005). Palatable foods that drive
obesity are often consumed after energy needs are met. It is thought that other brain
regions, such as the mesolimbic dopamine area, control the intake of energy dense
foods and this is one area pharmacotherapy can target in obese patients in the future.
The	
  Dopamine	
  Reward	
  Pathway	
  
	
  
The modern environment is characterized by the availability of highly palatable,
energy dense foods as well as powerful food cues. High fat and high sugar foods
activate the mesolimbic dopamine system to drive food intake even after energy
requirements have already been met (Berthoud et al., 2007; Stratford & Kelly, 1999).
Dopamine neurons in the mesolimbic pathway originate in the ventral tegmental area
and have been implicated in the reinforcing and motivational aspects of food intake
(Ikemoto & Panksep, 1996; Brennan et al., 2001; Ishiwari et al., 2004). Dopamine
neurons are found in the VTA and project to the NAC to form the classic reward pathway
studied in drug addiction. The dopamine neurons in the VTA also innervate several
regions of the prefrontal cortex (PFC), central amygdala, basolateral amygdala (BLA)
and hippocampus. All the reward related regions are inter-connected and synapse back
on each other in complex ways. The VTA–NAc circuit is crucial for the recognition and
consumption of rewards (Koob et al., 2008). DA in these regions is synthesized from
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tyrosine, through the conversion of l-tyrosine to l-dihydroxyphenylalanine (l-DOPA) by
the rate-limiting enzyme tyrosine hydroxylase (TH). DOPA is subsequently converted to
DA by the enzyme l-aromatic amino acid decarboxylase. DA is then transported from the
cytoplasm to storage vesicles via the synaptic vesicular monoamine transporter (VMAT).
After DA is released into the synapse, the plasma membrane DA transporter (DAT) can
transports DA in and out of the terminal depending the concentration gradient and other
factors (Amara and Kuhar, 1993). The conversion of DA to HVA occurs extra-neuronally
by the enzyme catechol-O-methyltransferase (COMT) (Feldman et al., 1997).
Receptors that translate dopamine release into a signal are found in projecting
regions NAc, PFC, amygdala, and other regions. DA receptors are classified into two
subfamilies, D1- and D2-like receptors (Brown and Makman, 1972; Kebabian and Calne,
1979), based on their pharmacological and functional properties. The D1-like receptors
are dopamine receptor D1 (DR1) and D5 (DR5) (Sunahara et al., 1990 and Sunahara et
al., 1991), whereas the D2-like receptors are dopamine receptor D2 (DR2), D3 (DR3),
and D4 (DR4) (Sokoloff et al., 1990) based on their respective gene sequences.
Dopamine receptors D1 and D5 are coupled to adenylyl cyclase through G protein Gs,
while dopamine D2, D3, and D4 receptors inhibit adenylyl cyclase by coupling to Gi/o.
The D1-like and D2-like receptors are both present in all dopamine-containing regions of
the rodent brain (Meador-Woodruff, 1994). Higher levels of DR2 mRNA are detected in
the substantia nigra and VTA. DR3 display a much more restricted pattern of distribution
and are mainly found in limbic regions (Levesque et al., 1992). D1R knock out (KO)
mice show normal appearance and no obvious neurological defects, but exhibit growth
retardation and low survival after weaning (Drago et al., 1994). Midbrain levels of
dopamine are elevated in D1R KO mice, suggesting a compensatory increase in
dopamine synthesis and/or release following inactivation of the receptor (El-Ghundi et
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al., 1998). D2R KO mice exhibit significantly lower levels of locomotor activity than
controls (Palmer et al., 2003) but total dopamine levels are not altered in D2R KO mice,
suggesting D2R does not exert strong tonic control of dopamine activity (Benoit-Marand
et al., 2001). On the post-synaptic side, the dopamine signal is transduced after
activation of DR1 by the actions of Protein phosphatase 1 regulatory subunit 1B
(DARPP-32). DARPP-32 is phosphorylated by cAMP-dependent protein kinase (PKA)
and cyclin-dependent kinase 5 (Cdk5) on threonine residues, thr34 and thr75, resulting
in inhibition of protein phosphatase-1. Additionally, DARPP32 dephosphorylation at
serine residue 97 has also been observed and this modification appears to be important
in both addiction and food intake behaviors (Stipanovich et al., 2008). Dopamine
signaling elicited by drugs of abuse or palatable foods also increases the activity of
ΔFOSB, cyclic AMP-responsive element binding protein (CREB), and cyclin-dependent
kinase 5 (CDK5) pathways in medium spiny neurons (Joressen et al., 2007; Carlezon et
al., 1998; Bibb et al., 2001). These proteins play a prominent role in the synaptic
plasticity seen after chronic drug intake and could possibly regulate plasticity after other
rewarding substances, such as palatable food.
Hedonic	
  Eating	
  
	
  
Energy dense foods are widely available and there are many aspects of modern
society tempting us to eat. Wanting’ and ‘liking’ reactions are generated by neural
systems after the intake of sweet, palatable foods. Drive to eat palatable foods is still
present even when the individual is sated. For example, in humans, pleasure ratings for
chocolate never hit zero even after consumption of two whole bars (Lemmons et al.,
2009; Small et al, 2001). The “always room for dessert” phenomenon is also seen in
mice who can consume 10% of their body weight in milk and have their drive for
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“sweetness” never completely diminish (Berridge et al., 1991). This suggests the ability
of certain foods to override homeostatic stop signals and drive over consumption. The
“wanting” and “liking” of palatable foods is regulated by dopamine and opioid
neurotransmitters in the reward regions. Palatable food activates “hedonic hot spots” in
the reward system, specifically the nucleus accumbens, ventral pallidum, amygdala,
obitofrontal cortex, anterior cingulate cortex and the anterior insula cortex (de Araujo et
al., 2003; Aldridge & Berridge, 2010; Kringelbach et al., 2004; Small et al., 2003).
Consumption of palatable foods increases dopamine concentrations in the NAc
(Bassarero & DiChiara, 1999). Dopamine in this region is thought to coordinate the
action of food intake, increase arousal, and conditioned learning in order to obtain the
food reward. Increases in dopamine, as seen in dopamine transporter (DAT) knockout
mice, produce elevated “wanting” for sweet foods (Pencina et al., 2003). Palatable food
is a powerful motivating force. Rats prefer palatable solutions to cocaine infusions
(Lenior et al., 2007), and will voluntarily expose themselves to a noxious environment or
pain to obtain high fat food over standard chow (Cabanac and Johnson, 1983; Foo and
Mason, 2005). In fact, DA is necessary for the motivation to consume food (Ungerstedt ,
1971; Zhou & Palmiter, 1995) and DA-deficient mice from tyrosine hydroxylase gene
knockout are hypophagic and eventually die of starvation unless DA is restored to the
striatum (Szczypka et al., 2001). Dopamine also controls food choice. Dopamine
agonists have been shown to enhance preference for and the motivation to obtain fatty
foods in rodents (Thanos et al., 2011, Cooper et al., 2006). These taken together show
that palatable foods activate the dopamine reward system acutely and cause
overconsumption of calories. How exactly palatable food elicits the release of dopamine
is currently unclear. It has been demonstrated, however, that the reward effect is
independent of taste receptor activation (Ferriera et al., 2012; De Araujo et al., 2008).
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Further investigation is needed to see what role post-ingestive factors, such as fat
sensing in the gut, have in reward signaling in the brain.
Interestingly, mutant mice lacking dopamine are still able register the hedonic
impact and show preferences, and learning to work for a palatable sweet reward. This
suggests other neurotransmitters have a role in maintaining hedonic intake of food. In
fact, a number of investigators found opioid or cannabinoid receptor activation in the
nucleus accumbens to stimulate appetite by enhancing the ‘liking’ for the perceived
palatability of food (Bodnar et al., 2005; Cooper, 2004; Kelly et al., 2002; Zhang &
Kelley, 2000). Opioids in the nucleus accumbens shell are involved with the “wanting”
aspect of palatable food intake through the modulating effect they have on dopamine
release. Activation of mu opioid receptors indirectly dis-inhibit dopamine neurons and
thereby increase dopamine release. For example, DAMGO, a mu-opioid receptor
agonist, more than doubled the amount of food intake when administered centrally to
rats (Pencina & Berridge, 2005). Moreover, anandamide, an endocannabinoid that likely
acts in the brain by stimulating the CB1 type of cannabinoid receptor, has been shown to
act in the nucleus accumbens to magnify the impact of sucrose taste (Mahler et al.,
2007). There has also been evidence for additional hedonic neurotransmitters acting in
the nucleus accumbens to enhance “liking” of palatable foods. The ventral
pallidum/nucleus accumbens region receives orexin inputs from the hypothalamus
(Nixon & Smale, 2007) and orexin in this region can enhance ‘liking’ for sweet rewards
(Harris et al., 2005). While more studies are needed, it is possible that dopamine
dysfunction in the reward system seen in obesity can allow these other
neurotransmitters to have a larger role and promote over consumption of palatable
foods.
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Neuroadaptations	
  in	
  DA	
  system	
  after	
  Chronic	
  HFD	
  
	
  
Research in both human and animals suggests that long-term intake of palatable
foods leads to neuroadaptations in the dopamine reward system that could have
implications for obesity treatments and other reward behaviors. Several lines of evidence
support the hypothesis of dysregulated dopamine function in obesity. Chronic
consumption of a high fat diet is associated with a state of reward hypofunction and
imaging studies reveal blunted activation of brain reward regions during consumption of
palatable foods in obese individuals (Stice et al., 2008). Other human studies have
shown a down regulation of dopamine D2 receptor in obese individuals (Wang et al.,
2001). This is consistent with obesity being overrepresented in Taq1AA1 allele carriers
that affects dopamine D2 receptor (DR2) expression (Blum et al., 1996, Nobel et al.,
1991). Down regulation of DR2 could potentially be involved in the increased craving
and increased reward seeking that is associated with the obese population (Blum et al.,
2008; Downs et al., 2009). Down regulation of DR2 has previously been associated with
many other disorders that are involved with dysregulation of motivation such as
addiction, and attention deficit hyperactivity disorder (Volkow et al., 2011a; Volkow et al.,
2011b).
Obesity prone rats have shown increases in extracellular dopamine in the
striatum (Narayanaswami et al., 2005). However, when animals become obese we see a
decrease in dopaminergic tone. Animal models of diet-induced obesity (DIO) exhibit
lower basal extracellular dopamine levels in the nucleus accumbens (NAc) and the
ventral tegmental area (VTA) (Geiger et al., 2007; Geiger et al., 2009; Cone et al., 2010;
Rada et al., 2010). Diet induced obesity models have lower dopamine turnover (Davis et
al., 2008), decreased dopamine release (York et al. 2010), and reduces DA clearance
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(Speed et al., 2011) compared to standard chow controls in the nucleus accumbens.
Genes involved in dopamine uptake and metabolism in addition to dopamine receptors
DR1 and DR2 have been reported to decrease expression in obese rodent models (Alsio
et al., 2010, Huang et al., 2005). Protein levels of both DAT and DR2 protein levels are
also diminished after high fat diet intake (Huang et al., 2006; South & Huang, 2008;
Johnson & Kenny, 2010). Decreases in sucrose preference (Vucetic et al., 2012, Carlin
et al., 2013), a decrease in response for a sucrose pellet (Davis et al., 2008) and a
decrease response to food reward (Corwin et al., 2011; Cottone et al., 2008; Johnson
and Kenny, 2010) are associated with the dopaminergic protein changes after high fat
intake. Changes in DR2 expression may impact the animal’s willingness to work for a
goal (Trifilieff et al., 2013) and an animal’s sensitivity to dopamine agonists. For
example, rats eating high fat chow are more sensitive to quinpirole-induced yawning (D2
and D3 receptor-mediated; Baladi and France, 2010).
Neuroadaptations	
  in	
  Leptin,	
  Insulin,	
  Ghrelin	
  in	
  the	
  VTA	
  
	
  
The previous body of literature supports altered dopamine function in obesity and
suggests a decreased sensitivity to reward in the obese population. Whether the high fat
diet is directly affecting dopamine metabolism and release at the molecular level or other
adjacent neurotransmitter systems are indirectly changing VTA activity is currently
unclear. It is possible that hormones involved with energy homeostasis may play a role
in natural reward intake and changes in signaling may disrupt dopamine and lead to
hedonic overeating. It is known that insulin, leptin, and ghrelin can decrease food reward
behaviors and modulate the function of neurotransmitter systems that mediate food
reward. Insulin receptors are expressed in brain regions that are rich in DA neurons and
studies have shown co-expression of insulin receptor with tyrosine hydroxylase
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(Figlewicz et al., 2003). This suggests an interaction between energy sensing and DA
systems occurring in the reward regions. Manipulations of insulin concentrations
significantly affect DA synthesis, turnover, and signaling in reward regions (Kwok and
Juorio, 1986; Lim et al., 1994; Lozovsky et al., 1981; Saller, 1984). For example, acute
injection of insulin into the brain enhances expression and activity of dopamine
transporter (DAT) (Carvelli et al., 2002; Figlewicz et al., 1994). High fat diet consumption
causes both peripheral and central insulin resistance over time. Because insulin
regulates DA systems, it is likely that decreases in insulin signaling could contribute to
the changes seen in dopamine circuitry and reward behaviors in obesity (Daws et al.,
2011; Niswender et al., 2011). Leptin levels are associated with total adipose fat stores
and may directly or indirectly regulate dopamine dysfunction in obesity. Leptin receptors
are also found in the VTA and are downregulated in DIO animals (Figlewicz et al., 2003;
Fulton et al., 2006; Blendy et al., 2005). Leptin has been shown to modulate response
for rewarding brain stimulation, and modulate conditioning for high fat food (Fulton et al.,
2000 and Fulton et al., 2004). Leptin knockout mice (ob/ob mice) have a significant
impairment of DA release and tyrosine hydroxylase capacity in the NAc (Fulton et al.,
2006).
Ghrelin is a gut-derived hormone that is associated with food-deprivation and
ghrelin receptors are also distributed in the ventral tegmental area and co-express with
tyrosine hydroxylase (Mitchell et al., 2001). Ghrelin is involved in appetitive actions and
the food seeking response (Naleid et al., 2005) possibly through the action of increasing
VTA action potentials and the release of dopamine in the nucleus accumbens (Abizaid et
al., 2006; Abizaid, 2009). It is thought that ghrelin signaling is altered in obese
individuals and affects dopamine dependent behaviors such as novelty seeking (Savage
et al., 2014) and high fat/high sugar intake (Menzie et al., 2013). One common
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downstream signaling mechanism in the VTA for these energy related hormones is
PI3Kinase. Studies have identified that insulin and leptin increase PI3kinase activity in
the VTA (Figlewicz et al., 2007) and increase JAK-STAT phosphorylation, which is
necessary for the decrease in feeding response (Morton et al., 2009). One potential
cellular target for PI3Kinase is the DAT. It has been shown that insulin regulates the
expression and activity of DAT through PI3Kinase (Garcia et al., 2005; Vaughan et al.,
1997) and diabetic models lacking insulin show DAT deficits (Figlewicz et al., 1994;
Sevak et al., 2008). This implies that insulin resistance in obesity may alter DAT
expression and activity and therefore alter DA signaling and reward seeking behavior.
Energy related hormones are perfectly poised to regulate reward behavior and palatable
food intake. If overweight individuals are less sensitive to homeostatic signals and
therefore less sensitive to natural rewards they may consume more in an effort to obtain
a larger positive effect. This is similar to the phenomenon of “tolerance” in addicted
individuals. Moreover, altered sensitivity to natural rewards may also mean altered
sensitivity to drugs of abuse that activate the same reward pathways.
The	
  Neurobiological	
  Overlaps	
  of	
  Addiction	
  and	
  Obesity	
  Pathways	
  
	
  
Dopamine is the key neurotransmitter involved in drug abuse as well as food
intake. It is important to understand factors, such as obesity, that might alter sensitivity to
the behavioral effects of drugs acting directly or indirectly at DA receptors. The repeated
stimulation of dopamine reward pathways leads to adaptations in neurotransmitters and
reward circuitry that may lead to increases in compulsive behaviors affecting both food
and drug intake (Volkow & Li, 2004). Human studies reveal that obese individuals
display decreased propensity to use recreational drugs and a decreased prevalence of
substance abuse disorders (Simon et al., 2006; Warren et al., 2006; Bluml et al., 2012).
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Additionally, obese individuals have been shown to self-administer less nicotine and
demonstrated diminished hedonic drive toward nicotine cigarettes than their lean
counterparts (Blendy et al., 2005). In one demographic study being “obese” or extremely
obese” has been associated with an increase risk of alcohol abuse disorder as well as
other mood and anxiety disorders (Petry et al., 2008). Research in both fields confirms
the mechanisms behind addiction and overconsumption of palatable food converge on
the same molecular targets in the reward system. One neuroadaptation found in both
obesity and addiction is the decreased expression of DR2. Positron emission
tomography has revealed decreased DR2 in the striatum of addicted individuals that
persists well after drug withdrawal (reviewed in Volkow et al., 2009). This finding has
also been replicated in preclinical rodent studies given chronic exposure to drugs of
abuse (Thanos et al., 2007; Nader et al., 2006; Volkow et al., 2001). Down regulation of
both DR2 and DR1 expressing neurons in the striatum that mediate the direct striatal
pathway enhances the sensitivity to drugs of abuse (Fergusen et al., 2010; Hideka et al.,
2010). Dysregulated dopamine signaling in this region is likely to contribute to the
compulsive and impulsive drug intake seen in addiction (Goldstein et al., 2002).
High impulsivity may underlie the inability of obese individuals to resist excessive
eating. Both addicted and obese individuals show impairment in PFC and OFC regions
of the brain that control reward and impulsivity (Volkow et al., 2001; Volkow et al., 1993;
Volkow et al., 2008). Moreover, decreased D2R striatal expression and signaling has
been detected among obese individuals (Geiger et al. 2009; Wang et al., 2001, de
Weijer et al. 2012) and in rodents given a high fat diet (Johnson & Kenny, 2010). Other
studies have shown overeating palatable foods can produce behavioral and
neurochemical signs that resemble dependence in laboratory animal models such as
compulsivity, adaptation, and sensitization to food (Avena et al., 2008, Corwin et al.,
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2011 and Volkow et al., 2011c). When rewarding substances target the same
downstream signaling mechanisms they have the ability to cross sensitize or cause
tolerance towards one another. For example, eating high fat chow increases sensitivity
of drugs acting at both D3 and D2 receptors (Baladi et al., 201, Corwin et al., 2011).
High fat diet intake also leads to increased sensitivity to cocaine (Baladi et al., 2012;
Shumsky et al., 1997) and methamphetamine (McGuire et al., 2011).
Addictive drugs act on known receptors to increase dopamine release or
dopamine levels in the nucleus accumbens. It is not yet fully elucidated how palatable
foods increase dopamine in nucleus accumbens, but there are some downstream
molecular targets that are affected in both palatable food consumption and addiction that
could give us some hints. Dopamine signaling in the accumbens modulates the activity
of ΔFOSB, cyclic AMP-responsive element binding protein (CREB), DARPP32 and
CDK5 signaling pathways in medium spiny neurons, and influences the rewarding
properties of both food and addictive drugs (Kenny, 2011). One example of this is
ΔFOSB. ΔFOSB is increased in the striatum of rodents given a high fat or high sucrose
diet and is associated with the motivation to obtain palatable food (Christiansen et al.,
2008; Teegarden & Bale, 2007). Cocaine and other drugs of abuse increase the
expression of ΔFOSB throughout the striatum, more specifically in the dopamine
receptor D1 and dynorphin-expressing medium spiny neurons in the direct pathway
(Muller et al., 2005). The overlap of addiction and food intake pathways can also be
seen with peptides involved in homeostatic feeding and is reviewed extensively in
(Volkow et al., 2013). Orexigenic peptides ghrelin, orexin, melanocortin, and
neuropeptide Y are found to affect reward regions and modulate reward behavior such
as alcohol intake (Leggio et al., 2011; Gilpin et al., 2012), conditioned reward learning for
cocaine (James et al., 2011) and morphine self administration and conditioned place
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preference (Harris et al., 2007; Proudnikov et al., 2008 ). Anorexigenic peptides also act
in reward regions of the VTA, NAc, and amygdala to modulate reward behavior.
Glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), peptide YY (PYY), galanin,
cocaine-and amphetamine-regulated transcript (CART), corticotropin-releasing hormone
(CRH), and oxytocin have been shown to affect behaviors towards amphetamines
(Erreger et al., 2012; Vaccarino et al., 1994; Crawley et al., 1985; Beinfeld et al., 2003),
alcohol (Barson et al., 2011; Le Strat et al., 2012), and cocaine (Cippitelli et al., 2012;
Upadhya et al., 2012). The regulation of homeostatic food intake, palatable foods, and
other natural rewards all converge on the dopamine neurons in the ventral tegmental
area. The dopamine reward system is hijacked by unnatural rewards (drugs of abuse)
and neuroadaptations that occur in addiction to drugs of abuse are similar to those seen
in obesity. The combined results suggest that both obese and drug-addicted individuals
suffer from overlapping impairments in dopaminergic pathways that lead to
overconsumption and impulsivity.
Another neurotransmitter system that is involved in both palatable food intake
and reward is the central opioid system. Both neurotransmitter systems are activated in
concert and are dependent on each other. For example, opioids increases intake of
palatable foods in sated animals and this depends on the expression of dopamine
receptor D2 (Hayward et al., 2007). Further, opioid receptors are distributed throughout
regions important for food and drug reward (Olszewski, et al., 2007) and mu opioid
receptor activation increases dopamine release (Bontempi et al., 1997; Horner et al.,
2012; Steiner et al., 1999). Mu opioid receptor (MOR) expression is altered by high fat
diet at different time periods. Chronic high fat diet in adulthood decreases MOR
expression (Vucetic et al., 2011; Ong et al., 2013; Blendy et al., 2005). Conversely, high
fat diet during pregnancy increases expression of MOR in reward regions of the offspring
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(Vucetic et al., 2010; Ong et al., 2011; Grissom et al., 2013; Carlin et al., 2013b). It is
yet to be discovered how high fat diet regulated the expression of MOR, however,
studies out of our lab point to possible recruitment of epigenetic markers (Vucetic et al
2010; Grissom et al., 2013). It seems that changes in opioid signaling could play a role in
the reward dysfunction of obesity either by amplifying the effects of dopamine
dysregulation or altering the palatability of food. Endogenous opioids code the
palatability of food in the brain and neuroadaptations in this system could have
implications in overconsumption of food in obesity. If MOR is down regulated in obesity,
it could be a homeostatic mechanism to reduce the drive to eat and the dopamine
dysfunction just happens to over ride that effect. Conversely, down regulation of MOR
can add to the hypo reward seen in obesity which could further drive palatable food
intake in order to normalize reward levels in the brain. Further experiments are needed
to answer how endogenous opioids are altered alongside dopamine and if these
neuroadaptations reverse after standard chow replacement.
Sex	
  Differences	
  in	
  the	
  Dopamine	
  Reward	
  System	
  and	
  Obesity	
  
	
  
Sex differences are found in both the central dopamine system and in the
presentation of obesity. The overlapping dopamine pathways seen in obesity and drug
addiction are also highly influenced by sex and sex hormones. We see that women are
more susceptible to developing eating disorders and obesity compared to men (Hoek et
al., 2003; Berghöfer et al., 2008; Keel et al., 2007). Women also have lower success
rates at dieting then men. This could be due to their more intense interaction with
palatable foods. Women tend to show increased brain activity in the prefrontal cortex
and OFC after ingestion of palatable liquids compared to men and this has been
associated with decreased inhibitory control when it comes to food intake (Del Parigi et
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al., 2002). This difference in inhibitory control could underlie the lower success rates
when losing weight with dieting (Appelhans et al., 2011). Studies have shown sex
hormones directly influence food intake, body weight, and fat distribution. Preclinical
studies in rodents have shown an opposite effect of what we see in humans. Male mice
are more vulnerable to HFD-induced weight gain (Martin et al., 2007) and this sex
difference can be attributed to the positive metabolic effects of estrogen in females
(Heine et al., 2000). Further studies are needed to see why this protective effect is
absent in the human population, which is clearly a more complicated issue than what is
observed in rodent. Sex hormones also have an effect in the brain and can modulate
central leptin signaling. Female rats are more sensitive to the anorexic effects of leptin
than male rats (Clegg et al., 2003). Given the gender differences in obesity and the high
rate of failure in weight loss therapeutics, examining overconsumption and dopamine
circuitry in females would be an extremely important contribution to the field.
Sex differences are also present in the incidence rates of psychiatric disorders.
For example, major depression, which involves the disruption in the dopamine reward
system, is twice as common in females then in males (Marcus et al., 2005). Women
also experience addiction to drugs of abuse differently than men. Female drug users
tend to be more sensitive to cocaine-conditioned stimuli and report more intense
cravings (Elman et al., 2001; Robbins et al., 1999). Sex differences persist when
examining the central reward system in rodents. Female rats develop cocaine CPP after
fewer conditioning sessions and with lower doses compared to males (Parylak et al.,
2008). This suggests that females are more sensitive to the rewarding effects of drugs
acting the dopamine system and this could be behind the sex differences seen in
addiction incidence rates (Zakharova et al., 2009). Estradiol has the ability to modulate
dopamine at the molecular level. In fact, estradiol rapidly increases dopamine efflux in
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the nucleus accumbens (Becker, 1999) and in cell culture (Alyea et al., 2008). Female
gonadal steroids inhibit DA neurotransmitter turnover in prefrontal regions and ventral
tegmental area (Handa et al., 1997) and regulate the reuptake of DA in regions involved
in satiety and motivation depending on estrus cycle (Thompson et al., 1997).
Experiments looking at sex differences have added richness to the addiction field.
Studies in the field of neuroscience of obesity often do not include females in the
analysis. This is potentially excluding 50% of the population that will receive the
pharmacotherapies that come out of these studies. Examining how neuroadaptations to
chronic high fat diet and their reversibility are influenced by sex is an important step in
developing proper drug targets to combat obesity.

Consequences	
  of	
  Early	
  Life	
  Nutrition	
  on	
  Obesity	
  and	
  Brain	
  Development	
  
	
  
Age is another critical factor to consider when studying obesity and the brain.
There are important times during development in which the brain seems to be
particularly sensitive to the environment. Changes in the environment during critical time
periods can alter the trajectory of development and affect the health of the adult in the
future. We see this sensitive time period come into play when setting adulthood body
weight. Obese children are more likely to become obese adults (Serdula et al., 1993)
and obese children will find it more difficult to lose weight when they become adults
(Cockrell-Skinner et al., 2010). It seems this critical time period is set before age five in
humans. A recent study showed that obesity by age 5 could predict future obesity at age
18 (Cunningham et al., 2014). At first glance, childhood obesity is similar to adult
obesity in that it is caused by increase food intake, sedentary lifestyle, complex
interaction between over 250 obesity-associated genes and early life factors (Rankinen
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et al., 2002). However, childhood obesity can be more detrimental to future health and
weight loss goals in the future.
Both genetic makeup and early-life environmental factors play a significant role
determining body weight and adiposity. The early life environment begins in utero and is
affected by maternal nutrition and health during pregnancy. It seems that the risk for
obesity can begin at conception and depend on the in utero nutritional and hormonal
environment. Both maternal overnutrition and maternal under nutrition has been
associated with obesity later in life (Whitiker & Dietz, 1998; Boney et al., 2005; Ravelli et
al., 1976). The in utero environment has the ability to program adulthood appetite,
neuroendocrine functioning, and metabolism. Modeling maternal obesity in animals has
yielded a wealth of data on altered genes and behaviors that can contribute to behaviors
in offspring. The brain is developing throughout gestation; the dopamine reward system
circuitry and its control on food intake are not spared from maternal programming.
Maternal high fat diet alters hypothalamic neurons that express appetite-regulating
neuropeptides, leading to hyperphagia (Plagemann et al., 1999; Muhlhausler et al.,
2006) and exacerbated preference for fatty foods in offspring (Vucetic et al., 2010; Bayol
et al., 2007). Naef and colleagues (2013a) have shown offspring exposed to high fat diet
in utero demonstrate reduced anticipatory response to a food reward. Additionally, these
offspring had increased responding for high fat food (Naef et al., 2011). It seems
maternal high-fat diet not only increases offspring’s risk for obesity, but it also leads to
alterations in dopaminergic circuitry. Our lab documented changes in DAT, dopamine
receptors DR1 and DR2, DARPP-32, and TH, and mu opioid receptor (MOR) mRNA in
reward regions in offspring from a high fat fed dam. These mRNA changes were
associated with alterations in DNA methylation at the promoter region of these genes
(Vucetic et al., 2010). This is evidence for possible epigenetic mechanisms linking
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maternal diet during pregnancy with offspring behavior. These studies show that
gestation is a particularly sensitive time period in programming feeding behavior and
dopamine circuitry. The brain continues to develop after gestation in humans and even
more so in rodents. Another study done by Naef, et al (2010) targeted the last week of
gestation as well as the 3 week weaning period. Maternal high fat diet during the later
gestation period and weaning led to offspring with weaker amphetamine-induced
extracellular NAc DA levels, higher NAc DAT activity, and reduced D2 receptor mRNA in
the VTA. This study demonstrates that post-natal time periods are also sensitive to
nutritional insults. The early post-natal period is very important for brain development
and sensitive to many types of environmental insults, not just nutrition, which can be
associated with dysfunction in adulthood. Disruption of early life environment in humans
can lead to increased risk of depression risk (reviewed in Hein et al., 2010, Chapman et
al., 2008), inflammation (Danese et al., 2008), glucocorticoid resistance (Carpenter et
al., 2004), reduced cortical volume (van Harmelen et al., 2010) and reduced
hippocampal volume (Vythilingam et al., 2002) in the adult population. These studies
point to the existence of important sensitive time windows in development that can set
an individual on a trajectory to dysfunction in adulthood. How early life nutrition interacts
with the brain during these critical development periods and leads to adult reward
dysfunction and obesity needs to be further explored.
The brain continues to develop from postnatal day one through adolescence. If
the environment is particularly damaging during that period, programming of adulthood
diseases can occur. “Metabolic imprinting” is a term used to describe how alterations in
developing young can predispose individuals to obesity and its associated illnesses. We
already examined how gestation was critical for the development of feeding and reward
circuits. The weaning period up until adolescence also represents a critical
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developmental window with regard to the establishment of metabolic-regulating neural
pathways (King et al., 2006). In fact, dietary preferences and feeding behaviors are
programmed during childhood (Sato et al.,1991). The projections from the arcuate
nucleus to other hypothalamic nuclei regulating energy balance mature by the 8th to
10th day of postnatal life (Grove and Smith, 2003; Grove et al., 2003; Bouret et al.,
2004a). These projections are sensitive to both gestational and postnatal overnutrition
(Plagemann, 2006; Chang et al., 2008). Additionally, levels of the metabolic hormones
leptin and insulin play a role in the development of the hypothalamus and projecting
areas during these developmental periods (Bouret et al., 2004b; Frank et al., 2005).
Projections from the VTA to the NAc and PFC mature post-natally as well (Antonopoulos
et al., 2002; Kalsbeek et al., 1988). These studies demonstrate that early life nutritional
insults could have consequences for DA circuitry and DA-mediated behaviors. Early
postnatal overnutrition in mice, simulated by a small litter number throughout lactation,
predisposes the offspring to adult obesity (Bouret, 2010). Early exposure to a high fat
diet for as little as one week was able to alter adult caloric intake and dopamine
signaling protein levels (Teegarden et al., 2009). Additionally, high fat during the
peripubertal period sensitized the response of dopamine in the NAc to a tail pinch test
(Naef et al., 2013b). Finally, high fat feeding was sufficient to disrupt PPI when given
during peripubertal period, whilst high fat feeding failed to affect PPI when limited to
adulthood (Labouesse et al., 2013). Other brain regions are also affected by high fat diet
given early in development, such as the HPA axis, and can also impact feeding and
metabolism through different mechanisms (McCormick & Mathews, 2007).
The previous studies demonstrate that the time from weaning until adolescence
is particularly sensitive to nutrition and can determine the risk of obesity in adulthood.
However, this time period is also sensitive to other environmental insults that can affect
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mental health throughout the lifetime (Michel et al., 2004; Boukouvalas et al., 2008). The
developmental period from PD 20 to 40 in rodents is analogous to preadolescence and
adolescence in humans (Spear, 2000). A surge of synaptogenesis occurs in the brain
during these adolescent years. Therefore, adolescence is one of the most dynamic
events of human growth and nutrition is just one example of the early life environment
that has consequences on circuitry development and adult mental health. Disruption in
maternal care is another example of an environmental insult that has long-lasting effects
on adulthood health and behaviors. Unsatisfactory maternal care leads to dysregulation
of the neuroendocrine response to stress (Plotsky & Meaney, 1993; Liu et al., 2000) and
can lead to an increased risk of addiction in adulthood (Piazza & Le Moal, 1997).
Because the early post natal time period is so sensitive, it may be possible to positively
impact development through intervention at this time. For example, early post weaning
exercise can reverse the damage done to metabolic feeding circuits caused by maternal
high fat diet (Sun et al., 2013). Understanding what molecules are specifically sensitive
to over nutrition during the early postnatal period will allow us to develop targets for
possible positive intervention to prevent dysfunction is adulthood. Many diet induced
obesity rodent studies begin the diet months after weaning (Kanoski et al., 2010; Baladi
et al., 2009; Lassiter et al., 2010) and therefore results from these studies cannot be
applied to childhood obesity treatments. Research is still needed to identify the periods
of sensitivity in the programming of dopamine reward system in obesity and determine
how permanent metabolic programming is after intervention.

The	
  Basics	
  of	
  Epigenetics	
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The body and brain respond to a changing environment by altering gene
expression patterns both acutely and on a long term basis. One reason for variations in
response to a changing environment could be a gene-environment interaction. For
instance, a polymorphism in an important gene could lead to increased risk of a
psychiatric disorder in a stressful environment. This has been seen in epidemiological
studies of serotonin receptor polymorphisms and the risk for depression (Caspi et al.,
2003). However, it is also possible to have increased risk for psychiatric disorder without
a corresponding change in genetic code. For example, early life stress in humans
(Chapman et al., 2004) and animal models (Kaffman & Meaney, 2007) can increase the
risk of depression and depressive-like behaviors. The mechanism by which early life
stress is able to program the brain involves epigenetic modulation of the expression of
individual genes or large clusters of related genes. Epigenetics refers to the potentially
heritable, but environmentally modifiable, regulation of genetic function mediated
through a mechanism that doesn’t involve altering the genetic code (Russo et al, 1996;
Wu and Morris, 2001). Epigenetics is viewed as the vehicle through which the
environment interacts with the genome to determine function, in health and disease.
Aberrations in epigenetic markers have been associated with many diseases such as
cancer, diabetes and addiction (Dawson & Kouzarides, 2012; Gilbert & Liu, 2012; Feng
& Nestler, 2013). DNA is wrapped around a cluster of histone proteins and covalent
histone modifications, such as acetylation, phosphorylation, methylation, sumoylation
and ubiquitylation, modulate gene expression via alterations in chromatin structure in
conjunction with DNA methylation. These epigenetic mechanisms in total can play a role
during times of development to program behavioral phenotypes in adulthood, or increase
vulnerability for a psychiatric disorder caused by other phenomena.
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DNA methylation has been widely studied in the context of early life
environmental insults. DNA methylation occurs with the addition of a methyl group to the
C5 position of cytosine (5-mC) predominantly at CpG sites (Klose and Bird, 2006). CpG
islands are stretches of DNA around 1000 base pairs long that have a high CpG density
(Bird et al, 1985). CpG islands are important for transcriptional regulation and 70% of
gene promoters reside within CpG islands (Saxonov et al, 2006). The importance of
CpG islands in transcription are maintained between species and conserved between
mice and humans and transcription factor binding sites often found to be within and
around these regions (Illingworth et al, 2010). Classically, DNA methylation reduces
access of transcription factors to regulatory elements and causes transcriptional
repression by decreasing the binding of specific transcriptional enhancers (Murgatroyd
et al., 2010). DNA methylation plays a pivotal role in cell differentiation, imprinting, and X
chromosome inactivation and is viewed as a more stable epigenetic mark compared to
others (Martinowich et al., 2003). A family of methyl CpG-binding domain proteins,
including MeCP2, and MBD1-4, bind to methylated cytosines and interact with histone
deacetylases and DNA-methyltransferases to repress genes and maintain methylation
(Chen et al., 2003). Methyl binding proteins, such as MeCP2, are highly expressed in the
brain and necessary for proper circuitry and behavioral development (Amir et al., 1999,
Skene et al., 2010).
DNA methylation is catalyzed by DNA methyltransferases (DNMTs) DNMT1,
DNMT3a and DNMT3b. The expression of DNMTs normally declines in terminally
differentiated cells in all tissues except for the brain. The brain is specialized for sensing
the environment and responding and adapting to change. One of the mechanisms
behind the ability to adapt to a changing environment is epigenetic plasticity. Both
DNMT1 and DNMT3a are expressed by post mitotic neurons and serve unique functions
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in the central nervous system (Goto et al., 1994). The best-studied DNMT in the nervous
system is DNMT1. Unlike the other DNMTs, DNMT1 preferentially methylates
hemimethylated DNA (Pradhan et al, 1999) and is involved in methylation repair and
maintenance (Mortusewicz et al, 2005). Chromatin structure can be altered because of
steric hindrance or charge introduced by the DNA methylation in combination with other
epigenetic markers, such as histone modifications. Epigenetic mechanisms controlling
transcriptional activity may be cell-type, and even gene-specific. There have been
several instances discovered where DNA methylation increased transcription at some
gene promoter sites (Mellen et al., 2012; Labonte et al., 2012). Changes in epigenetic
markers may explain how the environment regulates the genome in specific concepts.
These changes are well poised to mediate the effects of early environmental factors on
adult disease and behavior.

Epigenetics	
  and	
  the	
  Early	
  Life	
  Environment	
  
	
  
The crucial role of the epigenetic processes in mediating maladaptive
neurobiological and behavioral consequences of the early-life environment and
environmental adversity has been demonstrated in animal models. Brain specific brain
DNA methyltranferase knockouts have been generated and characterized and
demonstrated behavioral dysfunction (Feng, et. al 2010). This was the first proof of
concept that it was possible to alter behavior through epigenetic mechanisms. Further
advances in the field revealed in animal models of early life stress that epigenetic
mechanisms are recruited and could be the mechanism behind the observed behavioral
dysfunction (McGowan et al., 2009; McGowan et al., 2010; Weaver et al., 2004). Earlylife adversity triggers DNA methylation changes in several brain regions and controls
	
  

31	
  

genes that mediate a depressive phenotype (Lutz et al., 2013). For example, the
glucocorticoid receptor gene promoter methylation is increased by early life stress and
leads to adult stress dysregulation in both human (McGowan et al., 2009) and rodent
samples (Weaver et al., 2004; McGowan et al., 2010). Other studies have revealed that
DNA methylation is central to various types of aversive learning (Miller et al., 2010) and
synaptic plasticity (Roth et al., 2009) after early life insults. For instance DNMT1 has a
role in regulating the induction of synaptic plasticity in the hippocampus (Levenson et al.,
2006; Miller & Sweatt, 2007). The early life time period may provide a window where
epigenetic machinery is vulnerable to insult and could change developmental trajectories
and cause psychiatric dysfunction in adulthood.
Epigenetic Recruitment after Rewarding Substances
Activity-dependent methylation and demethylation of DNA is essential for the
behavioral and neuronal plasticity driven not only by early life stress, but in rewardrelated experiences as well. Epigenetic marks have been seen to change in reward
related brain regions in response to drugs of abuse (Hiroi et al., 2005). Reward learning
induces changes in DNA methylation patterns that are gene specific and correlate with
changes in mRNA levels (Day et al., 2013). Cocaine is one example of a drug of abuse
that alters DNMT levels and DNA methylation in the NAc. The epigenetic changes are
thought to program reward memory by regulating structural changes and influencing
addictive behaviors such as conditioned place preference (LaPlant et al., 2010). Druginduced neuronal plasticity is viewed as a major molecular mechanism for the
development of drug addiction and relapse (Kalivas et al., 2008; Nestler, 2001; Shaham
& Hope, 2005; Wong et al., 2011). Significant changes in DNA methylation have been
seen after alcohol (Bonsch et al., 2004; Marutha Ravindran et al., 2004; Philibert et al.,
2008), amphetamine (Deng et al., 2010), cocaine (He et al., 2006; Novikova et al.,
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2008), nicotine (Philibert et al., 2009; Sata et al., 2008) and opiate (Neilsen et al., 2008)
exposure in human and mouse models. These studies show that rewarding substances
have the ability to recruit epigenetic machinery and cause epigenetic changes in brain
circuitry that regulates behavior. Our lab identified DNA methylation as an epigenetic
mechanism linking the chronic intake of HF diet with altered dopaminergic gene
expression and mu opioid receptor expression (Vucetic et al., 2010; Vucetic et al., 2011).
Little is known about the mechanisms that drive gene expression changes in response to
diet and/or obesity. Epigenetic gene regulation, including DNA methylation, and histone
modifications, represent a pathway through which organisms can rapidly adapt to
nutritional challenges. There is also a strong possibility that these mechanisms are more
vulnerable to alteration when the brain is still developing, such as in utero or the preadolescent time period. Identification of such windows will be of major public health
importance, given the vast number of psychiatric and metabolic disorders linked to early
life adversity and early life nutrition.

Reward	
  System	
  and	
  Epigenetic	
  Effects	
  of	
  Exercise	
  on	
  the	
  Brain	
  
Exercise is an example of a non-nutritional environmental exposure that recruits
epigenetic machinery and causes neuroadaptations in the brain. Because it affects
similar brain regions as high fat diet, it is a potential option for the prevention of
neuradaptations of the reward system that occurs in obesity. Voluntary physical activity
is important to human health for the prevention of obesity and it has positive effects on
learning, memory, and cognition. The obesogenic environment of Western culture
includes overconsumption of palatable foods and increases in sedentary lifestyle. This
increase in inactivity has been associated with obesity, cardiovascular disease, Type II
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Diabetes, and certain types of cancer (Powell et al., 1994). Inactivity and obesity are
also associated with neurological disorders such as Alzheimer’s disease and
depression. There is a growing field of research that illustrates that high fat diet has a
direct damaging effect on the brain. Diets high in saturated fat are known for reducing
molecular substrates that support cognition and therefore increase the risk for
neurological dysfunction in both humans (Greenwood et al., 2005) and animals (Molteni
et al., 2002). Holloway et al. (2011) reported that healthy adults who ate a high fat diet
for 5 days performed worse on tasks measuring attention and speed of retrieval than
they had prior to the diet. Studies with rodents confirm chronic high fat diet produces
cognitive deficits and neuroinflammation in the hippocampus (Heyward et al., 2012,
McNay et al., 2010; Molteni et al., 2004 and Pistell et al., 2010). Rodents on high fat diet
also have reduced levels of BDNF and CREB, which are important for neuronal plasticity
(Molteni et al., 2002). Fortunately, exercise has positive actions on the brain and is a
low-cost, and common way to combat obesity. Studies looking at the beneficial effects of
exercise have mainly focused on learning and memory in the hippocampus. In humans,
exercise counteracts the mental decline associated with aging (Kramer et al., 1999),
enhances the mental capacity of young adults (Winter et al., 2007), and facilitates
functional recovery after brain injury or disease (Vayman & Gomez-Pinilla, 2006).
Rodent models of voluntary wheel running have given us insight to the
mechanism behind these cognitive benefits. Exercising rats show exercise promotes
neurogenesis in the brain (van Praag et al., 1999) and increases expression of BDNF
mRNA (Gomez-Pinilla et al., 2011). When exercise and high fat diet are paired together,
exercise has the ability to reverse the damaging effects of high fat diet on synaptic
plasticity in the hippocampus by normalizing BDNF levels and reducing oxidative
damage (Molteni et al., 2004). Exercise can protect the hippocampus from nutritional
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insults, but what about other brain regions? We now know that consumption of high fat
diet also causes neuroadaptations in the mesolimbic reward system. Damage to
hippocampal function by high fat diet seems to be through reduced BDNF signaling and
oxidative damage. Dysfunction in the reward system after high fat diet, however, is
through a different mechanism. Chronic intake of a rewarding substance leads to
changes in dopamine signaling and subsequent obesity causes central resistance of
metabolic hormones found in reward regions of the brain. It is possible that exercise is a
way to combat the dopamine dysfunction in the mesolimbic reward system seen in
obesity.
For years now, exercise has been used as a treatment for depression and other
psychological disorders (Lawlor & Hopker, 2001; Blumenthal et al., 1999; Petruzzello et
al., 1991). Recently, exercise has been suggested to be beneficial for treating drug
addiction (Smith & Lynch, 2011). Since the mechanisms of depression, addiction, and
palatable food overconsumption pathways overlap, exercise may also be beneficial for
treating dopamine dysfunction in obesity. There are many theories as to why exercise is
beneficial in these disorders. Exercise increases body temperature (Petruzzello et al.,
1991), causes an increase in serum calcium levels (Sutoo & Akiyama, 1996) and causes
an increase in monoamine synthesis (Dishman, 1997). The central belief among these
researchers is that exercise acts on the same pathway of antidepressant medications in
the treatment of depression. Mechanistically, physical activity and exercise activate the
same reward pathway as drugs of abuse. Exercise increases dopamine concentrations
and dopamine receptor binding (Greenwood et al., 2011 and MacRae et al., 1987) and
may act as an alternative reward so to prevent drug administration. It is unknown how
exercise in conjunction with a rewarding substance like high fat diet may interact within
the reward system. Because the consumption of palatable food and administration of
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addictive drugs are controlled by the dopamine reward pathway, I hypothesize that
exercise can also counter the dopamine dysfunction caused by chronic high fat diet.
Exercise functions as an alternative non-drug reinforcer and can compete with
the drug and reduce vulnerability to addiction. Rodents given concurrent access to a
running wheel and methamphetamine self-administer less drug as compared sedentary
rats (Miller et al., 2012). Similar findings have been reported for cocaine selfadministration (Smith and Pitts, 2011) and was protective both when the running wheel
was given concurrently or when given before drug exposure. This has possible
implications for exercise as a preventive measure against dopamine dysfunction before
it even begins. At the molecular level, exercise reduces drug induced dopamine release
(Chen et al., 2008, Marques et al., 2008). Additionally, running increases levels of
tyrosine hydroxylase, and total dopamine levels the reward pathway (Droste et al., 2006
and Greenwood et al., 2011). These neuroadaptations caused by exercise may
influence an individual's vulnerability to initiate drug use and/or develop addiction. One
way exercise prevents consumption of rewarding substances is that exercise has reward
value of its own. In fact, rats are willing to “work,” for and show conditioned place
preference to the running wheel (Belke et al., 2005; Brene et al., 2007). The reward
value of exercise comes from increases in dopamine in reward regions. Microdialysis
studies revealed increased in extracellular DA in the mesolimbic region after a 20-60min
treadmill run that remained elevated for 2hrs (Hattori et al., 1994; Meeusen et al., 1997;
Wightman et al., 2002). These findings are important because they suggest that exercise
may normalize the hypofunctioning in the mesolimbic system that occurs following
chronic high fat diet exposure and high fat withdrawal.
Molecules that could explain the beneficial effects of exercise in the reward
system may be the same as those discovered to be beneficial in the hippocampus. For
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instance, important factors in synaptic plasticity and cognitive function, such as BDNF,
synapsin I, calcium/calmodulin-dependent protein kinase II (CaMKII) and cyclic AMPresponsive element (CRE)-binding protein (CREB) are enhanced in both addiction and
after exercise in reward regions of the brain (Wu & Gomez-Pinilla,2007). Chronic
exposure to high fat diet alters epigenetic markers that may underlie the propensity to
develop neuroadaptations in reward regions. The beneficial effects of exercise may work
through a similar epigenetic pathway and remodel chromatin structure in a way that
prevents dopamine dysfunction (Gomez-Pinilla, 2011). Further research will be needed
to see if an epigenetic pathway is activated in reward regions by exercise to prevent the
dopamine dysfunction of obesity. Exercise seems to produce efficacious effects in other
brain regions, therefore, researching the effects of exercise in the reward system of the
obese brain will be important for future weight loss studies and the control of palatable
food consumption.
Conclusion	
  
	
  
We now see that obesity can be thought of as a disease of the central regulation
of food intake and many behavioral dysfunctions and neuroadaptations are associated
with the obese state. The brain is a highly adaptive organ and changes in response to
multiple internal and external environmental signals. However, these changes could lead
to maladaptive behavior or disease in the future. Studies described here support the
finding of dopamine dysfunction in obesity patients and animals given access to high fat
diet. The neuroadaptations seen after chronic high fat diet are similar to those seen after
chronic intake of drugs of abuse. The following experiments will characterize how
dopamine circuitry has adapted to chronic high fat diet intake at the molecular and
behavioral level. Understanding whether these reward system neuroadaptations are
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persistent after chronic high fat is critical for the field of obesity interventions; therefore,
the following experiments also characterize the dopamine system after high fat
withdrawal. We now see how critical the early nutritional environment is for optimal brain
development. Early postnatal life is a dynamic period where dopamine projections are
still being laid down. It is possible that the pre-adolescent period is more vulnerable to
the damaging effects of high fat diet than other points in time. Overnutrition during this
time period may lead to epigenetic programming and lasting neuroadaptations after
intervention. The following experiments characterize chronic high fat diet in preadolescent male and female mice and compared them to adult animals on high fat diet.
This experimental design allows us look at the effect of high fat diet on a critical time
period in brain develop and assess if any permanent damage is seen in adulthood. The
experimental design includes females as well as males. There are crucial sex
differences in the presentation of obesity and in dopamine system activation. Bringing
sex differences into the analysis of high fat intake and high fat withdrawal effects on the
brain will be important contribution to the obesity intervention field. Finally, there is
sufficient evidence that exercise activates the dopamine reward system and studies
show exercise to be beneficial in other brain areas important for learning and memory.
Exercise has the ability to be a rewarding replacement for palatable foods and may be
protective against dopamine dysfunction in obesity. Access to the running wheel recruits
epigenetic machinery similar to other rewarding substances and this may be the
mechanism underlying its protective benefits. Obesity is a complex state and
understanding the mechanisms behind obesity interventions like diet and exercise as
well as how the brain changes along with increasing BMI and decreasing BMI will help
us come up with viable drug targets and therapies to combat this widespread epidemic.
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Introduction	
  
	
  
Overconsumption of widely available, calorie-dense palatable food is considered a major
factor contributing to the high rates of obesity in the U.S (Swinburn et al., 2009).
Because palatable foods are often consumed after energy requirements have been met,
the rewarding properties of palatable foods may override homeostatic satiety signals.
Many neurotransmitters play a role in feeding behavior (e.g. opioids, dopamine, GABA,
serotonin) as well as the integration of peripheral nutrient signals (e.g., leptin, insulin,
ghrelin). Dopamine signaling is a key mediator in both food reward and reward-seeking
behavior, as dopamine in the mesolimbic/ mesocortical region is associated with the
	
  

39	
  

rewarding properties of food, sex, and drugs of addiction (Fibiger & Phillips, 1988).
Acutely, palatable food causes a burst of dopamine in the central reward system
(Hernandez et al., 1988; Sahr et al., 2008). With chronic consumption of rewarding food,
the increased dopamine release over time may lead to adaptations that are associated
with reward hypo-function.
Several lines of evidence support the hypothesis of altered dopamine function in
obesity. Human imaging studies revealed blunted activation in reward regions of obese
patients while drinking a highly palatable solution (milkshake) (Stice et al., 2008). The
blunted reward response was associated with less brain dopamine receptor D2
availability. In fact, mutations in the human dopamine D2 receptor have been linked with
both obesity and addiction (Noble et al., 1991). Dopamine content in the synapse is
largely controlled by dopamine transporter (DAT) uptake. Dopamine transporter levels
are negatively correlated with body mass index and genetic variants of DAT are also
associated with obesity (Chen et al., 2008; Need et al., 2006). Animal models of obesity
have demonstrated decreases in basal extracellular dopamine and reduced dopamine
neurotransmission in the nucleus accumbens and ventral tegmental area (Geiger et al.,
2007; Geiger et al., 2009; Cone et al., 2010). Decreases in dopamine-related genes after
chronic high fat (HF) diet suggest decreased signaling in reward regions (Vucetic et al.,
2012; Alsio et al., 2010; Johnson & Kenny, 2010, Huang et al., 2005). This decrease in
dopamine activity after chronic high-fat diet may reduce the sensitivity to natural rewards
and facilitate continued overconsumption and further weight gain.
Early life is a critical period in brain development, and the early nutritional
environment can influence brain pathways controlling food intake and energy
metabolism. Early exposure of mice to a high fat diet for as little as one week altered
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adult caloric intake and expression of dopamine-related signaling molecules (Teegarden
et al., 2009). Further, early postnatal over nutrition in mice, driven by a small litter
number throughout lactation, predisposes the offspring to adulthood obesity by altering
hypothalamic development (Bouret, 2010). While it is clear that early life nutrition can
affect brain development and obesity risk, little is known about the relative permanence
of these changes across the lifespan. Additionally, previous studies have been done in
male animals but females have been rarely studied in this context. To these ends, both
male and female mice were studied for changes in gene expression and dopamine
metabolism after they were made obese in early life through chronic consumption of a
HF diet from birth through 12 weeks of age. The dopamine system was also evaluated 4
weeks after removal of the HF diet, to examine whether the changes persisted or
reversed.

Methods	
  and	
  Procedures	
  
	
  
Animals and experimental model. C57BL/6J females were bred with DBA/2J males
(The Jackson Laboratory, Bar Harbor, ME). All dams were fed standard control diet
(#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) up until parturition when half the
dams/litters were placed on high fat diet (Test Diet, Richmond, IN #58G9; 18% protein,
60% fat, and 20.5% carbohydrate). Offspring were weaned at 3 weeks of age and
remained on either the control diet or the high fat diet until 12 weeks of age. Body
weights were recorded weekly, and both male (n=5-10) and female (n=5-10) mice were
used. The Institutional Animal Care and Use Committee (IACUC) of the University of
Pennsylvania approved all procedures.
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Sucrose and Saccharin Preference. In separate experiments, mice were
individually housed (n=8-10/group) in standard cages for 3 days with one bottle of
200 ml of the test solution (4% sucrose or 1% saccharin solution (w/v)) and another
bottle with 200 ml of tap water. House chow was available ad libitum. Sucrose (ml),
water (ml), and food consumption (g), were measured and the placement of the bottles
was reversed daily. Preference was calculated using the average of the measurements
from the last 2 days as follows: preference % = [(sucrose consumption/sucrose + water
consumption) × 100].
Genomic DNA and Total RNA isolation from the brain. Animals (n=5/group) were
euthanized with an overdose of carbon dioxide, followed by cervical dislocation; a
method recommended by the Panel on Euthanasia of the American Veterinary Medical
Association. Brains were then rapidly removed and placed in RNAlater (Ambion, Austin,
TX) for 4-6 hours before dissection. Brain dissections to isolate the prefrontal cortex, the
nucleus accumbens and the ventral tegmental area were preformed as previously
described (Vucetic et al., 2010; Reyes et al., 2003; Cleck et al., 2008). Genomic DNA
and total RNA were isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen).
Gene expression analysis by quantitative Real-Time PCR. For each individual
sample, 500ng of total RNA was used in reverse transcription using High Capacity
Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes was
determined by quantitative RT-PCR using gene specific Taqman Probes with Taqman
gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler. Gene
probes are listed in supplemental material. Relative amount of each transcript was
determined using delta CT values as previously described in (Pfaffl, 2001). Changes in
gene expression were calculated against an unchanged GAPDH standard.
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Western blot. Ventral tegmental area tissue was dissected out and flash-frozen
on dry ice and stored at -80 °C. Frozen tissue was homogenized in 350 ul of 1X
Extraction Buffer with 1:1000 DDT Solution and (1:1000) PIC added (Epigentek,
Farmingdale, NY). Homogenates were incubated on ice for 15 minutes with vortexing
every 5 minutes. Homogenates were then centrifuges at 14,000rpm for 10 minutes at
4°C. Supernatants were collected and processed for total protein concentration
according to the Micro BCA procedure (Pierce, Rockford, IL, USA). Protein levels of
tyrosine hydroxylase were measures by western blot analysis. Protein samples were
separated by electrophoresis on a 10% polyacrylamide gel and electrotransferred to a
PVDF (polyvinylidene fluoride) membrane. Non-specific binding sites were blocked in
Odyssey Blocking Buffer (Licor, Lincoln, Nebraska) for 1 hr at 4°C. Membranes were
incubated at 4 °C overnight, with the primary rabbit antibody anti-TH (1:200, Pel-Freez
Biologics, Roger, Arkansas #p40101-0) and rinsed with 0.01% Tween20 in Tris-buffered
saline. Membranes were then incubated for 1hr at room temperature with IRDye 800CW
Goat anti-Rabbit IgG (H + L,), 25 µL (Licor, Lincoln, Nebraska, 1:2000 in 0.01%
Tween20 Tris-buffered saline, 0.1% SDS) and washed with 0.01% Tween20 in Trisbuffered saline. Membranes were imaged with the LI-COR Odyssey Infrared Imaging
System and TH fluorescence was normalized to GAPDH florescence.
Ex vivo Dopamine and Dopamine Metabolites. High performance liquid
chromatography (HPLC) was used to measure the content of dopamine and its
metabolites in the mesolimbic reward areas of the brain (n=8-12), as described
previously (Mayorga et al., 2001, Vucetic et al., 2010). Brains were collected from
animals and bisected into right and left hemispheres. The NAc and PFC were dissected
out and quickly frozen by dry ice and stored at -80°C. The tissue was prepared for
analysis by homogenization in 0.1 N perchloric acid, centrifuged at 15,000 rpm for 15
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min at 2-8˚C, and the supernatant filtered. Samples were analyzed by a Bioanalytical
Systems HPLC (West Lafayette, IN, USA) using a LC-4C electrochemical detector.
Samples (12 ul) were injected onto a reverse phase microbore column at a flow rate of
0.6 ml/min and electrodetection set at +0.6 V. Separation for dopamine and dopamine
metabolites was accomplished by a mobile phase consisting of 90-mM sodium acetate,
35-mM citric acid, 0.34-mM ethylenediamine tetraacetic acid, 1.2-mM sodium octyl
sulfate, and 15% methanol v/v at a pH of 4.2. Peak heights of samples were measured
and compared with standards for dopamine and its metabolite 3,4-dihydroxyphenylacetic
acid (DOPAC).
Methylated DNA Immunoprecipitation (MeDIP) Assay. MeDIP assay was
preformed using MagMeDIP kit (Diagenode, Denville, NJ). Methylated DNA was
immunoprecipitated using 15ul of magnetic beads coated with anti-5methylcytidine
antibody (Diagenode) or mouse pre-immune serum. Enrichment in MeDIP fraction was
determined by quantitative RT-PCR using ChIP-qPCR Assay Master Mix (SuperArray)
on the ABI7900HT Real-Time Cycler. For all genes examined, primers were obtained
from SuperArray (ChIP-qPCR Assays (-01) kb tile, SuperArray) for the amplification of
genomic regions spanning the CpG sites located approximately 300-500 bp upstream of
the transcription start sites. MeDIP results were expressed as fold enrichment of
immunoprecipitated DNA for each site. To calculate differential occupancy fold change
(% enrichment), the MeDIP DNA fraction CT values were normalized to Input DNA
fraction CT values.
Statistics. Gene expression analysis was performed using Student T-test
comparing aged matched controls to HF and HF + recovery groups. The alpha level was
adjusted for the multiple brain regions surveyed. Significance of a gene used in one
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brain region was p=.05; for two regions, p=0.025, for 3 brain regions p=.016. Sucrose
preference, saccharin preference, HPLC and MEDIP, body weights and corticosterone
assay analyzed using one-way ANOVA to compare control, HF, and HF + recovery
groups. Post-hoc Bonferonni Multiple Comparison Tests were used to compare pair-wise
differences between groups. Significance for these tests was set at an alpha level of
p=.05.

Results	
  
	
  
Mice had continuous access to control diet (control) or 60% high fat diet (HFD)
until 12 weeks of age. At 12 weeks of age, half of the HF-fed animals were placed on the
house chow for 4 weeks (HF +recovery). In both males and females, HFD animals
(circles) were heavier than controls beginning at 9 weeks of age (p<.05) and remained
heavier than controls throughout the recovery period (Supplemental Figure 1).
Sucrose and saccharin preference tests were administered to assess animals’
response to natural and nonnutritive rewarding stimuli. Sucrose preference but not
saccharin preference was altered after HF diet exposure and returned to normal levels
after HFD recovery in males and females. One-way ANOVA revealed sucrose
preference was significantly decreased in males (Fig. 1A) and trended toward a
decrease in females (Fig. 1B) after HFD exposure (F(2,16)=4.82, p<.05; F(2,16)=5.41,
p<.06, respectively). After removal of the HFD, this behavior normalized and sucrose
preference no longer differed from controls. Saccharin preference was not altered in
either males (Fig. 1C) or females (Fig. 1D) as a result of HFD exposure.
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Because dopamine is a key regulator of reward behavior, dopamine-related gene
expression was examined within the reward circuitry of a separate cohort of males and
females after 12 weeks on the HFD, and in an additional group, after 4 weeks recovery
from the HFD. Table 1 summarizes the gene expression patterns and statistical analysis
in the VTA, PFC and NAc. In the VTA, three genes important in regulating dopamine
levels at synaptic terminals were measured: catecholamine methyl transferase (COMT)
involved in inactivation of catecholamine neurotransmitters; dopamine transporter (DAT),
membrane spanning pump that clears dopamine from the synapse, and tyrosine
hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis. Fold change values
for each group were determined using aged matched controls (e.g. both control time
points are set to 1, and for clarity only the control for HFD is depicted on the graph).
Student’s t-test (n=5/group) revealed in the male VTA that COMT, DAT, and TH mRNA
were significantly decreased by HFD exposure (Fig 2A) and returned to or exceeded the
control levels after a recovery period off the diet (HF +recovery).
In the PFC and NAC, genes important for dopamine signaling and dopamine
turnover were examined (n=5/group): COMT; protein phosphatase 1 regulatory subunit
1B (DARPP-32), a down stream signaling protein regulated by receptor stimulation;
dopamine receptor D1 (DRD1), a postsynaptic G-protein coupled receptor that
stimulates adenylyl cyclase; and dopamine receptor D2 (DRD2), a postsynaptic Gprotein coupled receptor that inhibits adenylyl cyclase. In the male PFC (Fig. 2B),
DARPP-32 was increased, while DRD1, and DRD2 were decreased after HFD
exposure, and these changes persisted after the removal of the HFD (although the
increase in DARPP-32 mRNA was not statistically reliable). In the male NAC (Fig. 2C),
COMT, DRD1, and DRD2 were decreased by HFD exposure, and remained below
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control levels after removal of the HFD. DARPP-32 levels were increased by HFD, but
significantly decreased from controls after 4 weeks off the HFD.
The same brain regions and genes were examined in female mice (n=5/group). As
shown in Table 2, there were significant differences observed in the pattern of gene
expression in response to the HFD, as well as to the recovery off the diet. Similar to
males, in the VTA, mRNA levels of COMT, and TH were significantly decreased after
HFD exposure (Fig 2D). However, unlike the males, these changes persisted after the
removal of the HFD. Further, in direct opposition to the pattern observed in males, HFD
exposure increased DAT mRNA expression in the VTA in females, and after removal of
the HFD levels were even lower than age matched controls. In the PFC, only DARPP-32
was affected by chronic HFD, with a significant increase in mRNA levels after 12 week
HFD, and a return to control levels after removal of the HFD. Both COMT and D1R
mRNA were significantly decreased after 4 weeks off the HFD. In the female NAC,
COMT, DRD1, and DRD2 were all decreased after HFD exposure (Fig. 2F). DRD1 and
DRD2 recovered to control levels after diet removal, while COMT remained levels
remained significantly decreased after 4wk recovery. Protein levels of TH were
quantified in the ventral tegmental area to confirm gene expression results. Chronic high
fat diet was decreased in males (Figure 3A F(2,18)=3.502, p=.0519) and remained
decreased after 4 week recovery period, however post hoc analysis showed this
decrease was only a trend not statistically reliable. Protein levels of TH in the VTA of
females (Figure 3B F(2,19)=3.544, p=0.0492) were also decreased after high fat diet
and levels trended toward normalization after a 4 week recovery period.
Given the consistent decrease in gene expression for dopamine regulating genes
in the VTA, dopamine and dopamine metabolites were quantified in regions that receive
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projections from the VTA, the PFC and NAC. Figure 3 shows dopamine (DA) and the
dopamine metabolite (DOPAC) from the PFC and NAC in males (Fig. 4A, 3C) and
females (Fig. 4B, 3D). In males, exposure to the HFD produced a decrease in dopamine
levels in PFC (Fig. 4A) and NAC (Fig 4C) (F(2,13)=3.95;F(2,18)=3.536, p<.05), which
recovered after HFD removal only in the NAC. Dopamine turnover (DOPAC:DA ratio)
increased in male PFC (F(2,12)=3.85, p<.05) and NAC (F(2,17)=4.69, p<.05). In
contrast, the effect of HFD on DA and DOPAC in females was qualitatively different than
in males. In the PFC, HFD did not affect DA or DOPAC levels. In the NAc, DA levels
were decreased in HFD-fed animals and remained decreased even after removal of the
HFD (Fig. 4D, F(2,23)=4.79, p<.05). DOPAC levels were unchanged in the NAc of
females, which resulted in an increase in DA turnover (DOPAC:DA ratio) (F(2,23)=7.00,
p<.01).
Given that DAT transcription can be regulated by differential DNA methylation and
the observation of a notable sex difference in the expression of DAT in the VTA, DNA
methylation in the promoter region of DAT was examined. In Figure 5A, 5C DAT gene
expression in the VTA is presented again for clarity (taken from Fig 2A and 2D). DAT
promoter methylation was significantly increased in males (Fig. 5B) after HFD and
returned to control levels in HFD + recovery males (F(2,11)=23.64, p<.01). In females,
DAT promoter methylation trended toward decrease in HFD animals (D) and was
significantly decreased in HFD + recovery females (Fig 5D, F(2,12)=5.70, p<.05).
To assess if removal of the HFD in the recovery period was a stressor, baseline
plasma corticosterone levels (ug/dl) were taken in control, HFD exposed (12 weeks),
HFD +1wk recovery and HFD + 4wk recovery groups (n=5/group, Supplemental Fig. 2).
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One-way ANOVA revealed no significant differences between groups in male animals
(F(3,16)=3.21, n.s.).

	
  
Discussion	
  
Chronic consumption of a high fat diet (HFD) beginning in early life was used to
establish diet-induced obesity in mice. Mice displayed decreased sucrose preference
and evidence of reduced dopaminergic tone in reward regions of the brain. After 4
weeks off the HFD, sucrose preference normalized in both males and females, however,
some dopamine gene expression changes persisted. These experiments provide
important new data describing the effect of chronic HFD on the brain reward system,
highlighting the capacity for recovery and key sex differences between male and female
mice.
In the HFD fed animals, a decreased sucrose preference was observed, which
reversed after a recovery period. These findings extend our previous report of HFD
intake driving a reduced sucrose preference (Vucetic et al., 2003) by demonstrating that
this can occur with a shorter duration of HFD exposure (12 weeks versus 22 weeks),
and importantly, that the response recovers in the absence of HFD. Female mice
demonstrated the same response patterns as males. These findings are consistent with
others in the literature which have shown through the inclusion of a pair fed group that
chronic HFD, and not obesity per se, attenuates the response for sucrose in an operant
task (Davis et al., 2008). Similarly, in the current study, sucrose preference recovered
after 4 weeks off the HFD, while body weight remained significantly elevated, supporting
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the conclusion that decreased sucrose preference was driven by the HFD exposure and
not the accompanying body weight gain. It was particularly interesting that there was no
change in saccharin preference. This may indicate that chronic HFD differentially affects
the response to caloric and non-caloric sweet rewards. Post ingestive effects have been
shown to influence preference independent of palatability, as sucrose intake has been
shown to induce dopamine release in “sweet-blind” taste receptor knockout mice (de
Araujo et al., 2008), nutritional value is required for reward and reinforcement (Beeler et
al., 2012) and taste-independent metabolic sensing pathways have been defined in
drosophila (Dus et al., 2011). Saccharin is significantly sweeter than sucrose, so an
effort was made to establish equivalency in sweetness (typically 4-10x higher
concentration of sucrose (Beeler et al., 2012)) however the overall preference for
saccharin was lower than that for sucrose in these animals. Therefore, an alternative
explanation may be that HFD differentially affected the sucrose preference because it
was relatively more rewarding than saccharin (high vs. low value reward), although
animals still evinced a strong preference for saccharin (~75-80% preference for
saccharin compared to ~85-90% preference for sucrose).
Overall, dopaminergic gene expression within the VTA, NAc and PFC was
decreased in male mice following chronic HFD. These findings are consistent with other
studies that observed decreases in dopamine related genes in response to HFD (Vucetic
et al., 2012; Alsio et al., 2010; Huang et al., 2005). Decreases in dopamine D2 receptor
expression and function have been observed in human imaging studies (Stice et al.,
2008; Wang et al., 2001) and rodent obesity models (Johnson & Kenny, 2010; Huang et
al., 2006). Decreased dopamine signaling reduces the sensitivity to natural rewards and
may therefore facilitate continued overconsumption of palatable foods and further weight
gain (Fortuna et al., 2012; Koob et al., 2008). Further, disrupted dopamine homeostasis
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driven through decreased DAT surface expression is known to drive increased intake of
high fat diet (Speed et al., 2008). An exception to this pattern was seen with DARPP-32,
a dopamine- and cyclic AMP-regulated phosphoprotein, which increased after HFD in
NAc and PFC. DARPP-32 plays a key role in integrating a variety of biochemical and
behavioral responses controlled by dopamine. It may be that DARPP-32 upregulation
was compensatory in response to the chronic down regulation of D1R. In a similar model
(12 wk HFD in mice), it has been shown that D1R down regulation was matched by an
increase in phosphorylation of DARPP-32 in NAc (Sharma et al., 2012).
Few studies have examined the capacity for recovery of these changes after
removal of the HFD. However, in two recent reports, gene expression changes and
reward system defects persisted after a short withdrawal period (14-18d) (Alsio et al.,
2010; Johnson & Kenny, 2010). In contrast, studies in obese patients before and after
gastric bypass surgery have shown a reversal of dopaminergic changes after a longer
period of weight loss (Steele et al., 2009). In males, the pattern of recovery varied by
brain region. In the VTA, the observed decreases in COMT, DAT, and TH were all
normalized with the removal of the HFD. In contrast, all gene expression changes
observed in the NAc and PFC did not normalize. In the current study, chronic HFD led to
significant weight gain and after 4 weeks off the diet, animals were still significantly
heavier than controls. Therefore, the subsequent metabolic and hormonal changes that
accompany obesity (e.g., increased leptin, elevated adipokines) were likely still present
at 4 weeks off the diet. Therefore, gene expression changes that normalized (e.g., in the
VTA) may have been primarily driven by the HFD, while those that were maintained (in
NAc and PFC) may be more tightly coupled to obesity. Maintenance of weight loss by
dieting is characteristically low (with 67% (Phelan et al., 2010) to 80% (Field et al., 2001)
of patients regaining the lost weight). This persistence of gene expression changes in
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reward regions could be important in partly explaining this common occurrence. It is also
important to note that the observed behavioral and gene expression changes are not
likely to be due to stress associated with changing diets, as there were no significant
changes in basal plasma corticosterone levels on the HFD or after 1wk or 4wk recovery.
Interesting sex differences were revealed, in both the response to chronic HFD, as
well as in response to diet removal. Females were similar to males in showing an overall
decrease in dopamine related genes that would predict a decrease in DA activity,
particularly in the VTA and the NAc. One noteworthy sex difference was the increase in
DAT mRNA expression in the female VTA after HFD. This difference in gene expression,
coupled with similar decreases in TH gene expression in both sexes, would suggest
significant differences in dopamine neurotransmission within the NAc, both at the end of
the HFD exposure as well as after the recovery period. A greater appreciation for the
functional significance of these differences is an important focus of future research.
Additionally, while COMT and TH decreases recovered in the male VTA, these
decreases persisted in the females after 4-week off the HFD. It is yet to be determined
whether these differences would reverse with a longer time off the diet, however, it
supports the conclusion that females are, at the very least slower to recover, if they
recover at all. Protein levels of TH matched gene expression levels on the high fat diet
but were not significantly decreased after a 4 week recovery period in both males and
females. Further, gene expression changes of D1R and D2R in NAc and PFC were quite
different between males and females. In males, there was a general decrease in gene
expression in both regions that largely persisted after diet removal. In females, D1R and
D2R were decreased in the NAc and then recovered, but there was no effect of HFD on
dopamine receptors in PFC. In the current studies, female animals were sacrificed
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without accounting for estrus stage. While some of the observed endpoints are known to
vary across the estrus cycle, female animals in this study did not demonstrate increased
variance across the endpoints, particularly when compared to the effect of the diet
manipulations.
To complement the gene expression and protein findings, dopamine was
measured in the primary projection regions of the VTA, namely the PFC and the NAc.
Dopamine levels tended to parallel changes seen in TH mRNA in the VTA. In the NAc of
both males and females, levels of DA decreased in response to the HFD diet; a
response which recovered in males, but not females. In the PFC, dopamine levels were
also decreased by HFD, however, there was no recovery off the diet in the PFC.
Additionally, females had lower levels of dopamine in the prefrontal cortex than males.
Sex differences in DAT expression and function are well known in the literature, with
females demonstrating increased DAT expression (Morissette et al., 1993) and function
(Bhatt et al., 2005), and these differences may contribute to the different baseline levels
of dopamine between males and females. Examination of the DOPAC:DA ratio is
informative as well. An increase in this ratio may have reflected a compensatory
response driven by decreases in DA. The long-term functional significance of these
changes in dopamine metabolism would be illuminated by measuring changes in
dopamine release using in vivo microdialysis.
Moreover, these data identify dynamic regulation of DNA methylation within the
promoter of the DAT gene, particularly in the males. Recently, we have demonstrated
that DAT expression can be dynamically regulated by differential DNA methylation in
response to HFD (Vucetic et al., 2012), and that increased DAT promoter methylation
correlates with a decrease in gene expression. Here we identify the plasticity of this
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response, as the increased DNA methylation (and decreased expression of the mRNA)
seen in males reverses upon removal of the HFD. Epigenetic gene regulation, for
example through changes in DNA methylation, presents a pathway whereby organisms
can readily adapt to environmental challenges. Epigenetic marks can be maintained
across the lifespan (Ollikainen et al., 2010), and in cultured embryonic stem cells, both
reversible and persistent patterns of differential DNA methylation were observed in
response to changing environmental conditions (Tompkins et al., 2012). These data are
the first to demonstrate in vivo a dynamic methylation pattern that changes with the
presence or absence of an environmental challenge. It was notable that this same
pattern was not observed in females. While the initial response to the HFD was as
predicted (decreased DNA methylation driving increased gene expression), this pattern
was not maintained throughout the recovery period. This suggests that DNA methylation
and gene expression may become uncoupled during the four weeks off the HFD or it
may suggest that DAT mRNA is regulated by other means in females.
In males, sucrose preference, DA-related gene expression in the VTA, and
dopamine in the NAc follow a consistent pattern, of suppression in response to the
chronic HFD that recovers after removal of the diet. Interestingly, while the behavioral
responses to sucrose are similar in the females, both the gene expression pattern and
NAc dopamine levels show a lack of recovery upon removal of the HFD. Reward-related
behaviors are clearly influenced by additional neurotransmitter systems such as the
opioids, and perhaps in females, the behavioral response to sucrose is more strongly
associated with changes in opioids. Overall, the present data suggest that sex
differences in the both the initial response to HFD, as well as to recovery after removal
of the HFD, with regard to dopamine-related gene expression represent an important
direction for future research directed at how chronic consumption of a HFD impacts the
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brain reward system. Most notably, these data identify significant plasticity in the
dopaminergic response to HFD, suggesting that while the adverse effects of chronic
HFD consumption and/or obesity are significant, the potential for recovery exists.

Table	
  and	
  Figure	
  Legends	
  
	
  
Table 1. Gene Expression Summary and Statistics in Males. Gene expression
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus
accumbens. Summary of fold change, significance and p values are presented for HF
and HF +recovery groups as compared to their age matched control.
Table 2. Gene Expression Summary and Statistics in Females. Gene expression
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus
accumbens. Summary of fold change, significance and p values are presented for HF
and HF +recovery groups as compared to their age matched control.
Figure 1. Sucrose preference but not saccharin preference is altered after high-fat
diet (HFD) exposure and returns to control levels after HFD recovery in males and
females. Sucrose preference (A,B) and saccharin preference (C,D) were evaluated in
counter balanced order of control (white bars) HFD (black bars) and HFD + recovery
(patterned bars) males and females. (n=8/group) *p<.05 significantly different from
control group.
Figure 2. Chronic high-fat diet (HFD) and recovery after HFD alters dopamine
related gene expression in males and females. Gene expression was measured in
the ventral tegmental area (VTA; A,D.), prefrontal cortex (PFC; B,E), and nucleus
accumbens (NAc; C,F) of control (white bars), HFD (black bars) and HFD + recovery
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(patterned bars) males and female mice (n=5/group). HFD and HF + recovery groups
are fold change from their own aged matched controls. Only one control group (12wk) is
shown and set to 1. *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly different from
own control group.
Figure 3. Chronic high fat diet (HFD) reduced TH protein levels in the ventral
tegmental area in both males and females. Protein levels of TH were visualized in the
VTA of both males (A) and females (B) and representative western blots are shown. C)
Quantification of TH protein florescence normalized to GAPDH from all male samples
(n=8). D) Quantification of TH protein florescence normalized to GAPDH from all female
samples (n=9). Statistically significant results are shown at an alpha level of p=0.05
Figure 4. Decrease in Dopamine levels in PFC and NAC after HFD from birth and
mixed recovery after HFD removal. Dopamine and dopamine metabolites were
measured in the PFC (A,B) and NAC (C,D) of control (white bars), HF from birth (black
bars) and HF + recovery (patterned bars). (n=8-10/group) *p<.05, **p<.01 significantly
different from control group.
Figure 5. Changes in DNA methylation status of DAT promoter parallel changes in
gene expression in the VTA. Genomic DNA was isolated from the dissected VTA of
control (white bars), HF from birth (black bars) and HF + recovery (patterned bars). DNA
was digested by restriction enzyme MSE1 and immunoprecipitated by a 5methylcytosine antibody. The enrichment of DNA methylation relative to input DNA in the
promoter region of DAT was quantified by qPCR (B, D). DAT mRNA levels, (A, C;
previously presented in Fig 1) are shown for comparison (n=5/group). *p<.05, **p<.01,
***p<.001 significantly different from control group.
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Supplementary	
  Information	
  Description	
  

Supplemental Figure 1. Body weights increase after 12 weeks HF diet and do not
normalize after 4wk recovery period. HF from birth animals (black circles) were placed
on 60% HF diet at postnatal day 1. After 12 weeks HF diet exposure, half the animals
were placed on control diet for a recovery period. Red line depicts time on HFD. Control
animals (black squares) remained on standard chow ad libitum throughout the
experiment. (n=5/time point/group) *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly
different from control group.
Supplemental Figure 2. Corticosterone levels in males were not different after 12
weeks HF diet or after HF + recovery. Plasma corticosterone levels (ug/dl) were taken
from trunk blood in control (white bar), HF from birth (black bar), HF +1wk recovery (gray
bar), and HF +4wk recovery (striped bar). Blood was taken at same time of day during
the light phase.
Taqman Gene Expression Primers:
COMT Mm00514377_m1
DAT

Mm00438388_m1

TH

Mm00447557_m1*

DARPP-32 Mm00454892_m1
DRD1 Mm01353211_m1
DRD2 Mm00438545_m1
Epitect ChIP qPCR Assay for MedIP assay:
DAT

	
  

Slc6a3, nM_010020.3(-)01Kb
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Tables	
  and	
  Figures	
  
	
  
Table	
  1.	
  Gene	
  Expression	
  Summary	
  and	
  Statistics	
  in	
  Males.	
  	
  

	
  

	
  

	
  

MALES	
  

Gene	
  

12wk	
  HFD	
  

P	
  value	
   	
  

Fold	
  change	
  

	
  

	
  

4wk	
  Recovery	
  	
  

P	
  value	
  

Fold	
  Change	
  

VTA	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.360	
  

<0.001	
  

	
  

1.93	
  

<0.01	
  

DAT	
  

0.423	
  

<0.001	
  

	
  

1.46	
  

<0.05	
  

TH	
  

0.380	
  

<0.01	
  

	
  

1.15	
  

0.145	
  

PFC	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.748	
  

0.0662	
  

	
  

.586	
  

<0.01	
  

DARPP-‐32	
   1.62	
  

<0.01	
  

	
  

1.55	
  

0.0386	
  

DRD1	
  

0.373	
  

<0.001	
  

	
  

0.553	
  

<0.01	
  

DRD2	
  

0.522	
  

<0.01	
  

	
  

0.450	
  

<0.01	
  

	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.402	
  

<0.01	
  

	
  

0.133	
  

<0.0001	
  

DARPP-‐32	
   2.03	
  

<0.025	
  

	
  

0.235	
  

<0.001	
  

DRD1	
  

0.521	
  

<0.01	
  

	
  

0.189	
  

<0.01	
  

DRD2	
  

0.512	
  

<0.001	
  

	
  

0.190	
  

<0.01	
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Table 2. Gene	
  Expression	
  Summary	
  and	
  Statistics	
  in	
  Females

	
  

	
  

	
  

FEMALES	
  

	
  

	
  

Gene	
  

12wk	
  HFD	
  

P	
  value	
  

	
  

4wk	
  Recovery	
  	
  

P	
  value	
  

Fold	
  
change	
  

Fold	
  Change	
  

VTA	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.502	
  

<0.0001	
  

	
  

0.074	
  

<0.0001	
  

DAT	
  

1.93	
  

<0.0001	
  

	
  

0.171	
  

<0.0001	
  

TH	
  

0.648	
  

<.05	
  

	
  

0.270	
  

<0.0001	
  

PFC	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.776	
  

<0.025	
  

	
  

0.376	
  

<0.0001	
  

DARPP-‐
32	
  

1.98	
  

<0.001	
  

	
  

0.853	
  

0.213	
  

DRD1	
  

1.21	
  

0.397	
  

	
  

0.567	
  

<0.025	
  

DRD2	
  

1.14	
  

0.662	
  

	
  

0.670	
  

0.1566	
  

	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

	
  

COMT	
  

0.678	
  

<0.01	
  

	
  

0.171	
  

<0.0001	
  

DARPP-‐
32	
  

0.830	
  

0.292	
  

	
  

2.05	
  

0.0521	
  

DRD1	
  

0.476	
  

<0.0001	
  

	
  

0.767	
  

0.186	
  

DRD2	
  

0.489	
  

<0.0001	
  

	
  

0.749	
  

0.0631	
  

	
  

59	
  

	
  

60	
  

	
  

61	
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Introduction	
  
	
  
Obesity rates have risen at an alarming rate in both children and adults over the
last decade (WHO, 2012). Obese children are more likely become obese adults with all
associated health issues (Reilly & Kelly, 2011; Wija et al., 2010; Wake M., et al., 2010)
and find it more difficult to lose weight in the future (Cockrell Skinner et al., 2013).
Overconsumption of readily available palatable food is one factor driving the increased
incidence of obesity in the U.S. Palatable foods are rewarding and acute consumption
releases the neurotransmitter dopamine, in a manner similar to the response to drugs of
abuse (Gieger et al., 2009). Repeated stimulation of dopamine (DA) reward pathways is
thought to cause adaptations in neurotransmitter levels and brain circuitry. These
adaptations can lead to an increase in compulsive behaviors and over consumption of
food/drugs of abuse (Volkow & Li, 2004; Verbeken et al., 2012). There is evidence of
dopamine dysregulation in obese patients. Obese individuals have decreased dopamine
receptor D2 binding (Wang et al., 2001) and decreased caudate activity (Stice et al.,
2008). Human dopamine D2 receptor mutations have previously been linked with
compulsive disorders and drug addiction (Blum et al., 1991; Vereczkei et al., 2013,
Wang et al, 2013). Palatable foods are often consumed when energy requirement have
already been met, indicating dysfunction in food intake behaviors. In fact, imaging
studies have revealed obese individuals have decreased activation in reward regions in
response to palatable food consumption (Stice et al., 201114,15; DelParigi et al., 2004).
The neuroadaptations that occur after chronic high fat intake alter the response
to drugs that act on the dopamine reward system; however, the reported effects have
been mixed. Some studies have shown the high fat diet to have a dampening effect on
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the rewarding aspects of drugs. Rodents on a high fat diet (HFD) have exhibited reduced
cocaine self administration (Wellman et al., 2007) and reduced conditioned place
preference for amphetamines (Davis et al., 2008). Rodents prone to develop obesity
show a reduced conditioned place preference for cocaine (Thanos et al., 2010). Johnson
& Kenny (2010) have reported reward dysfunction in obesity after rodents given high fat
diet had increased brain stimulation reward thresholds. One possible mechanism behind
the decrease reward value could be a decrease in basal extracellular DA (Gieger et al.,
2009) and reduced DA reuptake in the nucleus accumbens (NAc) (Cone et al., 2012) in
obese animals. Reward dysfunction has also been associated with decreases in
dopamine-related gene expression (Carlin et al., 2013; Alsio et al., 2010, Huang et al.,
2005). On the other hand, other studies have shown high fat diet to have a stimulating
effect on drugs acting in the dopamine reward system. Baladi et al. (2011) reported an
increase in cocaine-induced locomotion after high fat diet intake in adolescent and adult
rats. Additionally, a separate study reported obesity-prone rodents to have increased
extracellular dopamine (Narayanaswami, et al., 2013). These results demonstrate that
high fat diet alters the dopamine reward system, but direction and scale of effect may
depend on factors such as diet composition, length of exposure and age of the animals.
In fact, there are significant developmental and sex-related differences found in
dopamine neurochemistry (Rivest et al. 1999; Walker et al. 2000). Understanding the
critical factors that regulate the neuroadaptations seen in obesity may help the treatment
of the disease and the associated overconsumption of palatable foods.
Dopamine transporter (DAT) is a membrane-spanning pump that regulates
synaptic dopamine concentration by reuptake of the neurotransmitter into the synaptic
terminals and could be the target regulating the age and sex differences seen after high
fat diet. In obese individuals, DAT levels are reduced and negatively correlate with body
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mass index (Chen et al., 2008). Disruption of DAT expression increases synaptic
dopamine, elevates food intake, and increases preference for palatable foods (Pecina, et
al., 2003). Changes in dopamine levels in the synapse could alter the sensitivity to
natural rewards and facilitate even more overconsumption and further weight gain
(Johnson & Kenny, 2010; Pecina et al, 2003; McCutcheon et al., 2012).
Few studies have looked at the dopamine system after removal of the high fat
diet (Johnson & Kenny, 2010; Alsio et al., 2010, Steele et al., 2009) and none of these
studies have taken into account the age of onset of high-fat exposure. Research models
have also shown the importance of the early life environments in affecting behavioral
outcomes in adulthood (Zhu et al., 2010; Carlin et al., 2013b; Weaver et al., 2004;
Murgatroyd et al., 2009; Schwarz et al., 2011;). The first postnatal day through
adolescence is a particularly sensitive time period for brain development. Like early life
exposure to drugs of abuse, early exposure to HFD may induce stable changes in
circuitry that remain stable even after insult is removed. It has been increasingly
understood that timing of HFD modulates the development of adulthood reward seeking
behaviors (Teegarden et al., 2009; Labouesse et al., 2013; Naef et al., 2013; Naef et al.,
2012). The following experiments were designed to test the hypothesis that beginning a
high fat diet earlier in life would result in greater and more lasting changes in the
dopamine reward system. Further, they look to determine if age and sex are factors in
the development and persistence of dopamine changes and overconsumption of
palatable foods seen in obesity. Behavioral tests were preformed by the Gomez-Pinilla
lab at UCLA and the neurochemistry and gene expression experiments were performed
by the Reyes Lab at UPenn.
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Materials	
  and	
  Methods	
  
	
  
Animals and experimental model. C57BL/6J females were bred with DBA/2J
males (The Jackson Laboratory, Bar Harbor, ME) and were fed standard control chow
(#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) throughout pregnancy and
lactation. Offspring were weaned at 3wks of and a third of animals were then placed on
high fat diet (Test Diet, Richmond, IN #58G9; 18% protein, 60% fat, and 20.5%
carbohydrate). Another third of animals were placed on high fat diet at 6wks of age. The
final third were kept on standard hour chow. Animals remained on high fat diet for 12
weeks. A separate cohort after 12 weeks ad lib access to high fat diet was then switched
to control chow. Body weights were recorded weekly, and both male (n=510/experiment) and female (n=5-10/experiment) mice were used. The Institutional
Animal Care and Use Committee (IACUC) of the University of Pennsylvania approved all
procedures.
Fat pad Weights. Animals (n=5-10/group) were euthanized with an overdose of
carbon dioxide, followed by cervical dislocation; a method recommended by the Panel
on Euthanasia of the American Veterinary Medical Association. Body weights were
taken and white adipose tissue was removed. Specifically, the abdominal fat pads, the
gonadal fat pads, and the inguinal fat pads were weighed separately. Normalization of
fat pads to body weight was calculated.
Sucrose Preference. Mice were individually housed in standard cages for 3
days with access to ad lib food and two bottle choice. One bottle was filled with 200 ml of
4% sucrose solution (w/v), another with 200 ml of tap water. Sucrose (ml), water (ml),
and food consumption (g), were measured. Preference was calculated using the
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measurements from the last 2 days only as follows: preference % = [(sucrose
consumption/sucrose + water consumption) × 100]. (n=8-10/group)
One-Hour Palatable Food Intake. Mice were individually housed (n=1112/group) in standard cages for a total of 8 days. Each day, home cage food and body
weight were measured. Animals were given access to a bowl with palatable high fat/high
sugar food (Peanut Butter Chips) or control diet for one hour and measured. Daily caloric
intake of ad libitum chow, palatable food, and percent calories/day were calculated.
Because presence of high fat diet could have an effect on intake of palatable food, a
separate cohort of Pre-Adolescent HF and Adult HF were acutely placed on ad libitum
control chow during the experiment. This group is labeled HF+1wk recovery and
compared to HF and HF + 4wk recovery groups.
Genomic DNA and Total RNA isolation from the brain. Animals (n=5/group)
were euthanized with an overdose of carbon dioxide, followed by cervical dislocation; a
method recommended by the Panel on Euthanasia of the American Veterinary Medical
Association. Brains were then rapidly removed and placed in RNAlater (Ambion, Austin,
TX) for 4-6 hours before dissection. Brain dissections to isolate the prefrontal cortex, the
nucleus accumbens and the ventral tegmental area were preformed as previously
described (Vucetic et al. 2010, Reyes et al. 2003). Genomic DNA and total RNA were
isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen).
Gene expression analysis by quantitative Real-Time PCR. For each
individual sample, 500ng of total RNA was used in reverse transcription using High
Capacity Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes
was determined by quantitative RT-PCR using gene specific Taqman Probes with
Taqman gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler.
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Gene probes are listed in supplemental material. Relative amount of each transcript was
determined using delta CT values as previously described in (Pfaffl 2001). Changes in
gene expression were calculated against an unchanged GAPDH standard.
Ex vivo Dopamine and Dopamine Metabolite Measurement by HPLC. High
performance liquid chromatography will be used to measure dopamine content of the
mesolimbic reward areas of the brain (n=8-12). Brains will be collected from animals and
cut into right and left hemispheres. NAc and PFC will be dissected out and quickly frozen
by dry ice and stored at -80°C. Samples will be analyzed by the Bioanalytical Systems
HPLC (West Lafayette, IN, USA) with a PM-80 pump, a Sample Sentinel autosampler,
and an LC-4C electrochemical detector. Samples (12 ul) will be run through a reverse
phase micropore column at a flow rate of 0.6 ml/min and electrodetection at +0.6 V.
Separation for dopamine and dopamine metabolites will be accomplished by a mobile
phase consisting of 90-mM sodium acetate, 35-mM citric acid, 0.34-mM ethylenediamine
tetraacetic acid, 1.2-mM sodium octyl sulfate, and 15% methanol v/v at a pH of 4.2
(Mayorga et al., 2001; Vucetic et al., 2010).

Statistical Analysis. Gene expression analysis was performed using
Student T-test comparing aged matched controls to HF and HF + recovery groups.
The alpha level was adjusted for the multiple brain regions surveyed using a
Bonferronni correction (e.g. significance of a gene used in one brain region was
p=.05; for two regions, p=0.025, for 3 brain regions p=.016). Sucrose preference,
HPLC measurements, food intake, body weights, and fat pad weights were
analyzed using one-way ANOVA to compare control, HF, and HF + recovery
groups. Post-hoc Bonferonni Multiple Comparison Tests were used to compare
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pair-wise differences between groups. Significance for these tests was set at an
alpha level of p=.05.

Results	
  

Nomenclature.
Animals that started the high fat diet at weaning are labeled “Pre-Adolescent HF”, while
animals that started the high fat diet at 6 weeks of age are labeled “Adult HF.”
Body and Fat pad weights.
Body weights were taken weekly and fat pad weights were taken at the sacrifice at end
of study. Within 6 weeks on HF diet, animals reached significantly higher body weight
than control and remained significantly heavier than controls after a 4-week chow
recovery period in both Pre-Adolescent (Figure 1A, F(18,100)= 110.4, p<0.0001) and
Adult HF males (F(20,108)=97.60, p<0.0001). Pre-Adolescent HF females (Figure 1B,
F(17,95)=56.57, p<0.0001) took less time to reach significantly higher body weight than
Adult HF females (F(20,115)=34.89, p<0.0001). A 4-week standard chow recovery was
not sufficient to normalize body weights in females. Figure 1C shows male body weights
heavier in HF and HF+ recovery at experimental time points compared to their own aged
matched controls in Pre-adolescent (F(3,30)=39.59, p=0.0051) and Adult HF
(F(3,28)=26.67, p<0.0001). The same weight pattern is seen in females. HF and HF+
recovery Pre-adolescent (Figure 1E, F(3,40)=40.89, p<0.0001) and Adult
(F(3,54)=24.86, p<0.0001) females are heavier than their aged matched control at
experimental time points. Abdominal fat pad weights were taken and shown as a
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percentage of body weight and compared to own aged matched controls. PreAdolescent males have increased fat pad mass as a percentage of body weight after
high fat diet and after a 4 week standard chow replacement (Figure 1D, F(3,34)=103.9,
p<0.0001). Planned comparisons shown significant increase in fat pad mass in PreAdolescent HF males and in Pre-Adolescent HF+recovery compared to their own aged
matched controls (Figure 1D, p<0.0001, p<0.05). Adult males show a similar increase in
fat pad mass after high fat diet and after a standard chow recovery (Figure 1D,
F(3,29)=79.57, p<0.0001). Planned comparisons reveal Adult HF males to have
significantly heavier fat pad mass versus their aged match controls (Figure 1D,
p<0.0001) and Adult HF + recovery males were similarly increased versus their own
aged matched controls (Figure 1D, p<0.0001). In females we see a similar increase in
fat pad mass after high fat diet intake and failure of a 4 week standard chow
replacement to normalize body fat pad percentage.
Pre-Adolescent females have increased fat pad mass as a percentage of body
weight after high fat diet and after a 4 week standard chow replacement (Figure 1F,
F(3,30)=59.86, p<0.0001). Planned comparisons shown significant increase in fat pad
mass in Pre-Adolescent HF females and in Pre-Adolescent HF+ recovery compared to
their own aged matched controls (Figure 1D, p<0.0001, p<0.05). Adult HF females show
a similar increase in fat pad mass after high fat diet and after a standard chow recovery
(Figure 1F, F(3,32)=43.79, p<0.0001). Planned comparisons reveal Adult HF females to
have significantly heavier fat pad mass versus their aged match controls (Figure 1F,
p<0.0001) and Adult HF + recovery females to have increased fat pad mass increased
versus their own aged matched controls (Figure 1F, p<0.01).
Sucrose Preference
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Sucrose preference test was administered to assess the animals’ response to a natural
and nutritive rewarding stimulus. All animals preferred the 4% sucrose solution over
water (preference > 50%). In males, sucrose preference was significantly reduced after
12 weeks HF diet in the Pre-Adolescent animals (Figure 2A, F(2,17)=17.58, p<0.0001),
yet unchanged in adult HF animals. Sucrose preference was decreased in both female
Pre-Adolescent HF (Figure 2C, F(2,16)=12.07, p<0.0006) and Adult HF mice
(F(2,15)=7.497, p<0.0055) after 12 wks high fat diet. Preference in all groups where
sucrose preference was decreased returned to control levels after standard chow
recovery period.
One-Hour Palatable Food Intake
Animals were given one-hour access to high fat/high sugar food to assess their
response to intermittent palatable food. In Pre-Adolescent males, chronic HF reduced
the amount of palatable food intake (Figure 3A, F(7,39)=13.58, p<0.0001). 1 hr access
to control food was not changed. Post-hoc analysis shows that standard chow
replacement during the experimental period or for 4 weeks prior increased palatable
food intake compared to pre-adolescent animals on chronic HF (Figure 3A, p<.001,
p<.0001). Female Pre-Adolescent HF animals did not significantly reduce their 1hr
palatable food but they increased their intake after the 4wk standard chow replacement
(Figure 3B, F(7,41)=9.281, p<0.0001). Post hoc analysis revealed an increase in 1hr
palatable food intake after 4wk standard chow replacement to be statistically greater
than controls (Figure 3C, p<.01). Both a 1wk and 4wk standard chow recovery groups
were statistically higher than Pre-Adolescent HF female group (Figure 3B, p<.001,
p<0.0001).

	
  

75	
  

Similarly, adult HF males had significantly reduced 1hr palatable food intake
compared to controls. (Figure A F(7,38)=11.89, p<0.0001). A standard chow
replacement normalized 1hr intake levels after 1wk recovery and after 4wk recovery.
Post hoc analysis in males revealed Adult 1wk recovery group to be statistically higher
than Adult HF (Figure 3A, p<0.0001). Adult HF females also reduced their 1hr intake
while on HF diet and normalized intake after both a 1wk standard chow recovery and a
4wk standard chow recovery (Figure 3B, F(7,39)=16.47, p<0.0001). Post hoc analysis
revealed both HF+ 1wk recovery and HF+ 4wk recovery to be significantly higher than
Adult HF intake in females (Figure 3B, p<0.01, p<0.0001).
Percent of daily calories eaten during the 1 hr food access was also calculated in
Pre-Adolescent males (Figure 3C, F(7,37)=7.698, p<0.0001). There was a decrease in
percent of daily calorie intake in Pre-Adolescent HF males that normalized after standard
chow removal. Post hoc analysis revealed a statistical increase after 4 wk standard
chow replacement compared to animals on a HF diet (Figure 3C, p<0.0001). PreAdolescent HF females did not significantly decrease their 1 hr palatable food’s percent
of daily calories, however it was significantly increased after 1wk and 4wk standard
chow replacement (Figure 3D, F(7,41)=9.907, p<0.0001). Post hoc analysis revealed
standard chow replacement for 1wk or 4wks was significantly higher than controls
(Figure 3D, p<0.0001,p<0.05). 1wk recovery and 4wk recovery females also significantly
increased their daily calorie percentage compared to Pre-Adolescent females on HF diet
(Figure 3G, p<0.0001, p<0.001). Pre-adolescent HF females reached binge level intake
of palatable food after 1wk and 4 wk recovery (<25% daily intake). Adult HF males had
decreased percent daily intake of palatable food compared to controls and this was
normalized after 1wk or 4wk standard chow recovery (Figure 3C F(7,37)=11.62,
p<0.0001). Post hoc analysis revealed that a 4wk standard chow recovery leads to a
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significant increase in daily percentage compared to Adult males on HF (Figure 3C,
p<0.0001). Similarly, adult HF females had a decreased percentage of daily calories
from 1hr intake compared to controls and this was normalized by 1wk or 4wk standard
chow recovery (Figure 3D, F(7,39)=16.25, p<0.0001). Post hoc analysis revealed that
1wk recovery or 4wk recovery lead to significantly higher percentage of daily intake than
Adult females on HF (Figure 3D, p<0.001, p<0.0001).
Gene Expression
Dopamine-related gene expression was examined within the reward circuitry [Table 1
summarizes the statistical analysis and gene expression patterns in the VTA, NAc, and
PFC regions in both male diet groups compared to their aged matched controls]. All
gene expression data is presented in the table as fold change values from separate
aged-matched controls for HF and HF+ recovery cohorts. Only one control group for HF
group is shown on graph and set to 1 for clarity. Key findings will be highlighted here.
Significance was determined at a corrected alpha level of p=(0.05/# brain regions
assayed). Dopamine related genes in the VTA of Pre-Adolescent males were down
regulated after high fat intake and changes were more persistent than Adult HF males.
Student’s t-test (n=5/group) revealed in the VTA of Pre-Adolescent HF males DAT and
TH mRNA were significantly decreased after HF exposure (Figure 4A, p<0.001, p<
0.001). COMT followed a different pattern; mRNA levels were elevated after 12wks HFD
(Figure 4A, p<0.01). After a 4 week standard chow replacement, DAT and TH mRNA
levels remained significantly decreased (Figure 4A; p<0.0001, p<0.0001) and COMT
remained significantly elevated (Figure 4A, p<0.01). In the VTA of Adult HF males, DAT
and TH were similarly decreased after 12 week HF exposure (Figure 4B; p<0.05,
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p<0.01), however in these animals DAT and TH mRNA levels in Adult HF males to
control levels normalized after the 4wk standard chow replacement.
In the NAc and PFC, genes important for DA signaling and DA turnover were
examined (n=5/group). Pre-Adolescent HF males had a different pattern of gene
expression than Adult HF males in the NAc. Figure 4C shows Pre-Adolescent HF males
had increased mRNA levels of COMT and DARPP-32 after 12 wks HFD. DR1 and DR2
showed a different pattern of expression and were decreased in the NAc of PreAdolescent HF males (Figure 4C, p<.01, p<.01). A 4 week standard chow replacement
was able to normalize COMT and DARPP-32 back to control levels in Pre-Adolescent
HF male NAc. Pre-Adolescent HF male DR1 and DR2 mRNA levels remained
significantly decreased after a 4 week recovery period (Figure 4C, p<.025, p<.0001). In
Adult HF males a different pattern emerged. In the NAc of Adult HF, exposed mice had
decreased mRNA levels of COMT and DARPP-32 (Figure 4D, p<.01, p<.01) and
decreased DR1 and DR2 mRNA (Figure 4D, p<.01, p<.025) after 12wk HFD exposure.
All genes examined in Adult HF males normalized to control levels after a 4 week
standard chow replacement.
Gene expression of DA related genes decreased in the PFC of both PreAdolescent HF and Adult HF males and both were able to normalize to control levels
after a 4wk recovery in most genes analyzed. Figure 4E shows decreased expression of
COMT, DR1 and DR2 mRNA in Pre-adolescent HF (Figure 4E, p<.001, p<.001, p<.025)
after 12wks HFD. After a 4-week standard chow replacement, mRNA levels of COMT
and DARPP-32 normalized in the PFC of Pre-Adolescent HF males (Figure 4E). The
Adult HF male PFC had decreased COMT, DARPP-32 and DR1 mRNA levels (Figure
4F, p<.01,p<.01, p<.0001) after 12wk HFD. COMT remained significantly decreased in
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Adult HF+ recovery males (Figure 4F; p<0001); however, DR1 levels returned to control
levels normalized after the standard chow recovery period. DR2 mRNA levels in the PFC
remained unaffected.
The same regions and genes were examined in female mice (n=5/group). [Table
2 summarizes the statistical analysis and gene expression patterns in the VTA, NAc, and
PFC regions in both female diet groups compared to their aged matched controls]. There
were significant differences observed in the gene expression pattern in response to
12wks HFD and HFD followed by recovery at different developmental periods. Most
notably, we observed an important sex difference in the regulation of DAT in the female
VTA. DAT mRNA levels increased after 12 week HF diet (Figure 5 p<.05). Additionally in
the VTA, female Pre-Adolescent HF TH mRNA levels were decreased (Figure 5A;
p<.05) and COMT remained unchanged. DAT mRNA levels remained elevated (Figure
5A, p<.05) and TH mRNA remained decreased (p<.01) in Pre-Adolescent HF female
VTA after a 4 week standard chow replacement. In Adult HF female VTA, we observed a
similar increase in DAT expression (Figure 5B; p=.054) that recovered. COMT and TH
expression were unchanged in Adult HF female VTA.
In the NAc, both Pre-Adolescent and Adult HF females had a similar pattern of
disruption of dopaminergic gene expression after HF diet and diet removal. PreAdolescent females had decreased DR1 and DR2 receptor mRNA in the NAc (Figure
5C, p<.01, p<.01) as well as decreased COMT mRNA (Figure 5C, p<.01). A 4-week
standard chow replacement was unable to normalize the expression of COMT and DR2
and they remained significantly decreased in Pre-Adolescent HF females (Figure 5C;
p<.001, p<.001). Adult HF females showed a similar decrease in DR1 and DR2 (Figure
5D, p<.01; P<.001) as well as decreased DARPP-32 mRNA (Figure5D, p<.01) in the
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NAc. After a 4 week standard chow replacement, DARPP-32 and DR1 expression
normalized to control levels. However, DR2 mRNA remained decreased (Figure 5D,
p<.001) in Adult HF +recovery female NAc.
Gene expression analysis in the PFC revealed further differences between PreAdolescent HF and Adult HF exposed females. In Figure 5E, Pre-Adolescent females
showed decreased COMT, DARPP-32, DR1 and DR2 mRNA expression after 12wks
HFD (p<.001, p<.01, p<.0001, p<.025, respectively) and all but COMT recovered. A 4week standard chow replacement failed to normalize DARPP-32 (Figure 5E, p<.025)
and left DR1 significantly increased compared to controls (p<.025). 12 weeks HF diet in
Adult females did not alter dopaminergic genes in the PFC (Figure 5F). However, the
standard chow replacement did lead to significant increases in DARPP-32 and DR1
mRNA (Figure 5F; p<.025, p<.0001) in Adult female PFC.

Dopamine and DOPAC Levels
Given the changes in gene expression for dopamine (DA) regulating genes in the VTA,
DA and DA metabolites were quantified in regions that receive projections from the VTA:
NAc and PFC (n=7-10/group). Figure 6 shows DA and the DA metabolite, DOPAC,
measured in the NAc and PFC of males and females exposed to the HF diet at different
developmental periods. In general, the NAc had higher levels of DA and DOPAC than
the PFC. High fat diet altered DA levels only in Pre-Adolescent males while Adult HF
males were unaffected. Dopamine in the NAc was increased after chronic HFD in PreAdolescent males and remained significantly increased after standard chow replacement
(Figure 6A, F(2,26)=8.267, p< .0.01). DOPAC in the NAc was decreased by chronic HF
in these animals and remained decreased after standard chow replacement (Figure 6A,
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F(2,26)=6.127, p< 0.01). On the other hand, DA and DOPAC levels in Adult HF males
NAc were unaffected by HF and HF+recovery (Figure 6A, F(2,22)=1.832, p=0.1838;
F(2,22)=1.503, P=0.2444, respectively). A measure of dopamine turnover was
calculated as the ratio of DOPAC:DA for all groups and brain regions. Dopamine
turnover was decreased in Pre-Adolescent HF and remained decreased after recovery
period (Figure 6B, F(2,26)=10.25, p< 0.001). Dopamine turnover was unaltered in Adult
HF animals. In the PFC, only Pre-Adolescent male DA levels were affected by chronic
HFD. Figure 6E shows the DA and DOPAC levels in the PFC of Pre-Adolescent males.
One-way ANOVA revealed DA was increased compared to controls (Figure 6E,
F(2,25)=5.321, p< 0.05) after 12wk HFD. A 4wk standard chow recovery period
normalized DA back to control levels in this region. Pre-Adolescent HF DOPAC levels in
the PFC was unaltered (Figure 6E F(2,17)=1.135, P= 0.3447). DA and DOPAC levels
were not significantly different compared to controls in Adult HF.
DA, DOPAC and DA turnover were also measured in the NAc and PFC of
females. In general, females DA levels seemed less affected by HFD and age of
exposure in these regions. In contrast to males, female Pre-Adolescent group was
unaltered by HF and HF+recovery in the NAc. DA (Figure 6C, F(2,27)=0.1211,
P=0.8864) and DOPAC (Figure 6C, F(2,26)=2.840, P=0.0767) were not changed
compared to controls. DA turn over was decreased in Pre-Adolescent HF+ recovery
group ( Figure 6D, F(2,27)=5.543, P < 0.01). Adult HF females had higher levels of DA in
the NAc, but neither dopamine or DOPAC were significantly different than controls after
HF or HF+recovery ( Figure 6C, F(2,20)=1.132, P=0.342; F(2,20)=2.521, P= 0.1056).
Dopamine turnover in the female Adult HF NAc was also unaltered compared to controls
(Figure 6D, F(2,20)=0.9218, P=0.4141).
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Similar to males, female Pre-Adolescent HF PFC had increased DA after 12 wks
HFD that normalized after 4wk recovery (Figure 6G). One-way ANOVA revealed
dopamine was significantly different than control levels and DOPAC levels were
unaffected (Figure 6G, F(2,26)=3.845, p < 0.05; F(2,21)=0.1879, p=0.8301). In contrast
to the NAc, PFC dopamine turnover was unaffected by 12wk HF. However it was
increased in Pre-Adolescent HF+ recovery (Figure 6H, F(2,17)=16.03, P< 0.0001).
Similar to Pre-Adolescent HF females, dopamine in the Adult HF PFC was significantly
increased compared to controls (Figure 6G, F(2,23)=6.839, P < 0.01) and normalized
after 4wk recovery period. In Figure 6H, analysis revealed DOPAC to be unaltered in
Adult HF (Figure 6G, F(2,15)=1.630, P=0.2288) and dopamine turnover to be increased
in Adult HF+ recovery female PFC (Figure 6H, F(2,13)=16.67, P < 0.001).

Discussion	
  
	
  
We have investigated the age of onset and sex as critical variables in the neuroadaptations seen after chronic high-fat diet intake and standard chow replacement.
Chronic high-fat diet caused changes in sucrose preference, intake of palatable food,
dopaminergic gene expression, and dopamine neurotransmitter levels. We
demonstrated that it is possible to reverse the neuroadaptations and behavioral changes
seen after high fat diet by a 4-week standard chow replacement. However, in some
cases, we observed a pattern of persistence that depended on both age of diet onset
and sex. The rodent brain continues to development after parturition and this postnatal
development is highly influenced by the environment and nutritional state. We
hypothesized that an earlier exposure to high fat diet would be more damaging to the
dopamine reward system than if the diet was started later in life. We demonstrated an
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earlier onset of high fat diet intake decreased sucrose preference and increased
dopamine neurotransmitter levels while adult onset remained unaffected in our male
animals. We demonstrated that high fat diet had a similar effect in females starting high
fat intake early or later in life. However, there were important sex differences observed in
response to diet onset. We also hypothesized that an earlier exposure to high fat diet
would lead to more a more persistent phenotype than if diet was started later in life. After
a 4-week standard chow replacement, behavioral changes returned to control levels,
however gene expression changes and neurotransmitter level changes persisted in
males beginning the diet early in life. Gene expression changes also failed to normalize
in females who began the high fat diet earlier in life. Failure to normalize gene
expression changes after standard chow replacement may be due to disruption during a
sensitive time window from weaning to 6 weeks of age.
The two critical factors we looked to examined in response to high fat diet and
high fat withdrawal were sex and age of onset. Some important sex differences were
observed in body weight gain, one-hour palatable food intake, and dopaminergic gene
expression. Many of the sex differences were seen in response to the high fat diet and
not in the response to high fat removal. In both males and females age of diet initiation
had little impact on final body weight. However, Adult HF males gained weight more
rapidly than Pre-Adolescent males and obtained a significantly different body weight
after only 3 weeks on HF diet. The opposite was seen in females; it took longer for Adult
HF females to become significantly heavier than controls. This could be due to the
protective effects higher level of estrogen in the post-pubertal period that can increase
metabolism. Both males and females failed to normalize their body weight after a 4-week
standard chow replacement. This fact was important to analyzing the effects of removal
of the high fat diet and the response to significant weight loss. An important sex
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difference occurred in the sucrose preference test where adult HF exposed males
remained unaffected and females had decreased preference for sucrose. Sex has
previously been shown to be important in self administration of other rewarding
substances such as saccharin, cocaine and morphine (Dess et al., 1998; Dess, 2000;
Carroll et al., 2002) with females having a more rapid rate of acquisition and an increase
in administration. The decrease in sucrose preference is consistent with the reward
deficiency model of obesity. The decrease in value natural rewards could lead to
overconsumption of rewarding food in order to increase total reward levels.
To determine the risk of overconsumption in animals given chronic HF diet, we
gave mice daily 1-hour access to high fat/high sugar food and measured their caloric
intake. Intermittent access has been previously used to elicit binge eating in lean rodents
(Corwin et al., 2004). “Bingeing” is typically defined as a bout of food intake greater than
what normally would be consumed in the same period (>25% daily calories in one hour).
One important sex difference we see that females given high fat diet earlier in life do not
suppress their palatable food intake while on high fat diet as seen in males. This could
mean that pre-adolescent exposed females lose the ability to regulate their intake when
there is already calorically dense food available. Another important observed sex
difference was seen in response to high fat diet removal on one-hour palatable food
intake. Both males and females on the HF diet tend to reduce thier intake during the 1hr
palatable food access than controls. However, after acute and long term removal of high
fat diet, males normalized palatable food intake while pre-adolescent exposed females
greatly increased intake and reached binge levels of eating. Indeed, binge eating is more
prevalent in females than in males (Kessler et al., 2013) but this seems to be an
interaction with sex and removal of HF diet. Decreased inhibitory control could be the
underlying factor behind the difficulty with dieting and weight loss in women (Woods et
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al., 2003). Our study has shown that chronic HF intake does not cause
overconsumption when the HF is present. It is the acute removal of HF that causes an
increase in palatable food consumption and females may be prone to bingeing in this
state.
Dopamine is an important neurotransmitter that regulates the intake of rewarding
substances. Our lab has previously published decreases in DA and opioid related genes
in reward related regions after chronic HF for varying lengths of time (Vucetic et al.,
2012; Carlin et al., 2013). Changes in dopaminergic genes have been seen in many
obese rodent models, but few studies have looked at this system after a standard chow
replacement period. Interesting age and sex differences were revealed both in the
response to the HF diet and after a 4 week recovery period. In females, we observed an
interesting sex difference in the VTA. Females given chronic high fat diet had increased
DAT expression while males had decreased DAT levels. The difference in DAT
expression would oppositely affect levels of dopamine in the synapse and may be
important for some of the behavioral differences observed. Sex differences in basal DAT
expression have previously been observed in both humans (Lavalaye et al., 2000) and
animals (Rivest et al., 2005) and revealed DAT levels to be overall higher in females.
Our lab has previously published that high fat diet beginning at birth regulated DAT
levels through DNA methylation at the promoter region (Carlin et al., 2013). Further
studies are needed to understand how sex hormones and epigenetic machinery interact
to regulate gene expression in response to high fat diet and high fat replacement.
The second factor we found to be important in regulating the reward system’s
response to high fat diet and HF replacement was age of onset. We predicted that an
earlier age of onset for high fat diet would be more damaging to the dopamine reward
system than adult onset. Sucrose preference test in our study was one example where
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age of HF diet onset was important. The pre-adolescent time period is an important
window for programming the taste for palatable foods (Teegarden et al., 2009). We
found a decrease in sucrose preference for pre-adolescent HF males while adult HF
males remained unaffected. Sucrose preference is a broad measure of natural reward
intake. Decrease in sucrose consumption is considered an animal model of anhedonia.
The decrease in sucrose preference is consistent with the hypo reward hypothesis of
obesity. Obese patients show decreased activity in reward related regions when
ingesting a palatable solution (Stice et al., 2010). We also observed normalization of
sucrose preference after a 4 week standard chow recovery period. Normalization is also
observed in gastric bypass patients who show increases in sucrose preference after
surgery (Bueter et al., 2011). The decrease in sucrose preference seems to be caused
by the presence of the HF diet and not the factor of obesity itself. This factor emerges in
non-diet induced obese rodent models such as the OLETF CCK-1 knockout rats that
become obese on control chow. OLETF rats show increased preference for sucrose
preference compared to controls (Marco et al., 2012). This could be due to high fat diet
neuroadaptations causing decreases in reward value or increases in satiety levels.
We predicted that an earlier high fat diet would cause changes in the dopamine
reward system that would persist throughout a standard chow recovery period because
of possible programming effects that can occur during a vulnerable developmental
window. Pre-Adolescent and Adult HF animals had a similar gene expression response
to the high fat diet. It was in the standard chow replacement period where we observed
differences in the ability to normalize between age groups. For example, a 4 week
standard chow recovery period was unable to normalize the gene expression levels
COMT, DAT, and TH in the VTA in animals who began HF diet earlier in life. In the post
synaptic region of the NAc, animals that began high fat diet earlier in life had decrease
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expression of DR1 and DR2. This is consistent with the hypodopaminergic hypothesis of
obesity. Further, a 4 week standard chow recovery was unable to normalize DR1 and
DR2 in the NAc of these animals. Adult HF exposure had similar decreases in dopamine
receptors but normalized expression after the recovery period. Further, pres-adolescent
exposure to high fat caused increases in DA that persisted in the NAc after 4 week
standard chow replacement while adult exposure DA levels remained unchanged. Early
life exposure to high fat also seemed to be more detrimental in females. Early life
exposure to high fat decreased expression levels of COMT, DARPP-32, DR1, and DR2
in both the NAc and PFC. A 4 week standard chow replacement was unable to
normalize genes in the NAc, however DR1 and DR2 both normalized in the PFC.
Interestingly, the PFC of the Adult HF females exposure group was unaffected by high
fat diet. Decreases in DR2 were seen in response to high fat diet and remained
decreased after a recovery period in animals exposed to diet earlier in life. Low
dopamine receptor D2 levels are implicated in obesity, drug addiction and impulsive
behaviors (Wang et al., 2001). Decreased DRD2 in reward regions predicts reward
dysfunction and binge-like behavior (Johnson & Kenny., 2010) and decreases in gene
expression in diet induced obesity could leave animals more prone to overconsumption.
We see from these results that age of onset is an important factor when examining gene
expression changes and persistence after diet manipulation. It suggests the existence of
a vulnerable period that when manipulated, can alter the response to high fat diet in
adulthood.
In summary, we have shown that chronic HF diet leads to changes in dopamine
circuitry and reward consumption and that it is possible to reverse these changes before
body weight normalization with a 4 week standard chow replacement. We revealed
chronic HF diet leads to altered dopaminergic gene expression, neurotransmitter levels,
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and dopamine turnover in a sex and age dependent manner. Moreover, the reversal of
these changes is more difficult in animals who received high fat diet earlier in life.
Women and adults who were obese as children find it more difficult to lose weight then
the rest of the population. Altered dopamine circuitry that persists during “dieting” could
be behind high failure rates seen in these populations. Further studies are needed to
examine how these populations are more vulnerable to high fat diet circuitry changes
and which specific changes are behind the overconsumption of palatable food in obesity.
Other neurotransmitters, such as the endogenous opioid system, also regulate intake
and the “liking” of natural rewards. It has been shown that mu opioid receptors (MOR)
levels are decreased on high fat diet and this is associated with increase in epigenetic
marker levels, such as DNA methylation at promoter region (Vucetic et al., 2011). It is
possible that epigenetic machinery may be altered by high fat diet during the vulnerable
window from weaning to 6 weeks of age, therefore programming the obesity phenotype
into adulthood. Differences in the ability of these changes to normalize may be behind
the difficulty in weight loss and the relapse to over consumption that occurs in many
obese individuals. Understanding how age of onset and sex interact with gene
expression changes after removal of HF diet will help us predict who is most vulnerable
to overconsumption and point us in the right direction for better obesity interventions.
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Figure	
  and	
  Table	
  Legends	
  
Table 1. Gene Expression Summary and Statistics in Males. Gene expression
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus
accumbens in both Pre-Adolescent and Adult HF males. Summary of fold change,
significance and p values are presented for HF and HF +recovery groups as compared
to their age matched control.
Table 2. Gene Expression Summary and Statistics in Females. Gene expression
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus
accumbens in both Pre-Adolescent and Adult HF females. Summary of fold change,
significance and p values are presented for HF and HF +recovery groups as compared
to their age matched control.
Figure 1. 12 week exposure to high fat diet causes increase in body and fat pad
weights and these increases are not normalized by a 4 week standard chow
replacement. Body weights (n=10/group) were measured weekly in Pre-adolescent
(blue triangles) and Adult HF animals (green squares) males (A) and females (B) and
shown in grams. Red dashed line depicts time on HF diet, blue dashed line depicts time
of standard chow recovery. Control animals (black triangles) remained on standard chow
throughout the experiment. C) Bar graph of end point body weights of control (white bar),
HF (black bar), and HF+ recovery (horizontal striped bar) males in grams. D) Normalized
Abdominal Fat Pad weights in males shown as percentage of end point body weight E)
Bar graph of end point body weights of control (white bar), HF (grey bar), and HF+
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recovery (horizontal striped bar) females in grams. F) Normalized abdominal fat pad
weights in females shown as percentage of end point body weight.
Post hoc comparisons shown at alpha levels *p<.05, **p<.01, ***p<.001, ****p<.0001
significantly different from aged matched control group.
Figure 2. Sucrose preference is decreased after high-fat diet (HFD) exposure in
Pre-Adolescent HF males and females and recovers after standard chow
replacement. Percent preference for 4% sucrose was evaluated in control (white bars)
HF (solid bars) and HFD + recovery (striped bars) Pre-Adolescent and Adult HF age
groups (n=8/group). Males are shown in black (A), females are shown in grey(B). Post
hoc comparisons are shown at alpha levels *p<.05, **p<.01, ***p<.001 significantly
different from own control group.
Figure 3. Chronic HFD causes decrease intake of palatable food during one-hour
challenge. Standard chow replacement during experiment or 4 weeks caused an
increase in palatable food intake. Intake during one-hour palatable food access was
measured in control (white bars) HF (solid bars) and HF + 1wk recovery (dotted bars)
and HF + recovery (horizontal striped bars) for Pre-Adolescent and Adult HF males (A)
and females (B). Percent of daily calories eaten during the 1 hr palatable food access
was calculated for both male (C) and female (D) age groups (n=3/group for 1hr control
chow access and n=9/group for 1hr palatable food access. Post hoc planned
comparisons shown at alpha levels *p<.05, **p<.01, ***p<.001 significantly different from
own control group or ##p<.01, ###p<.001, ####p<.0001 significantly different from HF
group.
Figure 4. Chronic high-fat diet (HFD) alters dopamine related gene expression in
males. Pre-Adolescent HF males were less able to normalize gene expression in
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examined reward regions of the brain. Gene expression was measured in the ventral
tegmental area (VTA;A,D), nucleus accumbens (NAc; B,E), and prefrontal cortex (PFC;
C,F) of control (white bars), HFD (solid bars) and HFD + recovery (striped bars) PreAdolescent and Adult HF male age groups (n=5/group). HF and HF + recovery groups
are shown as fold change from their own aged matched controls. Only one control group
(15wk) is shown and set to 1 for clarity. Post hoc planned comparisons shown at alpha
levels *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly different from own control
group.
Figure 5. Chronic high-fat diet (HFD) and HF+ recovery alters dopamine related
gene expression differently in Pre-Adolescent and Adult HF females. Gene
expression was measured in the ventral tegmental area (VTA; A,D), nucleus accumbens
(NAc; B,E), and prefrontal cortex (PFC; C,F) of control (white bars), HFD (solid bars) and
HFD + recovery (striped bars) Pre-Adolescent and Adult HF female age groups
(n=5/group). HFD and HF + recovery groups are shown as fold change from their own
aged matched controls. Only one control group (15wk) is shown and set to 1 for clarity.
Post hoc planned comparisons shown at alpha levels *p<.05, **p<.01, ***p<.001,
****p<.0001 significantly different from own control group.
Figure 6. Dopamine levels are increased after chronic HFD in Pre-Adolescent HF
males. Dopamine levels in the NAc do not normalize after 4wk recovery. Dopamine
(DA) and dopamine metabolite 3,4-Dihydroxyphenylacetic acid (DOPAC) and dopamine
turnover were measured in the NAc (A-D) and PFC (E-H) of control (white bars), HF
(solid bars) and HF + recovery (striped bars) Pre-Adolescent and Adult HF age groups
(n=8-10/group). DOPAC:DA ratio is a measure of dopamine turnover. Males are shown
in black and females in grey. *p<.05, **p<.01 significantly different from control group.
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Tables	
  and	
  Figures	
  
	
  
Table 1. Gene Expression Summary and Statistics in Males
GENE	
  

Pre-‐Ad	
  HF	
  Males	
   P	
  VALUE	
  
fold	
  change	
  

VTA	
  

	
  

	
  

	
  

	
  

COMT	
  

1.48	
  

.0010	
  

2.013	
  

.0077	
  

DAT	
  

0.48	
  

.0004	
  

0.342	
  

<.0001	
  

TH	
  

0.46	
  

.0001	
  

0.471	
  

<.0001	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

COMT	
  

1.987	
  

.0002	
  

1.46	
  

.6527	
  

DARPP32	
  

1.87	
  

.0007	
  

1.25	
  

.0836	
  

DRD1	
  

0.580	
  

.0021	
  

0.719	
  

.0085	
  

DRD2	
  

0.672	
  

.0078	
  

0.405	
  

<.0001	
  

	
  

	
  

	
  

	
  

	
  

PFC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.485	
  

.0010	
  

1.267	
  

.0167	
  

DARPP32	
  

0.605	
  

.0491	
  

1.661	
  

.0406	
  

DRD1	
  

0.485	
  

.0010	
  

1.139	
  

.3756	
  

DRD2	
  

0.313	
  

.0069	
  

1.149	
  

.7138	
  

	
  

	
  

	
  

	
  

	
  

GENE	
  

Adult	
  HF	
  Males	
  
fold	
  change	
  

P	
  VALUE	
  

Adult	
  HF+	
  recov	
  
Males	
  fold	
  
change	
  

P	
  VALUE	
  

VTA	
  

	
  

	
  

	
  

	
  

COMT	
  

0.94	
  

.5670	
  

0.84	
  

.0128	
  

	
  

92	
  

Pre-‐Ad+recov	
  
Males	
  	
  fold	
  
change	
  

P	
  VALUE	
  

DAT	
  

0.674	
  

.049	
  

0.98	
  

.7538	
  

TH	
  

0.657	
  

.0083	
  

1.06	
  

.614	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.736	
  

.0013	
  

0.846	
  

.164	
  

DARPP32	
  

0.575	
  

.0011	
  

1.262	
  

.1945	
  

DRD1	
  

0.638	
  

.0025	
  

1.284	
  

.0474	
  

DRD2	
  

0.644	
  

.0078	
  

1.029	
  

.8949	
  

	
  

	
  

	
  

	
  

	
  

PFC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.662	
  

.0076	
  

0.520	
  

<.0001	
  

DARPP32	
  

0.543	
  

.0047	
  

1.145	
  

.4038	
  

DRD1	
  

0.136	
  

<.0001	
  

0.838	
  

.0879	
  

DRD2	
  

1.538	
  

.1629	
  

1.696	
  

.2261	
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Table 2. Gene Expression Summary and Statistics in Females
GENE	
  

Pre-‐Ad	
  HF	
  Females	
   P	
  VALUE	
  
fold	
  change	
  	
  

Pre-‐Ad	
  HF+	
  
recovery	
  Females	
  
fold	
  change	
  	
  

P	
  VALUE	
  

VTA	
  

	
  

	
  

	
  

	
  

COMT	
  

1.195	
  

.0202	
  

2.633	
  

.0352	
  

DAT	
  

1.76	
  

.0304	
  

1.46	
  

.0104	
  

TH	
  

0.558	
  

.0157	
  

0.446	
  

.0004	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.5708	
  

.0011	
  

0.682	
  

.0007	
  

DARPP32	
  

0.799	
  

.2061	
  

0.343	
  

<.0001	
  

DRD1	
  

0.256	
  

.0030	
  

2.95	
  

<.0001	
  

DRD2	
  

0.483	
  

.0042	
  

0.346	
  

.0004	
  

	
  

	
  

	
  

	
  

	
  

PFC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.496	
  

.0001	
  

0.657	
  

.0214	
  

DARPP32	
  

0.608	
  

.0014	
  

0.704	
  

.016	
  

DRD1	
  

0.338	
  

<.0001	
  

2.01	
  

.0108	
  

DRD2	
  

0.609	
  

.0195	
  

2.43	
  

.0722	
  

	
  

	
  

	
  

	
  

	
  

	
  

Adult	
  HF	
  	
  

P	
  VALUE	
  

P	
  VALUE	
  

GENE	
  

Females	
  

Adult	
  HF+	
  recov	
  
Females	
  

VTA	
  

	
  

	
  

	
  

	
  

COMT	
  

1.06	
  

.5672	
  

1.384	
  

.0498	
  

DAT	
  

1.28	
  

.0546	
  

0.692	
  

.0219	
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TH	
  

0.937	
  

.3179	
  

0.907	
  

.2155	
  

	
  

	
  

	
  

	
  

	
  

NAC	
  

	
  

	
  

	
  

	
  

COMT	
  

3.97	
  

.0172	
  

0.288	
  

.0003	
  

DARPP32	
  

0.456	
  

.0017	
  

0.639	
  

.1017	
  

DRD1	
  

0.374	
  

.0023	
  

0.833	
  

.0355	
  

DRD2	
  

0.178	
  

<.0001	
  

0.353	
  

.0019	
  

	
  

	
  

	
  

	
  

	
  

PFC	
  

	
  

	
  

	
  

	
  

COMT	
  

0.807	
  

.0438	
  

0.726	
  

.0348	
  

DARPP32	
  

1.057	
  

.8899	
  

1.468	
  

.0186	
  

DRD1	
  

1.129	
  

.5851	
  

3.08	
  

<.0001	
  

DRD2	
  

2.49	
  

.0897	
  

1.32	
  

.4875	
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96	
  

	
  
	
  
	
  
	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

97	
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CHAPTER	
  4:	
  Voluntary	
  wheel	
  access	
  and	
  highly	
  palatable	
  diet	
  
regulate	
  gene	
  expression	
  and	
  behavior	
  in	
  the	
  central	
  reward	
  
system	
  
Jesse L. Carlin, Zhe Ying, Fernando Gomez-Pinilla, Teresa M. Reyes

Introduction	
  
	
  
The rise in obesity rates in the United States has paralleled the increasing
availability of energy dense foods (Flegal et al., 2012). Palatable foods are often
consumed because of their hedonic properties after bodily energy requirements are
already met. Palatable foods increase dopamine in the reward regions of the brain and
over a long period of time, consumption cause neuroadaptations that alter reward driven
behaviors. For example, consumption of high fat diet does not just drive obesity, but
drives binge-like eating behavior (Corwin, et al. 1998, Lucas et al., 1989), decreases
dopamine receptor levels (Johnson & Kenny, 2010), decreases neurotransmitter levels
(Carlin et al., 2013; Geiger et al. 2007), and decreases natural reward intake (Carlin et
al., 2013; Vucetic et al., 2011). Part of the first line of treatment for obesity is daily
exercise. Exercise provides individuals with both positive metabolic effects (Rothman et
al. 2012) and cognitive benefits (extensively reviewed in Chang et al., 2012). The
majority of the central benefits of exercise have focused on the hippocampus; here we
examine the response of reward and feeding regions of the brain to exercise. Similar to
palatable food, exercise also activates reward regions of the brain and long-term wheel
running has been shown to produce neuroadaptations that may overlap with those seen
in obesity. Exercise is rewarding and rodents will work for access to a running wheel
(Brene et al., 2007). Wheel running has also been shown to modulate reward behaviors
such as decreased conditioned place preference to cocaine (Thanos et al., 2010).
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Because exercise is rewarding, it is unknown whether exercise can prevent the
dopamine dysfunction seen in the reward regions of the brain after chronic high fat diet.
We looked to examine first if exercise can affect the expression of reward related
genes in the prefrontal cortex after short term exercise exposure. Previous studies have
shown exercise can enhance cognitive function (Winter et al., 2007), and improve
symptoms of depression (Lawlor & Hopker, 2001). Access to a running wheel promotes
neurogenesis in the brain (van Praag et al., 1999) and increases expression of BDNF
mRNA (Gomez-Pinilla et al., 2011) and epigenetic related genes, such as DNMTs and
HDACs (Abel and Rissman, 2013). Research on the beneficial effects of exercise has
primarily focused on the hippocampus and brain derived neurotrophic factor (BDNF) as
the central mediator of brain plasticity in this region (Gomez-Pinilla et al., 2002; Hopkins
et al., 2010). We look to extend these studies by examining the effect of acute exercise
on reward related genes in the prefrontal cortex.
The interaction of exercise and high fat diet at the level of feeding and neural
substrates of reward is currently unknown. Specifically are the generally beneficial
effects of exercise on the brain able to prevent the negative effects of high fat diet, such
as dysfunctional gene expression changes and neuro inflammation in the reward system
and hypothalamus of mice. Exercise may be able to act as a reward replacement and
reduce the risk to over consume palatable foods. Exercise also has the ability to recruit
epigenetic mechanisms, such as DNA methylation, that could prevent the
neuroadaptations that occur after high fat intake. Exercise has previously been shown to
impart resilience to the molecular effects of stress on the brain (Haack et al., 2008;
Gerecke et al., 2013); however, studies have been mixed with the behavioral outcomes
of exercise. Voluntary wheel running has both anxiety producing (Burghardt et al. 2004;
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Fuss et al. 2010a,b) and anti-anxiety (Dishman et al. 1996; Salam et al. 2009) behavioral
effects in rodent models. We performed behavioral analysis to assess anxiety levels in
our model of high fat diet and exercise. To examine if the changes that occur after long
term exercise are inhibited by concurrent access to high fat, we gave male mice access
to a running wheel and a high fat /high sugar diet for 6 weeks. Four experimental groups
(Sedentary-Control, Sedentary-HF, Exercised-Control, and Exercised-HF) were
evaluated for changes in gene expression in brain areas that regulate reward and
feeding behavior. Expression of dopaminergic, epigenetic, and inflammatory related
genes in the nucleus accumbens (NAc), prefrontal cortex (PFC), and hypothalamus
(HYP) were examined. Behavioral assays (sucrose preference, elevated plus maze and
open field) were performed to examine if either exercise or palatable diet had the ability
to modulate sucrose preference or anxiety-like behavior. Understanding the mechanisms
of how high fat diet and exercise elicit neuroadaptations in the reward system will be
important for future weight loss studies and obesity treatments.

Materials	
  and	
  Methods	
  
Animals. C57BL/6 mice approximately 9 weeks of age were singly housed in standard
polyethylene cages in an environmentally controlled room (22–24°C) with a 12 h
light/dark cycle. For the first experiment, mice either remained sedentary (n=6) or were
given two weeks access to a voluntary running wheel in their home cages (n=12). These
mice had ad lib access to standard control diet (#5755; 18.5% protein, 12% fat, 69.5%
carbohydrate, Research Diets, New Brunswick, NJ). After two weeks animals were
euthanized by carbon dioxide overdose, followed by cervical dislocation; a method
recommended by the Panel on Euthanasia of the American Veterinary Medical
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Association. For the second experiment, mice had ad lib access to either standard
control diet (#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) or a western-style diet
(# D12079B, 17% protein, 40% fat, 43% carbohydrate, Research Diets, New Brunswick,
NJ). A subset of mice from each dietary group also received access to a voluntary
running wheel in their home cages, generating 4 experimental groups of sedentary +
CTRL diet, sedentary + HF diet, exercise + CTRL diet, and exercised + HF diet
(n=10/group). Sucrose preference was measured at baseline, 4 weeks, and 6 weeks;
while EPM and OF tests were measured only at 6 weeks. At the end of 6 weeks access
to exercise and/or high fat diet, animals were euthanized by carbon dioxide overdose,
followed by cervical dislocation. Animal housing and behavioral experiments took place
at University of California at Los Angeles. Flash frozen brain samples were shipped to
University of Pennsylvania for further analysis. Experiments were performed in
accordance with the United States National Institutes of Health Guide for the Care and
Use of Laboratory Animals. The UCLA Chancellor's Animal Research Committee
approved all procedures used in this study.
Elevated Plus Maze. The elevated plus maze (EPM) test was carried out according to a
previously established protocol (Walf and Frye, 2007 and Bhatia et al., 2011). The EPM
apparatus was made of laminated wood and consisted of 2 opposing open arms (10×50
cm) and 2 opposing closed arms (10×50 cm with 30 cm high walls). The maze was
placed 60 cm above the floor. White curtains surrounded the maze and behavior was
recorded by an overhead video camera. Each mouse (n=12) was placed in the middle of
the maze facing the open arm that faced away from the experimenter. The video camera
recorded the time each mouse spent in each of the arms over a period of 5 min. A
closed arm entry was counted when the mouse placed all four paws in a closed arm. An
open arm entry was recorded when the mouse placed all four paws in an open arm or
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when the mouse's hind-limbs were placed in the central area of the maze and both forelimbs in an open arm with its head protruding into the open arm.
Open Field Test. The open field test was performed in a 1.2 m diameter circular tank
with 60 cm walls. An inner circle, 80 cm in diameter, was marked on the tank floor to
serve as a central arena. Testing began when each mouse was placed in the middle of
the central arena and allowed to explore the field for 10 min. Mouse behavior (n=12) was
recorded by an overhead camera. Measurement included time spent and number of
entries in central arena (as described in Bhatia et al., 2011)
Sucrose Preference. Mice were individually housed (n=8-10/group) in standard cages
for 3 days where one bottle with 200 ml of 4% sucrose solution (w/v), another with 200
ml of tap water and house chow ad libitum were available. Sucrose (ml), water (ml), and
food consumption (g), were measured and the placement of the bottles were reversed
daily. Preference was calculated using the measurements from the last 2 days only as
follows: preference % = [(sucrose consumption/sucrose + water consumption) × 100].
Sucrose preference test was performed at baseline, 4 week diet and/or running wheel
access, and 6 week diet and/or running wheel access.
Genomic DNA and Total RNA isolation from the brain. Brains were rapidly removed
after behavioral tests, flash frozen and stored at -80C. Dissections were made on ice
and regions of interest were placed in RNAlater (Ambion, Austin, TX) Brain dissections
to isolate the prefrontal cortex and hypothalamus were performed as previously
described (Vucetic et al. 2010, Reyes et al. 2003) Genomic DNA and total RNA were
isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen).
Gene expression analysis by quantitative Real-Time PCR. For each individual
sample, 500ng of total RNA was used in reverse transcription using High Capacity
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Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes was
determined by quantitative RT-PCR using gene specific Taqman Probes with Taqman
gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler. Gene
probes are listed in supplemental material. Relative amount of each transcript was
determined using delta CT values as previously described in (Pfaffl 2001). Changes in
gene expression in the prefrontal cortex (n=6-8) and hypothalamus (n=2-6) were
calculated against an unchanged GAPDH standard.
Methylated DNA Immunoprecipitation (MeDIP) Assay. MeDIP assay was performed
using MagMeDIP kit (Diagenode, Denville, NJ). Methylated DNA was
immunoprecipitated using 15ul of magnetic beads coated with anti-5methylcytidine
antibody (Diagenode) or mouse pre-immune serum. Enrichment in MeDIP fraction was
determined by quantitative RT-PCR using ChIP-qPCR Assay Master Mix (SuperArray)
on the ABI7900HT Real-Time Cycler. For all genes examined, primers were obtained
from SuperArray (ChIP-qPCR Assays (-01) kb tile, SuperArray) for the amplification of
genomic regions spanning the CpG sites located approximately 300-500 bp upstream of
the transcription start sites. MeDIP results were expressed as fold enrichment of
immunoprecipitated DNA for each site. To calculate differential occupancy fold change
(% enrichment), the MeDIP DNA fraction CT values were normalized to Input DNA
fraction CT values.
Global Genomic DNA Methylation. Changes in genomic DNA methylation were
analyzed using LUminometric Methylation Assay (LUMA). Methylation sensitive and
insensitive restriction enzymes (HpaII and MspI, respectively) each digested 500ng DNA
with EcorI as an internal control (all enzymes from New England Biolabs, Beverly, MA) in
Tango Buffer (33mm Tris-acetate, pH 7.9, 10mM Mg-acetate, 66mM K-acetate, 0.1
	
  

107	
  

mg/ml BSA) purchased from Fermentas (Fermendtas Scandanavia, Stolkholm) for 4
hours at 37 degrees Celcius. 20ul of each digestion was mixed with 20ul “Annealing
Buffer” and transferred to Pyrosequencing plates. DNA quantification was preformed
using a polymerase extension assay by the Pyrosequencing tm platform. PSQ tm 96 SNP
reagents for pyrosequencing were purchased from Biotage (Biotage AB, Uppsala,
Sweden) and RediPlate tm 96 PicoGreen kit from Molecular probes (Eugene, Oregon).
Peak height results were obtained to calculate methylation percentage as follows: [1((HpaII/EcoRI)/(MspI/EcoRI))] x 100.
Statistical Analysis. In experiment one, Student t tests were performed to analyze gene
expression, promoter methylation, and global methylation in short term exercise
exposure (2wk) compared to sedentary controls. Statistical significance was set an an
alpha level of p<0.05. In experiment two, two-way ANOVA was used to evaluate the
effects of both diet and exercise and statistically significant main effects were presented
at an alpha level of p<0.05. Planned comparisons were performed to compare the effect
of high fat diet, the effect of exercise, and whether exercise could mitigate the high fat
driven response. Statistical significance was set an alpha level of p<0.05.

Results	
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Short term access to wheel was able to alter gene expression and DNA
methylation in prefrontal cortex.
In the first experiment, mice had continuous access to voluntary running wheel
for two weeks in their home cages and were maintained throughout on control diet.
Gene expression analysis of dopamine receptor D1 (DR1), dopamine receptor D2 (DR2)
and mu opioid receptor (MOR) was performed in prefrontal cortex samples. Two week
access to a wheel caused decreased expression of DR1 and MOR in the cortex (Figure
1A p<0.05, p<0.05). DR2 expression was unaffected by short term exercise exposure.
Quantification of DNA methylation at promoter regions of genes affected by short term
exercise was performed. Fold change from input is presented and ACTIN was used as a
control gene for comparison. Promoter DNA methylation was increased by exercise
exposure for both DR1 and MOR genes (Figure 1B, p<0.05, p<0.05). Global methylation
of genomic DNA was unaltered by a two week exercise exposure.
Access to running wheel and high fat diet for 6 weeks caused changes in body
weight and reward behavior.
In the second experiment, sedentary controls, sedentary + HF, exercised, and
exercised + HF animals were generated and body weights were taken at the end of the
experiment. High fat diet (HF) alone caused animals to gain a significant amount of body
weight compared to sedentary controls. For body weight at end of experiment there was
a significant interaction between diet and exercise (Figure 2A, F(1,36)=6.37, p=0.016).
There was a main effect of the high fat diet on increasing body weight (Figure 2A,
F(1,36)=47.96, p<0.0001), however weight gain in the exercised group was significantly
less than in the sedentary group (Figure 2A, p<0.01). Body weight gain was calculated
from start of experiment (baseline) up until 6 weeks and an interaction between diet and
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exercise was observed (Figure 2B, F(1,36)=4.9, p=0.03). Similar to final body weight, a
main effect of diet was observed (Figure 2B, F(1,36)=47.2, p<0.0001), such that all high
fat fed animals gained more weight, however the exercised + HF animals gained
significantly less then the sedentary HF animals (Figure 2B, p<0.01).
Anxiety-like behaviors were measured in these animals. There was no difference
in time spent in the open arm of the elevated plus maze between experimental groups
(Figure 3A), nor in the time spent in the open arena during the open field test (Figure
3B). Sucrose preference was measured at baseline, 4 weeks, and 6 weeks of the
experimental period. At baseline, there was no difference between experimental groups.
At 4 weeks there was a significant main effect of both HF diet (Figure 3C, F(1,36)=22.9,
p<0.0001) and exercise (Figure 3C F(1,36)=7.32, p=.01). At 6 weeks, sucrose
preference remained diminished in sedentary + HF, exercised, and exercised + HF
groups. There was an interaction between diet and exercise at this time point (Figure
3C, F(1,36)=9.86, p=.003). At 6 weeks there was a significant main effect of diet (Figure
3C, F(1,36)=22.5, p<0.0001).
Exercise was unable to reverse gene expression changes in reward related
regions.
Gene expression was analyzed in both the nucleus accumbens (NAc) and
prefrontal cortex (PFC). In the NAc, there was a significant main effect for diet which
increased the expression of both DR1 and DR2 (Figure 4A, F(1,16)=35.11, p<0.0001,
F(1,16)=4.62, p=0.04). Exercise alone did not alter expression of DR1 and DR2.
Expression of DNA methyltransferase 1 (DNMT1) was also examined in the NAc and
significant interaction of diet and exercise was revealed (Figure 4A, F(1,16)=35.11,
p<0.0001). There was a main effect of exercise which increase DNMT1 expression
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(Figure 4A, F(1,16) 13.06, p=0.002). Planned comparisons show DNMT1 to be elevated
after high fat diet compared to sedentary controls (Figure 4A, p<0.05). DNMT1 levels are
also significantly elevated in exercised animals compared to exercise + HF (Figure 4A,
p<0.05). In the PFC, DR1 expression levels had a non significant trend in the interaction
between diet and exercise (p=.1). DR2 expression had a similar non-significant trend for
interaction of diet and exercise (p=0.1). However, there was a significant main effect of
diet for DR2 expression in the PFC (Figure 4B, F(1,28)=4.62, p=0.04). DNMT1
expression was unaltered by diet and exercise in the PFC at this time point.
Exercise had differing effects on neuro-inflammatory markers increased by high
fat diet in the PFC and hypothalamus
Expression levels of neuro-inflammatory related genes were examined in both
the PFC and the hypothalamus. Table 1 provides detailed statistical analysis of genes
examined in the PFC, and important results will be highlighted here. Intake of HF diet
caused a significant increase in inflammatory related genes chemokine (C-C motif)
ligand 2 (CCL2), C-C chemokine receptor type 2 (CCR2), C-X-C motif chemokine 10
(CXCL10) as compared to sedentary controls (Figure 5A, F(1,17)=17.7, p<0.001,
F(1,16)=4.89, p<0.05, F(1,16)=4.63, p<0.05, respectively). Exercise alone had no effect
and exercise in combination with high fat diet normalized these genes to controls levels.
Post- hoc analysis revealed a significant difference between sedentary + HF and
exercise + HF groups for CCL2, CCR2, and CXCL10 (Figure 5A, p<0.001, p=0.01,
p=0.01). Intake of HF diet in sedentary animals also caused a significant increase of
inflammatory related genes interleukin-6 (IL-6), and COX-2 as well as a trending main
effect of diet in prostaglandin synthase E1 (PGSE-1) in the PFC (Figure 5B,
F(1,13)=11.74, p<0.01, F(1,19)-4.88, p=0.04, p=0.07). There was a significant decrease
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in these inflammatory markers when exercise and high fat were combined in PGSE-1
expression levels (Figure 5A, p=0.01). Gene expression examine in the hypothalamus is
considered preliminary because of the small sample size in the high fat group (n=2).
Table 2 lists the detailed statistical findings of genes examined in the hypothalamus.
Important results will be highlighted here. In the hypothalamus, there was a significant
main effect of high fat diet on neuro-inflammatory genes CCL2, suppressor of cytokine
signaling 3 (SOCS-3), and toll-like receptor-4 (TLR-4) expression (Figure 6A,B,
F(1,12)=7.67, p<0.05, F(1,12=25.9, p<0.001, F(1,10)=16.93, p<0.01, respectively).
There was also a significant main effect of exercise that increased expression levels of
SOCS-3 and TLR-4 (Figure 6B, F(1,12)=15.1, p<0.01, F(1,10)=26.12, p<0.001) as well
as a non significant trend effect on CCR2 and CXCL10 expression (Figure 5C, p=0.07,
p=0.07). IL-1R expression was also increased but did not reach significance in the
hypothalamus in the exercise + HF group (Figure 5C, p=.09).

Discussion	
  
Exercise has been shown to have many beneficial effects on the brain and is a
common treatment for obesity. The purpose of the first experiment was to demonstrate
that short term exercise has the ability to alter reward related gene transcription. The
purpose of the second experiment was to examine the interaction between high fat diet
and exercise in feeding and reward regions of the brain. It was previously unknown if
exercise was able to prevent neuroadaptations and behavioral changes that occur in
obesity. Overconsumption of palatable foods not only drives obesity, but also has
damaging effects on the brain. Chronic high fat diet causes circuitry changes in brain
regions involved in food intake and decreases reward intake behaviors (Vucetic et al.,
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2011a; Carlin et al., 2013). Exposure to a western-style diet is known to impair cognition
(Beilharz et al., 2013) and cause neuro-inflammation that can impact food intake and
learning and memory (De Souza et al., 2005, Jurdak et al., 2008). Our study
demonstrates that exercise is able to regulate gene expression in these regions;
however, it may not be an appropriate treatment for preventing reward dysfunction or
neuroinflammation caused by long term high fat diet intake.
In the first experiment, mice were exposed to only two weeks of wheel exposure
in adulthood. We found that with only two weeks of exercise, mice had decreased
dopamine D1 receptor (DR1) and mu opioid receptor (MOR) expression levels in the
prefrontal cortex. DA is hypothesized to be critically involved in movement and reward
and increases in DA receptors in the striatum have been associated with increases in
endurance capacity (Foley et al., 2006). Endogenous opioid levels have long been
known to increase in the brainstem, caudate, and mesolimbic regions after exercise
training (Boone et al., 1996; Werme et al., 2000, Sforzo et al., 1986, Janal et al., 1984).
Mu opioid receptors mediate the increase in nociceptive thresholds and positive mood
that occurs after exercise (Janal et al., 1984). However, our experiment shows the down
regulation of both DR1 and MOR in the prefrontal cortex. This suggests differential
regulation of DR1 and MOR in the prefrontal cortex compared to other brain regions.
Difference in DR1 and MOR response to exercise may also be because of shorter
exposure (2 weeks) to the running wheel and our use of mice instead of rats. Little was
known about how exercise how exercise regulates gene expression at the molecular
level and between in regions other than the hippocampus.
The likely mechanism behind down regulation of expression at this time point in
the PFC is an increase DNA methylation at the promoter region of these genes. Global
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DNA methylation was unaffected; therefore this suggests a specific signaling event and
not a global down regulation of methylation levels. DNA methylation plays a crucial role
in the remodeling of chromatin in the brain, and contributes to the regulation of brain
plasticity and gene transcription. DNA methylation regulates expression in a highly
context-dependent manner and a stimulus may have different effects at different genes
(Suzuki et al., 2008). One possible mechanism by which exercise may be able to alter
DNA methylation is through synchronous neuronal activation. Gou et al., (2011)
demonstrated that electroconvulsive stimulation produced de novo methylation and DNA
de-methylation throughout the genome; this could be similar to what is occurring after
exercise. The up regulation seen after longer time points on exercise may reflect further
remodeling events occurring after chronic exposure. Because exercise had the ability to
affect expression of reward related genes, we next set up a longer experiment to look at
exercise’s interaction with chronic high fat diet.
For experiment 2, we were interested in the ability of exercise to prevent both
behavioral and gene expression changes that accompany long term high fat diet. We
gave mice access to the running wheel and to ad lib 40% fat diet concurrently. Our
exercise + HF group gained less body weight than sedentary + HF animals, but were still
significantly heavier than controls. Our lab and others have previously shown that intake
of high fat diet causes decreases in dopamine and opioid related genes and this is
associated with dysfunction in food intake and reward behaviors (Carlin et al., 2013;
Vucetic et al., 2011, Johnson & Kenny, 2010). High fat/high sugar diets have been
shown to alter behavior in rodents (Soulis et al., 2007, Prasad et al., 1996). For example,
high fat/high sucrose diet decreased performance in learning and memory tasks (White
et al., 2009; Stranaham et al., 2008) and decreased exploration of open arm in an
elevated plus maze test (Anderson et al., 2013). In our model, mice did not show any
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changes in anxiety behaviors after consumption of high fat diet and/or access to running
wheel. This was interesting because in other models, such as mildly stressed rats,
consumption of a high fat/high sucrose diet was anxiogenic (Legendre et al., 2006).
Additionally, our study did not find any beneficial effects on anxiety-like behavior in
exercised mice, while other studies have found exercise to be anxiolytic. For example, in
humans, exercise reduces anxiety symptoms and is used as a treatment for both anxiety
and depression (Herring et al., 2010; Dunn et al., 2005a), while exercise in rats can
decrease anxiety in an open field test and elevated plus maze (Duman et al., 2008).
However, the length of the exposure to the diet varies between labs and a 6 week
exposure may not have been sufficient to elicit the anxiogenic response. Future
experiments could address whether these animals response differently in a challenging
or stressful situation to gain a more complete understanding of their stress reactivity.
Sucrose preference is a broad measure of natural reward intake and regulated
by both dopamine and the endogenous opioid system. We found natural reward intake
to be reduced in both exercise and high fat diet exposed animals. Sucrose preference
can be diminished under a variety of different conditions, such as high fat diet intake
(Carlin et al., 2013), chronic mild stress (Muscat et al., 1992), social deprivation (Berry et
al., 2012) and lipopolysaccharide injection (Cross-Mellor et al., 2003). Sucrose
preference is a model of anhedonia and diminished reward responsiveness in rodents.
Potential mechanisms behind reduced sucrose preference after high fat diet could be
reduced reward activation, reduced nutrient need, while reduced sucrose preference
after exercise could be due to reward replacement. Both exercise and high fat diet are
rewarding and we see access to one rewarding substance reducing of another
rewarding substance, sucrose. Both high fat diet and exercise cause gene expression
changes in reward related regions, therefore examining which genes parallel sucrose
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preference will help us further understand the mechanism behind diminished reward
intake in our model. Sucrose preference was diminished in animals given high fat diet,
exercise, and exercise + high fat diet; therefore we can conclude exercise is not the
optimal way to prevent the reward dysfunction that occurs in obesity. However, there
does not seem to be an additive effect for HF and exercise for sucrose preference.
Further studies are warranted to understand the mechanism driving decreased sucrose
preference after two distinct and qualitatively different stimuli.
The mesolimbic dopaminergic pathway is activated by many rewarding
behaviors, including the consumption of palatable foods and exercise. We examined
gene expression of dopamine receptors in our experimental groups in reward related
regions of the brain, nucleus accumbens (NAc) and prefrontal cortex (PFC). In the
nucleus accumbens, both DR1 and DR2 expression were upregulated after 6 weeks
high fat diet. Exercise alone did not alter the expression of dopamine receptors this
region, even though we observed down regulation of DR1 after 2 weeks in the first
experiment in the PFC. It may be the case a take a longer exposure is needed to alter
receptors in nucleus accumbens. Furthermore, exercise was unable to normalize the
expression of DR1 and DR2 in this region; and DR1 and DR2 remained elevated in
exercise + HF animals. In the PFC of the second experiment animals, we saw a
significant increase of DR2 expression after high fat diet and a trending increase in DR1.
Exercise again was unable to normalize DR2 expression in the exercise + HF group.
The PFC differs from the NAc in that there may be a possibility of an interaction for
exercise and diet. Moreover, the pattern of expression does not parallel what we see in
sucrose preference. Further examination of other neurotransmitter systems, such as the
endogenous opioid system, involved in sucrose intake is necessary to see how exercise
and high fat regulate natural reward intake behavior.
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Epigenetic enzyme DNA methyltransferase 1 expression was also examined in
reward related regions. We observed in experiment 1, that exercise may regulate gene
expression by recruiting DNA methylation to specific promoter sites. Changes in
promoter methylation have been observed in the brain, adipose tissue, and muscle after
exercise training and may underlie the exercise mediated gene transcription involved in
synaptic plasticity (Pareja-Galeano et al., 2014; Ronn et al., 2014, Gomez-Pinilla et al.,
2011, Abel & Rissman, 2013). DNMT1 is highly expressed in the brain, catalyzes
maintenance and de novo DNA methylation, and has been implicated in reward
signaling (Gou et al., 2011, Day et al., 2013). In the NAc, there was a main effect of
exercise on the upregulation on DNMT1. There was also an interaction between diet and
exercise for DNMT1 in this region. High fat diet and exercise signaling both seem to
converge to regulate DNMT1 transcription on their own. Interestingly, the combination of
high fat diet and exercise normalizes DNMT expression. If DNMT1 is involved in the
regulation of other genes involved in the damaging effects of high fat diet, exercise may
have some benefit in normalizing high fat diet neuroadaptations. DNMT1 is not altered in
the PFC in our second experiment model. Changes in DNMT1 activity levels may
potentially be behind the changes in DNA methylation that occur after exercise in the
short term. Further examination of this pathway will be needed to understand the
activation pathway in both diet and exercise. At the transcriptional level at least, we see
exercise is not able to prevent dopamine dysfunction and epigenetic regulation genes
altered in obesity.
Obesity seems to have a negative impact on the brain and behavior. Obesity is
associated with learning and memory deficits (Beilharz et al., 2013), dysfunction in
reward behaviors (Johnson & Kenny, 2010), and diminished homeostatic control over
food intake (Hellstrom et al., 2004). Obesity is also considered to be a chronically
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inflamed state. One possible mechanism behind obesity’s damaging effects on the brain
could be neuro- inflammation in prefrontal cortex and hypothalamus. Some key markers
of neuro inflammation is the increase in cytokine and inflammatory mediators that attract
immune cells and activate microglia. C–C motif) ligand 2 (CCL2), chemokine receptor
CCR2, and CXCL10 are part of the inflammatory chemokine response that elicit
lymphocyte migration and trafficking into the brain (Prinz & Priller, 2010). Interleukin-6 (I6) and IL-1β are increased in response to Toll-like receptor 4 (TLR-4) activation and are
essential pieces of the inflammasome process (Manakan et al., 2012). SOCS-3 is a
negative regulator of inflammatory cytokines as well as a negative regulator of the leptin
receptor and could be the mediator leptin resistance found after high fat diet intake
(Dunn et al., 2005b). Pro-inflammatory enzymes prostaglandin E synthase-1 (PGSE-1)
and cyclooxygenase-2 (COX-2) synthesize neuro-inflammation mediators and
perpetuate the inflammation cycle (Radler et al., 2013). These genes all together
mediate the neuro-inflammatory response and the migration of immune cells into the
brain, which may have damaging side effects. We demonstrated that inflammatory
cytokines and inflammatory cytokine receptors are upregulated in the prefrontal cortex
and hypothalamus after high fat intake and the effect of exercise may not be beneficial in
all cases. In the PFC, inflammatory cytokines CCL2 and CXCL10 and cytokine receptor
CCR2 mRNA was increased in animals fed high fat diet. Exercise alone had no effect on
these genes; however, exercise in combination with high fat was able to normalize the
inflammatory markers back to control levels in the PFC. We see a similar expression
pattern occur with IL-6, PGSE1, which are increased after high fat diet exposure and
normalized by exercise. Exercise has recently been shown to reduce neuroinflammation
in the hippocampus (Kohman et al., 2013; Gomes de Silva et al., 2013). We have
extended these finding to include the prefrontal cortex. Further experiments are needed
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to see if this reverses and cognitive impairments associated with neuroinflammation in
the PFC.
Exercise does not have a uniform anti-inflammatory effect in all brain regions,
however. In the hypothalamus, we see that it is the combination of exercise and high fat
to be the most detrimental. Although these results are preliminary because of small
sample sizes in the high fat group, we see some informative patterns emerge. Exercise
+ HF animals had increased expression of cytokines CCL2, CCR2, CXCL10 as well as
SOCS-3, TLR-4 and trending increase in IL-6. It seems that exercise actually
exacerbates inflammation from high fat diet in the hypothalamus. Interestingly, SOCS-3
is upregulated by high fat diet and exercise as well as the combination of the two. Leptin
resistance has been shown to be mediated by an increased expression of SOCS-3 and
this could be associated with central inflammation in the hypothalamus and may mediate
the observed dysregulated food intake and energy imbalance (Zhang et al., 2008; Cai &
Lui, 2012; Milanski et al., 2004). In our study, 6 week of high fat alone was not sufficient
to cause an upregulation of inflammatory markers other than SOCS-3. However, when
coupled with exercise, high fat diet is able to elicit this response. Why the hypothalamus
is so vulnerable to inflammation is unclear. It may be the region’s highly specialized role
in sensing energy utilization and metabolic activity that makes it particularly prone to
possible oxidative stress and therefore, inflammation. The high level of vasculature and
open blood brain barrier in certain hypothalamic areas may also play a role. This
exacerbation of inflammation by exercise suggests that exercise may not be the optimal
means to prevent the damaging central effects of high fat diet. This has implications for
individuals who look to remain on a high fat diet while treating obesity with exercise.
Ways to prevent neuroinflammation as well as dopamine dysfunction in this state will
need to be further explored.
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In summary, we demonstrated that a short exposure to exercise has the ability to
alter dopaminergic and opioid gene expression and promoter methylation in a region not
previously explored. This increase in promoter DNA methylation was specific to genes
that were changed after 2 week running wheel exposure. Further, we have
demonstrated that high fat diet causes decreases in natural reward intake and
dopaminergic and inflammatory gene expression changes in the nucleus accumbens,
prefrontal cortex, and hypothalamus. Behavior and gene expression were unable to be
reversed by exercise and, in fact, exercise seem to have its own diminishing effect on
sucrose intake. These gene expression changes lead us to believe that central reward
signaling and epigenetic mechanisms may be altered after high fat diet intake and that
concurrent exercise is unable to prevent these changes. We have also seen that the
hypothalamus is particularly sensitive to the combination of exercise and high fat diet
when it comes to inflammation. In conclusion, we believe that although exercise is
extremely beneficial to cognitive enhancement and weight loss, other add on therapies
may be needed to combat the neuroadaptations that occur in obesity and lead to reward
dysregulation.

Figure	
  Legends	
  	
  
	
  
Figure 1. Two weeks of voluntary wheel running decreased dopamine receptor D1
and mu opioid receptor gene expression and altered DNA methylation at promoter
regions. A) Two week exposure to running wheel (black bars) decreased mRNA levels
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of dopamine receptor D1 (DR1) and mu opioid receptor (MOR) compared to sedentary
controls (white bars; n=6/group). Dopamine receptor D2 (DR2) was unaltered. B) Gene
expression changes were associated with increases in DNA methylation at gene
promoter regions of DR1 and MOR. C) Global DNA methylation in sedentary and
exercised animals. Statistically different than controls at alpha level *p<0.05.
Figure 2. Animals with access to HF + exercise did not gain as much weight as
sedentary animals on HF, but were still heavier than controls. A) Body weights at
experimental end point were taken of sedentary controls (white bars), sedentary +HF
(solid bar), exercise (vertical striped bar) and exercise +HF (checkered bar) groups
(n=10/group). B) Body weight gain throughout 6 week was also analyzed. Statistically
significant main effect of high fat diet at alpha level ****p<0.0001. Post hoc analysis
between sedentary HF and exercise HF groups at significant level ##p<0.01.
Figure 3. Animals given access to running wheel and/or high fat diet did not show
alterations in anxiety behavior. However, both exercised and/or high fat diet
access reduced natural reward intake. Animals of sedentary controls (white bars),
sedentary +HF (solid bar), exercise (vertical striped bar) and exercise +HF (checkered
bar) groups (n=10/group) were tested in both the elevated plus maze (A), open field, (B)
and sucrose preference (C) to assess anxiety behavior and natural reward intake. A)
Time in open arm in elevated plus maze in seconds (s). B) Time in center arena of open
field test in seconds (s). C) Percent preference of 4% sucrose solution to water. Main
effect of high fat diet shown as significant at alpha level of,****p<0.0001. Main effect of
exercise shown at alpha level of ^^p=0.01.
Figure 4. Gene expression of dopamine receptors and DNA methyltransferase are
increased by high fat diet and not reversed by exercise in reward regions of the
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brain. Gene expression was measured in the nucleus accumbens (NAc, A) and the
prefrontal cortex (PFC, B) in sedentary controls (white bars), sedentary +HF (solid bars),
exercise (vertical striped bars) and exercise +HF (checkered bars) groups (n=6-8/group).
Fold change is calculated compared to sedentary controls. *p<.05 represents a
significant main effect of diet, ##p<.01 main effect of exercise.
Figure 5. Gene expression of neuro-inflammatory related genes were increased by
high fat diet and normalized by exercise in the prefrontal cortex. Gene expression
was measured in the prefrontal cortex (PFC, A) in sedentary controls (white bars),
sedentary +HF (solid bars), exercise (vertical striped bars) and exercise +HF (checkered
bars) groups (n=6-8/group). Fold change is calculated compared to sedentary controls.
A statistically significant main effect of high fat diet is shown at an alpha level *p<0.05,
**p<0.01, ***p<0.001. Planned comparisons show significant difference between groups
at an alpha level of #p<0.5, ##p<0.01, ###p<0.001.
Figure 6. Neuro-inflammatory related genes were increased by high fat diet and
further increased by the combination of high fat diet and exercise in the
hypothalamus. Gene expression was measured in the prefrontal cortex (PFC, A) in
sedentary controls (white bars), sedentary +HF (solid bars), exercise (vertical striped
bars) and exercise +HF (checkered bars) groups (n=6-8/group). Fold change is
calculated compared to sedentary controls. A statistically significant main effect of high
fat diet is shown at an alpha level *p<0.05. A statistically significant main effect of
exercise is shown at an alpha level ^^p<0.01, ^^^p<.001. Planned comparisons show
significant difference between groups at an alpha level of ##p<0.01
Table 1 Neuro-inflammatory gene expression in the prefrontal cortex. Summary of
two-way ANOVA analysis of gene expression from the PFC preformed in sedentary,
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high fat, exercise, and exercise + high fat groups. Interactions and main effects are
presented alongside their p values.
Table 2 Neuro-inflammatory gene expression in the hypothalamus. Summary of
two-way ANOVA analysis of gene expression from the hypothalamus preformed in
sedentary, high fat, exercise, and exercise + high fat groups. Interactions and main
effects are presented alongside their p values.
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Table 1. Gene expression in PFC

	
  

Gene

Interaction

Diet effect

Exercise effect

CCL2

F(1,17)=20.4,
p=0.0003

F(1,17)=17.7,
p=0.0006

ns

CCR2

F(1,16)=6.58,
p=0.021

F(1,16)=4.89,
p<0.05

F(1,16)=4.63,
p<0.05

CXCL10

F(1,17)=13.6,
p=0.002

F(1,17)=12.15,
p=0.0028

ns

IL-6

F(1,13)=7.00,
p=0.02

F(1,13)=11.74,
p<0.0045

ns

PGES

F(1,18)=15.73,
p<0.0009

Trend, p=0.07

ns

COX- 2

ns

F(1,19)=4.88,
p=0.04

ns
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Table 2. Gene expression in hypothalamus

	
  

Gene

Interaction

Diet effect

Exercise effect

CCL2

ns

F(1,12)=7.67

ns

CCR2

ns

ns

Trend p=0.07

CXCL10

ns (p=.11)

ns

Trend p=0.07

SOCS-3

ns

F(1,12)=25.9,
p=0.0003

F(1,12)=15.1,
p=0.0022

TLR-4

F(1,10)=11.56,
p=0.0068

F(1,10)=16.93,
p=0.0021

F(1,10)=26.12,
p=0.005

IL-6

ns

ns

ns

IL-1R

ns

ns

ns
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CHAPTER	
  5:	
  GENERAL	
  DISCUSSION	
  
Only 56 years ago, the prevalence of obesity was 13%. Today it is estimated that
69% of adults and 30% of adolescents are overweight (BMI 25-29.9) or obese (BMI >
30) in the United States (Ogden et al., 2011). The enormous toll that obesity takes in
money and health from our society justifies an exploration of the drivers of the epidemic,
the mechanisms of the disease, as well as the factors that aid in its prevention and cure.
There are many drivers of the obesity epidemic, and it is now clear that this 5 fold
increase over 50 years cannot be explained by genetics alone. Although certain genes
can increase one’s risk of obesity, an individual cannot become obese without the
availability of calories to consume. The emergence of fast food establishments, a “snack
food” industry and policies that favor corn and soybean production are just a few trends
that have paralleled the obesity trend. Corn and soybean production is so inexpensive
that an enormous supply of “junk” has been created using solely these two crops. Corn
alone makes up over 25% of the food found on the supermarket shelves (Pollan, 2002).
The inexpensive input has made it easy and profitable for companies to make food with
high concentrations of sugar and fat that increase overconsumption. Companies that
produce the combinations of highly concentrated sugar and fat have only been around
60 years or so. For instance, the first McDonalds opened in 1957, and the first marketed
potato chip brand, Lays, began in 1938. The snack food market is a $46.1 billion industry
and they produce highly concentrated sugar and fat products that are extremely difficult
to resist. People are over consuming these modern manufactured foods and the
consequences have been disastrous. Cheap, palatable foods are a permanent part of
America’s food landscape and its imperative for us find ways to lessen their impact on
our health.
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Why is it so difficult to say no to these manufactured, calorie-laden foods? We
can imagine throughout the millions of years of human evolution, there was no need for
the ability to suppress appetite. What was important was the ability to hunt and gather
enough food to survive during lean times. We can imagine the brain to consider
overeating of high-calorie food as beneficial, especially if you are uncertain of your next
meal. Having large fat stores was a luxury, and the brain and body evolved ways to
maintain them. Today, this behavior is no longer adaptive and is even counterproductive
in a world where food is bountiful and energy-dense. The ability of these energy dense
foods to override our homeostatic mechanisms leads to a brain-environment mismatch
and increasing fat stores and declining health in many individuals. Obesity is associated
with many chronic illnesses, such as cardiovascular disease, diabetes, osteoarthritis,
and certain types of cancer. Fortunately, obesity is largely preventable and highly
curable if we can only find ways to combat their effect on our brains. Even in the face of
the facts and negative health outcomes, many people continue to over consume highly
palatable foods, and thereby gain fat. Obesity, in this light, has often been compared to
drug addiction. This comparison is highly controversial because of the negative
associations accompanying the label “addiction” and many feel that one cannot be
“addicted” to something necessary for survival. However, if the comparison is made on
the neurobiological level and leads to better therapies and better drug targets, it may be
a useful framework.
We have been introduced to the similarities between the neural circuits regulating
feeding and drug addiction in chapter 1. Obesity neuroscience and drug addiction have
previously been researched separately and addiction was identified as a disease much
before obesity and manufactured foods were a problem. The inability to suppress intake
despite negative consequences (e.g. foot shocks, cold environment) were shown with
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cocaine intake studies first. Today, neuroscience is seeing the effects of highly
palatable food mirror what was seen in the early addiction studies. Drugs of abuse hijack
this extended motivation/feeding circuit by supra-natural activation and, over time,
change it so other desires are dampened, and normal functioning is no longer possible.
Obesity is also characterized by the unnatural hijacking of the dopamine
motivation/feeding circuit. The foods we are eating today are unnaturally high in reward
value and can stimulate and alter the brain in ways similar to drugs of abuse.
Manufactured foods found in the modern diet contain concentrations of sugar and fat not
found in nature and previously unavailable to human beings. Studying these caloriedense foods like an addictive drug at the neurobiological level may be beneficial and
lead to better obesity treatments.

Hypo-reward Hypothesis of Obesity
The hypo reward hypothesis of obesity is similar to the development of tolerance
in addicted individuals. The hypo reward hypothesis postulates that there is diminished
reward value for palatable foods in obese and obesity-prone individuals. The diminished
reward value would necessitate more consumption in order to reach desired reward
level. This is similar to tolerance that develops over time after chronic intake of drugs of
abuse. An addicted individual needs to escalate his intake in order to achieve the
desired effect. In chapter 2, 3, and 4 it was demonstrated that chronic high fat diet does
indeed alter the mesolimbic dopamine region and reward behaviors. Four models of dietinduced obesity were examined in this dissertation. Chapters 2 and 3 examined different
age groups on chronic high fat diet and used standard chow replacement as an obesity
intervention in both male and female mice. We discovered that both age and sex were
critical factors in the development and reversal of neuroadaptations seen in obesity. In
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chapter 4, we examined exercise as an intervention for obesity and discovered how
exercise can have its own effects on the brain that may not be entirely beneficial when
paired with high fat diet. The decrease in dopaminergic gene expression, diminished
dopamine neurotransmitter levels, and decreased sucrose preference were consistent
with the hypo reward hypothesis of obesity and comparable to what is seen after long
term drug intake. However, these changes did not necessarily show that chronic intake
of high fat lead to further overconsumption. In fact, overconsumption of palatable food
did not occur until acute or long term standard chow intervention and binge like
consumption was only observed in females.
The hypo-reward hypothesis of obesity predicts that diminished inhibitory control
paired with the decrease reward value of palatable foods will lead to further
overconsumption of palatable foods. We saw decreases in dopaminergic genes and
dopamine neurotransmitter levels in the prefrontal cortex as well as the nucleus
accumbens. The prefrontal cortex is involved in inhibitory control of reward intake and
dysfunction in this region is associated with impulsive behavior. Females were seen to
have an imbalance of dopamine receptor DR1 and DR2 in the prefrontal cortex after
standard chow replacement, which may be the mechanism seen behind the binge-like
consumption of palatable food in this group. Our findings further strengthen the hyporeward hypothesis of obesity. However, our results also highlight the importance of sex
difference and nutritional status when examining palatable food consumption in the
future.

Chronic high fat diet alters the dopamine reward system in an age and sex
dependent manner.
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Age Effects
We have investigated the age of onset and sex as critical variables in the neuroadaptations seen after chronic high-fat diet intake. Taking the results of both chapters 2
and 3 we see that the timing of chronic high fat diet is a critical factor that affects the
development of dopamine system neuroadaptations and adulthood reward behaviors.
One behavior that was altered in an age dependent manner by chronic high fat diet was
sucrose preference. Sucrose preference is a measure of natural reward and diminished
sucrose intake is a mark of anhedonia in rodents and suggests decreased reward
sensitivity. These results corroborate with other studies that show high fat diet is
associated with depressive-like behaviors in rodents (Sharma et al., 2013). Males who
began the high fat diet at birth and at pre-adolescence showed decreased sucrose
preference; however, males who began the diet in adulthood had control level
preference for sucrose. This suggests a critical time period from weaning (3 weeks of
age) to pre-adulthood (before 6 weeks of age) to be extremely important for
programming natural reward value in adulthood since the change was seen in both
models of early hat fat exposure. High fat diet exposure during lactation has previously
been shown to promote obesity in offspring (Tsuduki et al., 2013) and has implications
for monitoring food consumption in lactating mothers in addition to monitoring food
intake of offspring during early postnatal period. Interestingly, this age effect was not
seen in females and all female groups had decreased sucrose preference. This
suggests that all stages of female brain development may be vulnerable to high fat diet
programming of reward dysfunction. This has implications for the treatment of obesity in
the female and childhood obesity populations. If it is true that decreased reward value
causes individuals who were obese as children and females to over consume palatable
foods, interventions that can stop over consumption should be focused on these
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populations. For example, strategies such as portion control at mealtime may be more
beneficial than total caloric restriction or exercise in these groups.
We next explored how intake of another rewarding substance, high fat diet, and
how it can regulate dopaminergic gene expression to elicit a decrease in reward
sensitivity. Mesolimbic dopamine and opioid signaling after sucrose consumption
determines the reward value of the sucrose solution. Dopamine signaling is mostly
involved with the “wanting” aspect of sucrose intake, while opioid signaling mediates the
“liking” aspect of sucrose intake (Mahler et al., 2011). In chapter 2 and 3 we see that
dopaminergic genes were down regulated by chronic high fat diet in a sex and age
dependent manner. However, because of the decrease in sucrose preference, we would
also predict a down regulation of opioid signaling in the same regions. In fact, our lab
has previously shown mu opioid receptor expression to be diminished after 20 weeks
high fat diet in the VTA and NAc (Vucetic et al., 2011). The earlier high fat models also
had more vulnerability in regards to changes in dopamine neurotransmitter levels. The
difference in COMT regulation after high fat diet intake could be the basis behind the
opposite regulation of dopamine (DA) neurotransmitter levels. It is also possible that the
differences in COMT could be in response to the changes seen in total neurotransmitter
levels. An earlier exposure to high fat diet also lead to decreased DA levels in VTA
projecting regions NAc and PFC. High fat from pre-adolescence caused an increase in
DA levels in these same regions. It seems that high fat diet from postnatal day 1
throughout lactation affects the expression of COMT, and therefore DA metabolism, in
an opposing trajectory than pre-adolescence HF. Being able to observe dopamine
circuitry at an earlier time point might give us insight to projections are developing at this
time that can change the trajectory of how the brain responds to high fat diet.
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Sex Differences
The ventral tegmental area was also a region where we not only saw an age
effect, but also a significant sex difference. Dopamine transporter (DAT) was regulated
by high fat diet in opposite directions in males and females. Chronic high fat diet caused
decreased expression of DAT in males and increased expression of DAT in females in
all of our DIO models. In chapter 2 we explored this sex difference further at the
epigenetic level. Levels of DAT reflect the general state of dopaminergic function in the
brain, and changes in DAT activity will alter dopamine function and dopamine dependent
behaviors (Jaber et al., 1997; Amsterdam et al., 2007). A down regulation in DAT, as
seen in DAT knockout mice, leads to an increase in dopamine levels and elevated
motivation for sweet foods (Pencina et al., 2003). Although motivation for palatable foods
was not assessed, elevated consumption of palatable food was seen in the DIO animals
only after acute HFD removal. Palatable food consumption was mostly depressed by the
presence of the high fat diet. However, females who received high fat earlier in life did
not significantly decrease their palatable food intake in the presence of ad lib high fat
diet. Additionally, pre-adolescent HF females reached binging levels of palatable food
intake when HFD was removed. The sex difference seen in DAT expression in response
to high fat diet may underlie the higher level of palatable food intake seen in preadolescent HF females. Indeed, it has been shown that female rats have a higher level
of total DAT protein in the nucleus accumbens and striatum than males (Becker, 1999).
It is also true that females are more sensitive to the rewarding effects of cocaine, a drug
that binds to DAT (Zakharova et al., 2009). DAT is an important pharmacological target
for obesity treatments as well as treatments for depression and attention-deficit
hyperactivity disorder (ADHD) (Sakrikar et al., 2012; Ledford et al., 2010).
Understanding the mechanisms behind how DAT expression is regulated in obesity will
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be important when treating both male and female populations. It was not previously
known that DAT was regulated by DNA methylation at the promoter region. Targeting
epigenetic machinery may be a new drug target with the ability to reverse reward deficits
seen in obesity. Insulin receptor/AKT/PI3kinase pathway also regulates DAT expression
and dopamine homeostasis (Speed et al. 2011). This is also a potential target pathway
where diet, hormones and metabolic sensing pathways intersect in the VTA and affect
dopaminergic function. Future experiments will be needed to see if the insulin/PI3Kinase
pathway is affected by high fat diet and converges on epigenetic proteins such as DNA
methyltransferase-1(DNMT1) and alters transcription.

Dopamine Receptor Balance
Interesting gene expression patterns were observed in the nucleus accumbens
and prefrontal cortex after high fat feeding. These areas are important for reward
behaviors and impulsivity and are implicated in the control of feeding behavior as well as
the administration of drugs of abuse. It has previously been shown by other labs that
dopamine receptor levels are down regulated in obese models (Johnson & Kenny 2010,
Ong et al., 2013, Alsio et al., 2010). We observed a down regulation in dopamine
receptor D1 and D2 in the nucleus accumbens and prefrontal cortex in males and female
mice on high fat diet in chapters 2 and 3. However we see a different pattern emerge
after a shorter period of high fat intake in chapter 4. Mice in chapter 4 were placed on a
40% fat, 41% carbohydrate diet at 9 weeks of age for 6 weeks total. In that model we
observed an increase in DR1 and DR2 in the nucleus accumbens and prefrontal cortex
in this model. Differences in expression may possibly be due to starting the diet even
later in life and for be maintained on diet for a shorter period of time. Additionally, a lower
percentage of fat (40% vs 60% of calories) was used over the 6 weeks and this
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exposure may not have been sufficient to down regulate dopamine receptors in these
postsynaptic regions as we observed in chapters 2 and 3. It has previously been shown
that 4 weeks of high fat feeding is insufficient to alter gene expression in the
hypothalamus (De Leeuw van Weenen et al., 2009). Future experiments looking at
earlier time points and different diet compositions will help us narrow down what
molecules are responding to the high fat diet itself and which are homeostatic
responses.
Dopamine impacts energy balance and reward behavior through activation of
both DRD1 and DRD2 receptors. In the prefrontal cortex, this balance of DR1 and DR2
was disrupted in an age and sex dependent manner. It seems that the post-weaning to
adolescence time period is critical in the development of normal dopaminergic circuitry in
the prefrontal cortex. The prefrontal cortex forms later in development and early
postnatal nutritional insults are poised to affect projections and proper synapse
formation. Decreases in DR2 levels may have implications for increased risk for
impulsivity and bingeing in obese individuals who were also obese as children. Drugs
that block DRD2 enhance appetite and induce weight gain in animals and humans (Ader
et al., 2005, Baptista et al., 2002). Lack of normal DR2 levels is associated with “reward
deficiency syndrome”, which elicits exaggerated response to reward in the face of
diminished signal transduction (Comings and Blum, 2000). Reward deficiency syndrome
increases the risk of engaging in compulsive activities such as gambling, eating, and
sex, and risk taking behaviors. These behaviors should be monitored in the obese
populations and may be become an issue when trying to calorie restrict. Total dopamine
levels (Giros et al., 1996), treatment by pharmacological agents (Buckland et al., 1992),
as well as external rewards, such as sexual activity (Melis et al., 1995), and exercise
(Foley et al., 2006) also all affect dopamine receptor expression level. We have since
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added to these findings and show that chronic high fat diet alters dopamine receptor
expression in a sex and time dependent manner.

Neurotransmitter Levels
Dopamine neurotransmitter levels were measured in nucleus accumbens nd
prefrontal cortex after high fat diet intake. We observed the early life high fat diet to be
important in altering neurotransmitter levels in adulthood; however diet exposure during
the lactation period seems to be different than exposure during post weaning. High fat
diet from birth leads to diminished DA levels in both males and females in adulthood,
while high fat from weaning leads to increased DA levels in adulthood. Both age groups
have diminished TH expression, however, opposite regulation of COMT expression in
the VTA of animals that began the diet at birth and animals who began the diet at
weaning. Looking at an earlier time point on the diet may give us clues to what is
specifically altered in the lactation period that drives DA in one direction and what is
affected in the post weaning period that drives DA in the other direction. We know that
the sensitive window for DA regulation is closed by 6 weeks of age because Adult HF
animal’s DA levels remain unaffected by high fat diet.

Palatable food consumption was affected by presence of ad lib high fat diet.
In order to assess if high fat diet increased the consumption of palatable foods
we gave mice access to high fat/high sugar food (peanut butter chips) for one hour every
day and measured their consumption. We saw that consumption of the palatable food
depended on the presence of ad lib high fat diet in both male and female animals.
Animals decrease their total daily intake and their one hour palatable food intake when
given high fat diet ad lib. Acute removal of the ad lib high fat diet causes normalization in
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males and a binge-like consumption of palatable food consumption in females. Animals
still had ad lib access to food and were not food restricted. Moreover, the acute removal
of high fat diet during the experimental period is not a sufficient amount of time to
reverse neuroadaptations seen in obesity. Therefore, we can see that the
neuroadaptations caused by high fat diet increase the risk of over consumption during a
diet withdrawal. Binge eating disorder is found in a subset of obese patients and is
associated with dopamine dysfunction in the frontal-striatal (Davis & Carter, 2009). It is
also thought that binge eating disorder arises in adolescence from development
abnormalities (Michaelides et al., 2012). It is possible that high fat diet during this time
can help program the propensity for bingeing later in life. Persistent changes occurring in
the prefrontal cortex, either in dopamine neurotransmitter levels or decreased dopamine
receptor levels could be the mechanism behind females reaching binge levels of
consumption (>25% daily calories). These findings have implications for obese
individuals trying to treat obesity with a low fat diet strategy and suggest that females
may find this strategy more difficult. Which specific neuroadaptations are responsible for
the increase in palatable food consumption are not yet known. These results highlight
the need for targeted studies investigating the mechanisms of palatable food intake in
both males and females.
Reversal of neuroadaptations by standard chow replacement depends on age of
diet onset and sex
We demonstrated that it is possible to reverse the neuroadaptations and
behavioral changes seen after high fat diet with a 4-week standard chow replacement.
However, in some cases, we observed a pattern of persistence that depended on both
age of diet onset and sex. A 4 week standard chow replacement was chosen as an our
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first obesity intervention. Four weeks was a sufficient length of time to reverse behavioral
adaptations but not a sufficient length of time to normalize body or fat pad weight. This
allowed us to look at the effects of high fat diet itself while animals remained significantly
heavier and did not go through the added stress of significant body weight loss. Sucrose
preference was an example of behavioral normalization in diet induced obesity models
before body weight returned to control levels. This suggests diminished sucrose
preference was attributed to presence or intake of high fat diet itself and not increased
body weight. The availability of high fat diet was also associated with diminished one
hour palatable food intake. Once ad lib diet was removed, animals normalized or
increased their one hour consumption of high fat/high sugar pellets. This down
regulation was consistent with the hypo reward hypothesis of obesity that predicts a
decreased reward value for food. However we do not see the risk of over consumption
until removal of the high fat diet. Although we demonstrated the ability to reverse
behavioral deficits, there were many instances where the neuroadaptations persisted
after high fat removal. Moreover, we found that sex and age were critical factors that
affected the persistence of these circuitry changes.

Dopaminergic Neurobiological Changes after Diet Removal
Many dopaminergic gene expression changes remained decreased after diet
removal and were associated with the overconsumption of palatable foods. Gene
expression after a 4 week standard chow replacement had an interesting pattern of
persistence and reversal that varied by sex, brain region, and age of onset. Overall, the
early high fat diet models seen in chapters 2 and 3 had a more persistent gene
expression phenotype than the adult HF model. Females who began HFD from birth
were less able to normalize gene expression changes in the VTA after standard chow
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replacement. This inability to normalize after a 4 recovery period was also seen in
dopamine receptors and DA neurotransmitter levels in the PFC of the males who began
the high fat intake from time of birth. This implies the lactation period to be a particularly
vulnerable period for male prefrontal cortex development and could have implications for
cue induced feeding (Petrovich, 2013), self control (Alonso-Alonso et al., 2007), and
food related decision making when “dieting” (Hare et al., 2009) in adulthood. One hour
consumption of palatable food was not assessed in the high fat from birth group. Future
studies will have to determine if high fat during lactation is a risk factor for over
consumption during a dieting period.
In chapter 3, we further assessed the impact of age on the persistence of high fat
diet brain and behavioral adaptations. We found that beginning high fat consumption
earlier lead to more persistent changes after a standard chow replacement period. Preadolescent HF males had reduced dopaminergic gene expression in the VTA and NAc
after standard chow replacement, while Adult HF males were able to normalize
expression. Pre-adolescent HF males also had increased amount of DA and DA
turnover in the NAc after standard chow replacement, whereas Adult HF males DA
levels were unaffected. There was also a persistence of diminished gene expression in
females who began the diet in pre-adolescence while adult HF females were able to
normalize.

Dopamine Receptor Expression after Diet Removal
Removal of the high fat diet in females lead to a dysfunctional balance of DR1
and DR2 in the NAc in both pre-adolescent and adult exposed groups. In both the NAc
and PFC, DR2 expression levels remained decreased while DR1 was able to normalize.
This disruption of positive and negative control in dopaminergic tone was associated
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with increase consumption of palatable foods. Females reached binge levels of
consumption (<25% caloric intake) after a standard chow recovery period and this is
possibly due to the increased risk of impulsivity that is associated with diminished DR2
tone (Johnson & Kenny, 2010; Noble, 2000). Withdrawing palatable food has previously
been shown to heighten craving and motivation for sucrose and high-fat food as well as
increase physiological and behavioral indices of anxiety (Sharma et al., 2013;
Teegarden et al., 2007). High fat diet caused lasting neurochemical and behavioral
changes related to dopaminergic function that have also been observed during chronic
drug administration and their withdrawal (Russo et al., 2009; Robinson & Nestler, 2011).
The diminished DR2 tone after HF withdrawal could have implications for altered
consumption of drugs of abuse. For example, rodents on a high fat diet have exhibited
reduced conditioned place preference for amphetamines (Davis et al., 2008), impairment
of cocaine self administration (Wellman et al., 2007) and an obesity-prone rat strain has
shown a reduced conditioned place preference for cocaine (Thanos et al., 2010).
Disruption of the dopamine circuitry is implicated in the loss of control seen in both
addiction and obesity (Volkow et al., 2011) and being able to reverse these
neuroadaptations may be the key to obesity therapy.

Switching to a lower fat or lower calorie diet is the first line of defense against
obesity; however, long term compliance on a new diet is the reason behind high failure
rates of “diets”. It is possible that the neuroadaptations that persist after long term high
fat consumption contribute to dietary relapse. Understanding how age and sex impact
brain and behavior in the high fat withdrawal stage will have implication for obesity
management and interventions. We know now that the obese brain is markedly different
than the lean brain and these changes can predispose one to overconsumption once
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high fat diet is removed. Since both pharmacological and behavioral therapies are often
combined with diet replacement, understanding the brain during this switch and factors
that can raise adherence rates will help the success of therapies in the future.
Exercise does not reverse reward dysfunction and neuroinflammation seen in
obesity
Our experiments in chapter 2 and 3 compared the physiologic, behavioral,
biochemical, and molecular alterations occurring after high fat diet intake and acute and
long term withdrawal in both males and females at different ages of exposure. We
demonstrated it is possible to reverse some of the neuroadaptations and reward
dysfunction that occurs in obesity by replacing HFD with standard chow. However, there
were some instances were adaptations persisted and this suggests that some
populations may be more resistant to central normalization with dieting. Chapter 4
explores exercise as an additional way to prevent the neuroadaptations caused by high
fat diet. Exercise has the ability to activate reward regions of the brain and alter reward
behavior (Bothe et al., 2013; Greenwood et al., 2011). Many of the studies
demonstrating the cognitive benefits seen after exercise were focused on the learning
and memory in the hippocampus. Exercise is now a potential treatment option for
addiction disorders (Smith & Lynch, 2011). However, it was previously unknown if
exercise could prevent the dysfunction seen in reward related regions in obesity. We
found that although exercise has the ability to reduce body weight in obese individuals, it
was not an optimal treatment for reward dysfunction in obesity. Exercise was unable to
prevent the increases in dopamine receptor expression and decreases in natural reward
consumption caused by high fat diet. This has implications for obesity treatment
regimes. Exercise alone would not be sufficient to treat reward dysfunction in obesity
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and additional therapies should be added. Our study examined exercise in conjunction
with a high fat diet; it is possible that a low fat diet is needed with exercise to prevent
reward dysfunction after high fat diet intake.
We also examined the ability of exercise to inhibit neuroinflammation seen in the
brain after high fat diet intake. Obesity is increasingly being linked with a sub-clinical
inflammatory state, as seen by higher than normal levels of pro-inflammatory mediators
such as the cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α in the
circulation of chronically obese individuals (Somm et al., 2006, Mantzoros et al., 1997). It
is now known that this is due in part to expanding adipose tissue, major source of
cytokines and cytokine-like hormones, such as leptin (Trayhurn & Wood, 2005).
Expanding adipose tissue and the high fat diet itself can both increase the production of
inflammatory markers. Although the cellular and molecular pathway underlying how the
high fat diet increases cytokine production are unclear, studies have demonstrated that
saturated fatty acids can directly stimulate TLR-4 (Milanski et al., 2009). If direct
stimulation of the inflammatory response is possible by fat molecules from the diet, an
intervention of exercise and a low fat diet, not exercise plus a continuation of the high fat
diet, should be the recommended way to combat neuro inflammation in obesity.
We observed that intake of high fat diet caused an increase in inflammatory
markers in the hypothalamus and prefrontal cortex. Inflammation in these regions could
disrupt feeding and reward behaviors and maybe even lead to problems with impulse
control. Exercise has many beneficial effects on the brain and is a first line of treatment
for obesity. Exercise has the ability to normalize expression of inflammatory markers in
the prefrontal cortex, but may have an additive effect in the hypothalamus. Exercise has
beneficial effects on adiposity in the periphery, but would not be able to decrease the
damaging effects of central inflammation. Exercise’s inability to normalize reward
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dysfunction and neuroinflammation has implications for future obesity treatments. It may
be recommended that individuals switch to a lower fat diet while exercising or use
supplementation with anti-inflammatory medications during intervention. We observed
an interaction with exercise and high fat in some brain regions. However, studies show
that the quality of fat in the diet is just as important as the quantity. The ratio of
arachidonic acid (AA) to docosahexaenoic acid (DHA) is important for pro-and antiinflammatory processes, and supplementation with DHA may be beneficial for the
treatment of neuroinflammation (Bazan, 2005; Serhan, 2005). The experimental diet was
high in saturated fat to match the western diet eaten by people today. It is now known
that diets rich in saturated fat increase oxidative stress in the brain (Stranaham et al.,
2011) reduce neurogenesis (Lindqvist et al., 2006), and enhance neuroinflammation
(Thaler et al., 2012). It could be recommended in the future that if individuals are to
remain on high fat diet while exercising, DHA or fish oil supplement is necessary to
prevent the exacerbated inflammatory response seen in certain brain regions.

High fat diet and exercise cause lasting changes in gene expression possibly
through the recruitment of epigenetic machinery.

Results from these experiments demonstrate that early life nutrition can have
long-lasting genetic and behavioral consequences that are linked to alterations of the
epigenetic state. Our results suggest that there may be multiple sensitive windows
throughout development that can change the trajectory of reward circuitry development.
One way a sensitive window could occur is through chromatin remodeling over
development leaving some genes open for both transcription and modification of
transcription levels. Some genes may no longer be vulnerable as the brain develops and
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some might continue be vulnerable way into adulthood. Another important factor
determining sensitive windows would be the timing of development of each specific brain
regions. The PFC continues to develop throughout adolescence and maybe open to
remodeling later in life, whereas a more caudal region like the VTA is fully developed.
For instance, we observed high fat from birth lead to increased DNA methylation at the
DAT promoter region in the VTA. On the other hand, a different stimulus of short term
exercise beginning at 9 weeks of age increased DNA methylation at DR1 and MOR
promoter in the cortex. We also observed more persistent dopaminergic gene
expression changes in the prefrontal cortex of early high fat from birth than in the PFC of
animals receiving high fat from adulthood. Each brain region has different levels of
plasticity and sensitive time periods that can alter the developmental trajectory of
neurotransmitter system will vary over space and time.
Epigenetics is viewed as the way through which the environment interacts with
an individual's genome to determine aspects of gene expression. A subset of
epigenetic changes is very stable, which makes them ideal mediators both of reward
system vulnerability and of the long lasting drug or food-induced brain maladaptations
that underlie an addiction disease. DNA methylation was classically thought of as a
very stable means of gene repression (Klose & Bird, 2006). However we show that
DNA methylation at the DAT promoter region was reversible with 4 week standard
chow replacement in males starting high fat from birth. The de-methylation step may
be an additional hurdle to overcome before gene expression can return to normal
levels. This time needed to demethylate the promoter region could account for the
persistence of gene expression changes seen in pre-adolescent high fat animals after
standard chow replacement. How the high fat diet and exercise interact with DNA
methyltransferase on a molecular level is currently unknown. However, identifying
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sensitive windows for epigenetic modification can point to time periods where drugs
acting on these pathways may be more beneficial and prevent chronic illnesses, like
obesity, in the future.
We demonstrated that exercise was unable to reverse the dysfunction in natural
reward intake seen after high fat diet consumption. In fact, exercise alone reduced
sucrose preference similar to high fat diet. Since exercise and high fat are both
rewarding and increase dopamine levels in the mesolimbic region of the brain, it is
possible they elicit neuroadaptations through a similar pathway. One common
mechanism that exercise and high fat diet may converge on is regulation of DNA
methylation at promoter regions to elicit gene expression changes. Exercise and high fat
intake do not alter global DNA methylation, however global methylation assays detect
intergenic and genome wide levels of methylation. Exercise and high fat seem to work to
alter DNA methylation at the promoter region to regulate gene expression in the specific
genes we examined. It is possible that other genes promoters were altered by DNA
methylation in a similar manner even though global methylation levels remained
unchanged.
DNA methyltransferase 1 (DNMT1) is involved mainly in maintaining existing
DNA methylation patterns and its activity is regulated by phosphorylation. The N-terminal
region of Dnmt1 is known to interact with various proteins, such as methyl-CpG-binding
protein 2 (MeCP2),and various protein kinases (Kamesita et al., 2008). Further
molecular studies are needed to analyze the specific pathways involved in both high fat
and exercise that converge on DNMT1 to regulate gene expression. One possible
upstream pathway previously shown to be involved in both reward mechanisms and
epigenetic modulation would be the PI3Kinase/AKT phosphorylation cascade that can
activate DNMT1 (Speed et al., 2011; Mei et al., 2010; Day et al., 2013). Understanding
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this pathway could give us new potential targets for the treatment of obesity and its
associated reward dysfunction. Our results on both diet withdrawal and exercise suggest
new directions in the development of more successful therapies for obesity prevention.
We demonstrated the importance of finding additional obesity interventions and further
appreciate the potent rewarding effects of both palatable food and exercise on the brain.
Limitations

Other Neurotransmitter Systems
As we attempted to answer how age and sex affected the response to high fat
diet and the response to obesity intervention such as high fat withdrawal and exercise,
many more questions were created in the process. The hypo reward hypothesis of
obesity predicted the diminished sucrose preference we observed after high fat diet,
however we did not find a good candidate gene that predicted diminished sucrose
followed by reversal after a standard chow replacement. This could be because the
rewarding aspects of sucrose come from both dopamine and the endogenous opioid
system. Our lab has previously shown diminished MOR levels after high fat diet that was
associated with increases in DNA methylation at the promoter region (Vucetic et al.,
2012). However, it is currently unknown how MOR may respond to a standard chow
replacement. Levels of MOR in the withdrawal period would give us a better
understanding of both sucrose preference and one hour palatable food intake. Moreover,
sucrose preference and palatable food consumption do not give a full picture of the
“wanting” aspect of reward. Experiments such as progressive ratio training can be
compared to dopaminergic gene expression and help us better understand the
motivational state of being on and off the high fat diet.
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Functionality of Gene Expression Changes
Examining the full functionality of gene expression changes was also a limitation
of this set of experiments. Dopamine receptors were altered in response to high fat diet;
however, we did not see any alterations in dopamine receptor signaling. There was no
difference in response to a DR1 agonist locomotion or c-FOS induction (data not
shown). However, a dose response to DR1 agonist was not performed and it is possible
we may see differences in sensitivity to DR1 agonist at additional doses in future
experiments. Additionally, it is known that dopamine receptor mRNA levels can change
in response to increasing or decreasing dopamine neurotransmitter levels in the
examined regions. Downstream signaling at the c-FOS induction step could have been
up regulated to account for the decrease in receptor levels and the response remained
at normal levels. There were no functional experiments performed for DR2. DR2
signaling is extremely important for over consumption behaviors and analyzing DR2
signaling in addition to mRNA levels would have given us a richer picture of the reward
system on high fat diet.
Sex Hormones
An additional limitation to this study is the unknown level of sex hormones in
animals at time of diet onset. We can assume that animals beginning high fat diet at birth
had lower levels of both estrogen and testosterone than animals in adulthood. The
differences we see between age of onset and sex could be due to a complex interaction
with levels of sex hormones changing throughout life. All animals were adults during
data collection and measurements occurred at the same time each day to minimize
variance that occurs across the circadian cycle. One future way to incorporate hormone
levels into the analysis would be to measure both estrogen and testosterone at start of
diet onset and see if hormone level correlates with body weight changes and gene
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expression changes in adulthood. One way to control for variations in hormones over
time would be to monitor female cycling and only take measurements of females in the
same point of the estrus cycle. Since we know estrus cycle is important for
administration of drugs of abuse, like cocaine (Roberts et al., 1989) it may also be
important for the intake of sucrose or palatable foods. We saw that both early life and
adult exposed females had reduced sucrose preferences and increased levels of DAT
expression after high fat diet intake. Seeing if these sex differences remain at all time
points of the estrus cycle or in ovarectomized animals will give us insight into the
importance of sex hormones in the central response to high fat diet.

Obesity Resistant Animals
Another limitation to this study was not observing metabolic and behavioral
effects before onset of diet. When mice are placed on a high fat diet, often times there
are some obesity resistant animals as well as highly obesity prone animals in the group.
Examining the behavioral correlates in the two extremes (obesity resistant and obesity
prone before and after chronic intake would have been another interesting and
informative way to analyze the data. We did not find a high level of obesity resistant mice
in our experimental model in order to power the proper analysis. This could have been
due to the high level (60%) of dietary fat eaten, which is known to quickly drive obesity in
our mouse strain. Obesity resistant animals may be more prevalent at a lower level of
dietary fat obesity model. Even without this analysis, our results provide possible risk
factors that may predict adherence to dietary intervention.
Analyzing the time point before diet intake would have provided us with additional
risk factors that predict extreme obesity and hyperphagia or factors that predict obesity
resistance at different times of development. Looking at metabolic and adiposity data at
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earlier time points on the diet could have provided us with further understanding on
adiposity development in younger aged mice. Both brain development and fat cell
development are occurring at the same time. It is possible that early life adipose tissue is
just as vulnerable to the nutritional environment as the brain. If beginning high fat diet
earlier in life leads to more or less fat cells that could mean possible differences in leptin
signaling to the reward regions and therefore an altered dopaminergic tone.

Lactation Period
Chapter 2 examines the response to high fat diet and withdrawal in animals
exposed since birth. One confounding factor of this study is availability of the high fat
diet during the lactation period. This would mean the mother was also exposed and the
offspring were receiving the high fat diet through the mother’s milk. It is difficult to
compare the diet induced obese animals in chapter 2 with the other experimental models
in chapters 3 and 4. The data are still extremely valuable because of how important the
lactation period is for the developing brain. However, it is difficult to tease apart the
maternal diet and the effects of the high fat diet in offspring when looking at data later in
adulthood. We controlled for this confounding factor in later experiments and compared
high fat beginning from weaning and high fat beginning at six weeks of age.

Age of Exercise Exposure
In chapter 4 we examined both a short term and long term exposure to exercise
and its effect on behavior, dopamine receptor levels, and neuro inflammatory markers.
We also examined the interaction of long term exercise with long term high fat diet. One
limitation to this study is not being able to compare the high fat diet effects in chapter 4
with the high fat diet effects observed in chapters 2 and 3. Animals in the exercise and
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high fat diet study received different diet composition, had a shorter length of time on the
diet, and began intake at a much later age (9 weeks). The differences in results from our
exercise model compared to our other DIO models highlights how important it is to
control for all these variables in future studies.
High Fat Diet Composition
The composition of the diet is another limitation of these experiments. Animals
received ad lib exposure to 60% or 40% high fat diet. Although these diets quickly and
reliably drive obesity, these formulations are not an exact model of the modern diet. The
typical American diet is 50% carbohydrate, 15% protein, and 35% fat (Last et al., 2006)
and people are provided with a wide variety of choices. There is also the enormous
presence of food cues to consider, such as advertisements and cultural norms weaved
throughout the day that can prime the individual and increase the consumption of food. It
has been demonstrated that humans habituate when given the same food items and
decrease intake when presented with them daily. But when presented a variety of food
choices, people tend to increase their intake (Epstein et al., 2011). We observed a
similar phenomenon in our animal models. Animals on the ad lib 60% high fat diet have
decreased daily intake of their ad lib chow (data not shown). However, when the diet is
removed, and they are presented with a new palatable food choice, they rapidly
normalize or increase their intake. This decrease of high fat diet intake after 12 weeks
means that animals may be habituated or “bored” with the diet. The habituation to the
diet could be a factor of the hypo-reward state of obesity or a parallel characteristic.
Other labs have used a “cafeteria” diet that may mirror the variability seen in modern
human diet better than the homogenous 60% diet used in our study. If further studies
show that a variety of tastes increase energy intake and drive obesity, this could have
implications for school menu planners, public health officials, a nutritionist that find
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combating obesity important. Suggesting that people stick to a routine and the same
foods may be a good strategy, in conjunction with caloric restriction and exercise, for
obesity treatment.
Interaction between Voluntary Exercise and High Fat diet
No previous study has examined the interaction of high fat diet and exercise in
reward regions of the brain or the interaction with regard to neuro inflammation. Since
both palatable food consumption and physical activity have actions at the mesolimbic
dopaminergic system, our attention focused on the influence of chronic exercise in the
prevention of the neuroadaptations seen in obesity. However, we found that exercise
had its own effects on reward behaviors and the dopaminergic gene expression.
Furthermore, we did not find any strong effect of exercise or high fat diet on anxiety
behavior; although this has been shown in other models. This could be due to
differences in rodent species, housing conditions (singly versus communal), duration of
exercise, and exercise intensity. One big limitation of this study was lack of information
on the length and distance the animals ran. Animals were given voluntary access to the
running wheel and there is a chance that some animals did not obtain sufficient amount
of exercise per day in order to see behavioral changes after 6 weeks of exposure.
Although a large amount of exercise is not necessary to see behavioral effects. In fact,
previous studies have shown that a minimum of 8 wheel revolutions per day was enough
to increase leptin sensitivity and decrease body weight on a control diet (Shapiro et al.,
2011). One way to control for variation between running animals would be to use forced
running instead of voluntary running so all the animals have equivalent speed,
frequency, duration, and intensity of exercise exposure. Forced exercise is often
thought to be an added stressor to the animal. However, other researchers have
suggested that forced exercise more closely models the average human exercise
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regimen, while a voluntary exercise may only model highly motivated endurance athletes
(Leasure et al., 2008). Data on intensity of exercise and distance travelled could help
stratify the analysis into high and low volume runners and we would possibly see
predicted anti-anxiety effects.

Sex Differences in Exercise Response
Another limitation to the exercise study is that it was only performed in males. We
have seen from chapters 2 and 3 that there are many sex differences in response to
high fat diet and would predict sex specific responses for exercise exposure. Other labs
have shown sex specific responses to exercises, such as the reduction of cocaine
administration after exercise in females (Cosgrove et al., 2002). Voluntary wheel running
has also been shown to increase extinction and attenuate reinstatement of cocaine selfadministration in adult female rats (Zlebnik et al., 2010). These results suggest that
females may benefit more from exercise in abolishing reward dysfunction after high fat
diet intake. Further studies in female mice are needed to confirm this prediction.

Additionally, it is possible that exercise may have a more beneficial effect in
prevention of reward dysfunction before high fat diet onset rather than concurrently with
high fat diet intake. One important experiment would be to see if exercise exposure in
adolescence prevents future reward dysfunction when placed high fat diet in adulthood.

Implications	
  and	
  Conclusions	
  

As the number obese individuals continue to rise every year, many people are
seeking answers for why so many people struggle with overconsumption and why there
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are such high failure rates for weight loss. Although obesity is the consequence of
imbalanced caloric intake and energy expenditure, diet and exercise alone have not
been enough to combat most cases of obesity. Decreased caloric consumption and
increased physical activity can be effective in normalizing weight in the short term;
however these lifestyle modifications have proven very difficult to sustain (Volkow et al.,
2007). When attempting to diet, obese individuals initially lose weight; however, this
weightloss slows down until about an average of six months where then weight begins to
return back to baseline (Jeffery et al., 2000). Adherence to the weight loss strategy is the
most difficult part to curing obesity and individuals often “relapse” back to old, unhealthy
eating habits (Knowler et al., 2009). Current pharmacologic treatments for obesity have
failed to adequately address the problem and seem to only have short term benefits
(Yanovski, 2005). Our experiments suggest that the obese brain is markedly different
with than the lean brain and changes along with BMI changes. Drugs that work in the
short term may no longer be effective after significant weight loss. We also
demonstrated that sex differences and age of obesity onset are other potential factors
behind the failure rates of pharmaceutical interventions. Characterizing how the
dopamine system responds to the development of obesity and to obesity interventions is
important for understanding what factors lead to increased success rates in weight loss.
The development of effective weight loss interventions requires a thorough
understanding of the factors that drive and/or prevent the overconsumption of palatable
food. Obesity is increasingly recognized as a behavioral disorder and certain
populations, such as females and adults who were obese as children, may benefit from
adjunct behavioral strategies to combat over consumption.
We demonstrated that early life periods such as lactation and pre-adolescence
periods in the mouse are important factors in the response to high fat diet and
	
  

158	
  

intervention. High fat diet caused more neurochemical and gene expression changes in
the dopamine system if started earlier in life. These changes tended to be more
persistent and may put adults who were obese as children at increased risk for failure
when attempting to diet. The lactation period in the mouse is not equivalent to the
lactation period in humans because of the timing of brain development. The lactation
period in mice is more equivalent to the third trimester in humans. This has potential
implications for pregnant mothers to maintain healthy eating habits throughout
pregnancy and for parents and schools to help instill healthy eating habits in their
children.
As adults, the most important issue is maintaining the weight reduction. Our
results have implications for adults who were obese as children and are beyond the
preventative stage. It might be beneficial for this population to know that reversal of
central dysfunction might take longer than the rest of the population, and additional
strategies may be required when trying to lose weight. For instance, psychotherapy
could be useful to help combat dysfunctional reward behaviors in combination with diet
and exercise. The view that obesity is caused by a lack of willpower or poor self-control
is extremely prevalent, and promotes the stigmatization of overweight and obese
individuals. These results demonstrate that the high fat diet itself is acting on the brain to
change it and promote overconsumption. High fat diet can activate epigenetic machinery
to make these changes last very long and be more difficult to reverse. In addition to the
scientific value of these studies, further promoting that obesity is a disease caused by
environmental factors similar to addiction, may help the psychology of obesity patients
and direct attention away from the poor “character” or “morality” stereotypes that are
associated with the obese state.
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Our results demonstrate that high fat diet has the ability to cause
neuroadaptations in the reward pathway such as changes in gene expression and
dopamine neurotransmitter levels. Altering levels of dopamine and dopamine signaling
may have implications in drugs acting in on these proteins. It is possible that if tested
under the right conditions, we would see an altered response to drugs such as cocaine
and amphetamines. We would predict a decrease in the rewarding effect of cocaine in
males and increase in the rewarding effect of cocaine in females. This can be tested
through cocaine place preference or progressive ratio tests for cocaine administration.
Furthermore, increases or decreases in dopamine transporter levels seen after high fat
diet would also have implications for drugs already on the market that target this protein,
such as methylphenidate and bupropion, used in the treatment of Attention Deficit
Hyperactivity Disorder (ADHD) and depression. This may have implications for treating
obese patients and they may need different dosing schedules that depend on sex and
age of obesity onset. The link between obesity and depression has been repeatedly
established (Luppino et al., 2010). We see that high fat diet affects the pathway
implicated in both addiction and major depression. Researchers looking to target
dopaminergic proteins in these regions for obesity treatment will have to be cautious of
the potential addictive or depressive effects that can occur. In fact, in the case of
Rimonabant, this anti-obesity drug failed to make it through clinical trials because of the
increase in suicide rates that were associated with its usage.
Obesity is a complicated state that is associated with increases in adiposity,
changes in hormone levels, inflammation, and neuroadaptations that affect the
homeostatic and hedonic food intake systems. We see from our study that just one
intervention may not be sufficient to prevent all these symptoms. Although both exercise
and dieting have beneficial weight loss effects, they may not be optimal treatment on
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their own in curing the reward dysfunction and neuro-inflammation occurring after high
fat diet. Combinations of treatments together or at different time points may be the most
effective way to treat obesity. Additionally, as BMI decreases due to intervention, other
adjunct therapies may be necessary. Experiments studying how the brain changes in
response to high fat diet and weight loss will help us work out the optimal age and sex
specific targets for treatment.
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